syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.521265784	57.07203569796753
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.7205421218767
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
OBESITY	1.00390625	37.662697695574224
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.51615023372374
PLUMMER-VINSON SYNDROME	1.0	37.51615023372374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
DIABETES MELLITUS, NONINSULIN-DEPENDENT	1.0	37.51615023372374
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.91443075	34.305921395336675
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.910586896276513
EARLY MYOCLONIC ENCEPHALOPATHY	0.70941035	26.61434526795854
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.69456067	26.05724244215582
ROLANDIC EPILEPSY	0.6461769	24.242069657961885
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	22.28340772848452
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.5833333	21.884419719133845
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517787982	19.425411721928647
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.515429128	19.336916600885225
XQ12-Q13.3 DUPLICATION SYNDROME	0.511011184	19.17117235005705
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50969036	19.121620118440738
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50969036	19.121620118440738
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50390625	18.904622578712356
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5030581	18.872803255891622
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.501811934	18.826051905019465
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.500961538	18.794148320925306
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.778387073405263
CREST SYNDROME	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.5	18.75807511686187
RESTRICTIVE DERMOPATHY	0.5	18.75807511686187
RHYNS SYNDROME	0.5	18.75807511686187
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.75807511686187
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
CITRULLINEMIA TYPE II	0.47673141899999993	17.8851275363403
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.44703715000000005	16.7711128794557
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.43717484000000006	16.401116975844143
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.4242421	15.915930359070451
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42357369	15.890854189092728
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42126578400000003	15.804270440871418
SPINOCEREBELLAR ATAXIA TYPE 10	0.409852838	15.376100644126039
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38965680999999996	14.618423423553548
PLACENTAL INSUFFICIENCY	0.38310061	14.372460039391207
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.38140101	14.30869759045397
PERIORAL MYOCLONIA WITH ABSENCES	0.36508484399999996	13.696577855559594
CHROMOSOME 17Q12 DELETION SYNDROME	0.36241398399999997	13.59637747054635
CHROMOSOME 5Q12 DELETION SYNDROME	0.35808819099999994	13.43409037047836
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
MENTAL RETARDATION, X-LINKED 12; MRX12	0.353337972	13.255880440831275
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348302828	13.06698122207884
COG4-CDG	0.3480389	13.057079659579953
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.347540762	13.038391439534827
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.345529884	12.962951038385137
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.343806829	12.89830864814417
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34326541	12.877996691600776
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.34268041	12.856049743714049
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34037525	12.769569014841279
PREECLAMPSIA	0.33962231	12.741321604684297
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.3369133429999999	12.639691591734096
OROFACIODIGITAL SYNDROME TYPE 3	0.33643859	12.621880686862186
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.33462	12.553654191208638
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.33385793399999997	12.525064408664624
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.333333	12.505370905857834
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31619084399999997	11.862263206031907
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.301697398	11.318524908491545
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.2760734	10.35721114993491
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.2760734	10.35721114993491
PALLISTER-HALL SYNDROME	0.274334434	10.291971840227571
ESOPHAGEAL ATRESIA	0.27222219999999997	10.212728952154789
DISTAL MONOSOMY 12Q	0.268661872	10.07915915202546
BETA-KETOTHIOLASE DEFICIENCY	0.263140429	9.872015866930518
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.25609701900000004	9.607774239212805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255609334	9.589478175486072
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	9.477765059386003
LYSINURIC PROTEIN INTOLERANCE	0.251811934	9.447014346588528
DYSTONIA 6, TORSION	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430936
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	9.379037558430936
HEMOPHILIA B	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
SEVERE HEMOPHILIA A	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
TRICHOTHIODYSTROPHY	0.24489508800000004	9.187520912908997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24302453400000001	9.117344928024703
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23852347200000001	8.9484824098214
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.23628216900000001	8.864397349754103
LENNOX-GASTAUT SYNDROME	0.23309624399999998	8.744873708820727
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.22440085	8.418656001175307
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.22433443400000003	8.416164328541385
GITELMAN SYNDROME	0.22350960000000003	8.385219732279502
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075037
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.220732694	8.281040909598572
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.2192308	8.224695628659443
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.218319744	8.19051631489211
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.216493709	8.12201051150007
COHEN SYNDROME	0.215213751	8.073991414879215
KEPPEN-LUBINSKY SYNDROME	0.21485176900000003	8.06041124378531
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.21344093000000003	8.007481995905714
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.212989481	7.990545367398849
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2117647	7.944596299399438
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.20520833000000002	7.69862653749156
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002378
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.204783931	7.682704720848517
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.202188528	7.58533519198346
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.20152905000000002	7.560594116259624
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095553
ROMANO-WARD SYNDROME	0.200541419	7.523542003288142
PITUITARY GIGANTISM	0.2	7.50323004674475
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	7.50323004674475
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	7.50323004674475
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.50323004674475
X-LINKED ACROGIGANTISM	0.2	7.50323004674475
MYOCLONIC EPILEPSY OF INFANCY	0.18379836	6.89540688647204
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18379836	6.89540688647204
PFAPA SYNDROME	0.18064726	6.777189745470554
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17994293	6.750765995376436
EHLERS-DANLOS SYNDROME, TYPE VI	0.179537528	6.735556873039384
ACUTE ADRENAL INSUFFICIENCY	0.17493073900000003	6.562727884820319
ADDISON DISEASE	0.17370374900000002	6.516695943645042
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.172902528	6.486637216238626
GRANULOMATOSIS WITH POLYANGIITIS	0.172416749	6.4684126582942385
PEMPHIGUS VULGARIS	0.17187533000000002	6.448100701750846
UNILATERAL POLYMICROGYRIA	0.17105979999999998	6.417505155750735
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.16992188100000002	6.374814815592929
GITELMAN SYNDROME	0.168495419	6.32129945289823
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.168478934	6.320680999161627
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004036
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004036
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	6.252704211004036
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16599404999999998	6.22745771770425
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164135494	6.157731851590461
PRADER-WILLI SYNDROME	0.162478369	6.095562901134403
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.16127993399999999	6.05060223362905
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
ACROOTOOCULAR SYNDROME	0.15732986	5.9024106640107235
WRINKLY SKIN SYNDROME	0.15716734999999998	5.896313914436241
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.155893848	5.848537022081294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15531283799999998	5.826739763633997
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.7068164631521805
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	5.674706390167137
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.15056904899999998	5.64877106283291
1P21.3 MICRODELETION SYNDROME	0.14982135	5.620720274819306
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14975354999999999	5.61817667983346
DE BARSY SYNDROME	0.14973809	5.617596680150847
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14925097800000003	5.599322113178198
CHRONIC HICCUP	0.14806533	5.554841164685883
BRAIN-LUNG-THYROID SYNDROME	0.14720209999999997	5.5224560983196245
CONGENITAL MYASTHENIC SYNDROME	0.14545240299999998	5.4568142028041295
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.14545240299999998	5.4568142028041295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14495823800000002	5.438275034423882
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.144144	5.407727959289875
COMBINED SAPOSIN DEFICIENCY	0.143818538	5.395517878002507
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.143381934	5.379138176745862
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	5.3594446739390715
CHOANAL ATRESIA	0.14285699999999998	5.3594446739390715
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.133003634	4.989784314775208
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.122219064	4.585188766449097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12133179799999999	4.551901961895822
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.12115313000000001	4.5451990263658635
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12106874000000001	4.54203303844764
PRADER-WILLI SYNDROME; PWS	0.12029926700000002	4.513165373778846
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11867818399999999	4.452348580409509
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
AICARDI SYNDROME; AIC	0.117369528	4.403252845309245
TEMPLE SYNDROME	0.11668989800000001	4.3777557441259
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11484722400000001	4.308625709510124
15Q OVERGROWTH SYNDROME	0.11309986899999999	4.243071676818475
BILATERAL POLYMICROGYRIA	0.11305566000000002	4.241413125332793
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.11120909100000001	4.172136965311855
INSULINOMA	0.110681319	4.152336991670702
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.10995650000000001	4.125144573174445
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.10881664	4.082381414169032
PRADER-WILLI-LIKE SYNDROME	0.107972813	4.05072427366576
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.106776594	4.005846741949325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10673824400000002	4.0044079975878635
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.105269784	3.9493170316156485
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.10507549	3.9420278687221364
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.104793474	3.931447714097823
MODY	0.10463885	3.925646816884084
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.10408483800000001	3.9048624194607986
AROMATASE DEFICIENCY	0.09900425000000002	3.714258316777144
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.09876743	3.7053737420787938
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326815
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.6811540658109063
WILSON DISEASE	0.097929364	3.6739327321170174
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.0978836	3.672215843017721
LEPRECHAUNISM	0.09770855	3.6656486409193083
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.09653641400000001	3.621674610648953
INSULIN-RESISTANCE SYNDROME TYPE B	0.09611743	3.6059559439594255
ADRENOCORTICAL CARCINOMA	0.09611743	3.6059559439594255
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.096089589	3.6049114568207683
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09596549999999998	3.6002561152544152
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.09565069999999999	3.588446031160839
SCHINZEL-GIEDION SYNDROME	0.09560006000000001	3.5865462133130044
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.09545965000000001	3.581278570658687
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.09544160000000002	3.5806014041469685
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.09544160000000002	3.5806014041469685
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09445900900000001	3.5437383725726637
SMITH-MAGENIS SYNDROME; SMS	0.09293699100000001	3.486638116626232
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.09197545300000001	3.4505649125627973
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0909091	3.410559453212615
HEPATIC VENO-OCCLUSIVE DISEASE	0.0909091	3.410559453212615
HELLP SYNDROME	0.0909091	3.410559453212615
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.09032868399999999	3.388784479358558
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.09032868399999999	3.388784479358558
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.09003566900000001	3.3777916845978235
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.08994645000000001	3.374444531190121
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.08975706900000001	3.367339685142708
49,XXXYY SYNDROME	0.08792327400000002	3.2985427564248577
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.08711866000000001	3.2683567367207
YUNIS-VARON SYNDROME	0.086287998	3.237193496335254
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.08627051000000001	3.236537413899967
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0861345	3.2314348423066774
49,XYYYY SYNDROME	0.08508522400000001	3.1920700462540377
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.08486235000000002	3.183708671786847
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.08486235000000002	3.183708671786847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.083884438	3.1470211782794846
YUNIS-VARON SYNDROME	0.08381965000000001	3.1445905819381426
ISOLATED BILIARY ATRESIA	0.083753829	3.142121231413608
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.083693588	3.1398612210073784
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08337539000000001	3.127923657035309
OVARIAN DYSGENESIS 8; ODG8	0.08333330000000001	3.1263446022719714
PRIMARY DYSTONIA, DYT4 TYPE	0.08333330000000001	3.1263446022719714
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.08280545	3.1065417023711
RAMOS-ARROYO SYNDROME	0.081513074	3.058056730196641
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.081000237	3.0388170602592286
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.08082935000000001	3.0324060378942383
BARDET-BIEDL SYNDROME 21; BBS21	0.08082935000000001	3.0324060378942383
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.08082935000000001	3.0324060378942383
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.08057010900000001	3.022680313591498
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0799812	3.0005867150735055
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0797842	2.993196033477462
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.07941368800000001	2.9792958496220647
16P13.2 MICRODELETION SYNDROME	0.07927645300000001	2.9741473207447395
KENNERKNECHT SYNDROME	0.07897708400000002	2.9629161483654203
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07869265	2.952245279689841
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.078484788	2.944447097669958
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.077884638	2.9219317801071893
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.07692310000000001	2.885858576043755
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.07692310000000001	2.885858576043755
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07692310000000001	2.885858576043755
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.07692310000000001	2.885858576043755
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.074340564	2.788971767483755
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.780987805487915
MARFAN SYNDROME	0.07331114	2.750351742045554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07291507200000001	2.735492795454784
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.07247295	2.718906080081149
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.072286361	2.7119059791251887
KEUTEL SYNDROME; KTLS	0.072077819	2.704082286123148
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07206639999999999	2.7036538892036286
TUBEROUS SCLEROSIS COMPLEX	0.07205513399999999	2.7032312322550953
WERNER SYNDROME	0.07204970000000001	2.703027369494726
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071798093	2.693588043482869
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.67972608858456
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.653582584132687
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.070481	2.644175784623083
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.070142228	2.6314663633761044
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.070142228	2.6314663633761044
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06891523799999999	2.585434422200827
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.068249338	2.560452417760191
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067628238	2.537151136850025
CITRULLINEMIA TYPE I	0.067551459	2.5342706843512297
WHITE-SUTTON SYNDROME; WHSUS	0.067343052	2.5264520560294703
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.066868353	2.508643177029672
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06684269100000001	2.507680437582374
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
STICKLER SYNDROME	0.06641459	2.4916197361511667
EMANUEL SYNDROME	0.065878901	2.4715227471486134
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.065339734	2.4512952769755474
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0653291	2.4508963302339617
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
CHROMOSOME 1P36 DELETION SYNDROME	0.06424412099999999	2.410192095069526
KAGAMI-OGATA SYNDROME	0.063582213	2.3853598551006225
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.06259785000000001	2.3484303449081043
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
CHRISTIANSON SYNDROME	0.0624202	2.341765600819083
MEIER-GORLIN SYNDROME 1; MGORS1	0.062261894	2.335826569140183
CONGENITAL ANALBUMINEMIA	0.06207722	2.3288983116119204
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.061971169	2.324919686363484
KNIEST-LIKE DYSPLASIA, LETHAL	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
MOMO SYNDROME	0.060614153	2.2740096702379167
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.2523158438168154
LUSCAN-LUMISH SYNDROME; LLS	0.059532981	2.233448259057421
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.059461850000000004	2.2307796977751466
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.059461850000000004	2.2307796977751466
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.059153990000000004	2.219229975764192
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.058613700000000005	2.1989603749544133
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.057609584	2.161289808246327
DISTAL MONOSOMY 7Q36	0.057324009	2.150576133643332
THAUVIN-ROBINET-FAIVRE SYNDROME	0.057170599999999995	2.1448208185521267
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.057170599999999995	2.1448208185521267
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.1325155212754656
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.120305439988097
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.056386034	2.115386922627855
ZUNICH NEUROECTODERMAL SYNDROME	0.05612942099999999	2.105759790767928
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.056080534	2.1039257387314523
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.056080534	2.1039257387314523
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.056080534	2.1039257387314523
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.056080534	2.1039257387314523
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.055555600000000004	2.084232235924663
GRANGE SYNDROME	0.055555600000000004	2.084232235924663
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.055555600000000004	2.084232235924663
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.055555600000000004	2.084232235924663
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.054820127999999996	2.0566401578799653
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.054712549	2.0526042079539715
SHPRINTZEN OMPHALOCELE SYNDROME	0.053807928	2.0186663106133906
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.053593138	2.010608216704689
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.05282775	1.9818938055095996
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.052704438	1.9772676139919783
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.052645449999999996	1.9750546113219913
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412546
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412546
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9745350126412546
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.05232459	1.963017179357999
PEHO SYNDROME	0.05231289	1.9625782404002645
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052222132	1.9591733496373522
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.05188166	1.9464001509349758
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051482088	1.9314097477537862
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.051280200000000005	1.9238356872154003
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MAN1B1-CDG	0.050336759	1.8884414129227458
SLC35A2-CDG	0.05006959	1.8784182605809516
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04984660999999999	1.8700529094018359
ERYTHERMALGIA, PRIMARY	0.0494995	1.8570306784942086
FAMILIAL THROMBOCYTOSIS	0.049228049	1.8468468819971142
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.048809500000000006	1.8311445348329392
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.048568964000000006	1.8221205501203201
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.820707541837917
PELIZAEUS-MERZBACHER DISEASE	0.048063433	1.8031549731765155
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.04804732799999999	1.8025507755770012
SILVER-RUSSELL SYNDROME	0.04802755	1.8018087811576786
BECKWITH-WIEDEMANN SYNDROME	0.04788381	1.7964162097230834
3P25.3 MICRODELETION SYNDROME	0.04728696	1.7740246954560854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.047238867000000004	1.7722204312428949
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047187734	1.7703021179329939
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.047146333	1.7687489117971675
GANGLIOCYTOMA	0.0470086	1.763581699877026
248100 MACROSOMIA ADIPOSA CONGENITA	0.046946550000000004	1.7612538227550236
SCHAAF-YANG SYNDROME; SHFYNG	0.046845813	1.7574745583289288
ALG13-CDG	0.046377537999999996	1.7399066830782315
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04611104	1.729908704073245
MENTAL RETARDATION, X-LINKED 98; MRX98	0.045968823	1.7245732697354552
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.04586214	1.720570934280071
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.04568528	1.7139358279497345
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.045657097	1.7128785102876976
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.045434671999999995	1.7045339805719615
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.045322580999999994	1.700328757776113
ZIMMERMANN-LABAND SYNDROME 1	0.045185087	1.6951705122158778
FG SYNDROME TYPE 1	0.044927578999999995	1.685509803401492
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.04473844	1.6784140362624358
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503038
LASSA FEVER	0.044019719000000006	1.6514503912503038
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.044003234	1.6508319375137006
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.043963257000000006	1.649332154375807
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.6414216114859745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043664738	1.638132870724186
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04359198	1.6354032706654809
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.6311384347069111
YELLOW FEVER	0.043478300000000004	1.6311384347069111
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.6311384347069111
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.6311384347069111
ASHERMAN SYNDROME	0.043478300000000004	1.6311384347069111
HYDATIDIFORM MOLE	0.043478300000000004	1.6311384347069111
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.6311384347069111
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.6311384347069111
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.6311384347069111
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.042782089999999995	1.6050193157526897
AICARDI SYNDROME	0.042473029999999995	1.5934245743614555
CAMURATI-ENGELMANN DISEASE	0.0424603	1.5929469937689802
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0424603	1.5929469937689802
COSTELLO SYNDROME; CSTLO	0.04204734399999999	1.5774544744330623
COG2-CDG	0.041666699999999994	1.5631741769434968
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.041477022	1.5560581885994649
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.041467509	1.5557012974622915
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.041316007	1.5500175256695818
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04105227399999999	1.540123278819991
TEMPLE SYNDROME	0.04088782	1.5339535978494543
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.040377984	1.5148265138788934
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.040229641	1.5092612556047722
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04014259	1.5059954372107764
16P13.11 MICRODELETION SYNDROME	0.04014259	1.5059954372107764
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0400951	1.504213795236177
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.040016822	1.5012771060281813
JOUBERT SYNDROME 32; JBTS32	0.039593838	1.48540837473772
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
NOONAN SYNDROME 7; NS7	0.03906593099999999	1.4656033364162853
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.038986434	1.4626209150211553
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.038705173999999995	1.452069122606418
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143658
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143658
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4429274122143658
MAL DE MELEDA	0.0384615	1.4429274122143658
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143658
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143658
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143658
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143658
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143658
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143658
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4429274122143658
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143658
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143658
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143658
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143658
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143658
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143658
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.038375788	1.439711827945533
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038371772	1.4395611630861942
FRYNS-SMEETS-THIRY SYNDROME	0.038368124	1.4394243041701418
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.038319664	1.4376062715298155
ADNP SYNDROME	0.038290719	1.4365203665613002
CANAVAN DISEASE	0.03826399	1.435517597381703
LISSENCEPHALY 2; LIS2	0.03826399	1.435517597381703
7Q11.23 MICRODUPLICATION SYNDROME	0.038215097	1.4336833202483257
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.03818243699999999	1.432458042781692
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03814045	1.4308828521818286
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698603
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
MONOSOMY 9Q22.3	0.037867543	1.4206444321699938
PROTEUS SYNDROME	0.037682553	1.4137043195382573
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.037495840999999995	1.4066996040958182
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.037466429999999995	1.405596216601294
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.037284677999999995	1.3987775812640144
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.037214063	1.39612837831526
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.03685862799999999	1.382793825456936
17Q24.2 MICRODELETION SYNDROME	0.036823919000000004	1.3814916773984742
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.036672644000000004	1.3758164217718678
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03654973	1.3712051616820398
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.03626323399999999	1.3604569347046784
CUTIS LAXA	0.03613013	1.3554633850439692
ALPERS-HUTTENLOCHER SYNDROME	0.03604704	1.3523461681210491
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.03602274900000001	1.351434863315722
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.03585674	1.3452068447315713
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
DOORS SYNDROME	0.0355983	1.335511170865168
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.035428074000000004	1.3291249466754822
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.03530295099999999	1.3244308134097875
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.035026984	1.3140775939782376
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.034995169	1.312884017658552
MONOSOMY 18Q	0.034986969	1.3125763852266354
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.03490175	1.3093792964198678
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.034778017	1.3047373106029985
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03477208999999999	1.3045149523805626
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03467435	1.3008481238567189
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.034643699	1.299698216335905
CORNELIA DE LANGE SYNDROME	0.034611908999999996	1.2985055779199748
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034594184	1.297840604157082
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034594184	1.297840604157082
22Q11.2 DISTAL DELETION SYNDROME	0.034592044	1.2977603195955822
15Q24 RECURRENT MICRODELETION SYNDROME	0.034592044	1.2977603195955822
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.034587397	1.2975859820454458
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.034557738000000005	1.296473290545664
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.034518359	1.29499594206561
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.034444590000000004	1.2922284131790187
KOSAKI OVERGROWTH SYNDROME; KOGS	0.034368039999999996	1.2893565518786267
CENTRAL PRECOCIOUS PUBERTY	0.03420925	1.2833993623830138
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034070034	1.2781765140120758
DWARFISM, LEVI TYPE	0.034067110000000005	1.2780668167887925
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0340536	1.277559973599135
CHROMOSOME 19P13.13 DELETION SYNDROME	0.033950008999999996	1.273673638080273
NEUROFIBROMATOSIS, TYPE I	0.033902519	1.2718919961056736
PITT-HOPKINS SYNDROME	0.033823469	1.2689263444296979
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.033730384	1.2654341535851916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.033594764	1.260346213290494
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.03355788099999999	1.2589625051214233
NETHERTON SYNDROME; NETH	0.033545099999999994	1.2584830112052863
MARFANOID HYPERMOBILITY SYNDROME	0.0334256	1.2539998312523564
TUBEROUS SCLEROSIS 2; TSC2	0.033324453	1.2502051852046658
TUBEROUS SCLEROSIS-1	0.033324453	1.2502051852046658
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03331631	1.249899691193313
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.03321795	1.2462096026563236
MARSHALL-SMITH SYNDROME; MRSHSS	0.032988102000000005	1.2375865905574028
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032783033999999996	1.2298932286612732
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032783033999999996	1.2298932286612732
HYDROXYKYNURENINURIA	0.032783033999999996	1.2298932286612732
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.032743343	1.2284041751423467
COCKAYNE SYNDROME	0.032721453	1.2275829466137305
15Q26 OVERGROWTH SYNDROME	0.032356984	1.2139094728541955
SOTOS SYNDROME	0.032330313000000006	1.2129088796113119
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03231701	1.2124098022647527
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
INFANTILE MYOFIBROMATOSIS	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
DESMOID TUMOR	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544839
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544839
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544839
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.032193547	1.2077779458084466
CK SYNDROME	0.032128341	1.205331667716306
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03204225	1.2021018648265347
PERLMAN SYNDROME	0.031907474000000005	1.1970455881626345
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.031813218000000004	1.1935094659062044
SOTOS SYNDROME 2	0.031789472	1.1926186074027543
MENINGIOMA	0.031684050000000005	1.188663579812815
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.031677834	1.188430379422962
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031636280999999995	1.1868714708322998
CLAPO SYNDROME	0.03158999999999999	1.1851351858833328
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.03138745	1.1775362896534922
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.031369352999999996	1.1768573598827123
MCDONOUGH SYNDROME	0.031363034	1.1766202953293856
AMISH INFANTILE EPILEPSY SYNDROME	0.031317849999999994	1.1749251655972248
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.031152899999999997	1.1687368766161723
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.031129650000000002	1.1678646261232384
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.030995500000000002	1.1628318345693844
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.030995500000000002	1.1628318345693844
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.03093264	1.1604735693656925
PEHO-LIKE SYNDROME; PEHOL	0.03092511	1.1601910727544325
FAMILIAL MULTIPLE LIPOMATOSIS	0.030844418999999998	1.157163857075923
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030835900000000003	1.156844256992082
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.030680119	1.1509999535925222
PETERS-PLUS SYNDROME; PTRPLS	0.030584859000000002	1.1474261651212578
EPILEPSY, PYRIDOXINE-DEPENDENT	0.030509271999999997	1.1445904318735411
OSTEOPENIA AND SPARSE HAIR	0.030491262	1.143914766007832
CLASSICAL EHLERS-DANLOS SYNDROME	0.0304158	1.1410837222788945
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.030302999999999997	1.1368519005325306
BECKWITH-WIEDEMANN SYNDROME	0.030302999999999997	1.1368519005325306
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.030302999999999997	1.1368519005325306
SCLEROSTEOSIS 1; SOST1	0.030302999999999997	1.1368519005325306
ESTROGEN RESISTANCE SYNDROME	0.030302999999999997	1.1368519005325306
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.030302999999999997	1.1368519005325306
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.030302999999999997	1.1368519005325306
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.030302999999999997	1.1368519005325306
NIEVERGELT SYNDROME	0.030302999999999997	1.1368519005325306
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.030302999999999997	1.1368519005325306
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.03021912	1.1337050458509257
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.030138699999999997	1.1306879970491297
NEMALINE MYOPATHY 2; NEM2	0.03010045	1.1292530043026898
DISTAL NEBULIN MYOPATHY	0.03010045	1.1292530043026898
NEMALINE MYOPATHY 3; NEM3	0.03010045	1.1292530043026898
15Q13.3 MICRODELETION SYNDROME	0.030071143	1.1281535184877902
20Q13.33 MICRODELETION SYNDROME	0.029998073	1.1254122133902118
MALAN OVERGROWTH SYNDROME	0.029946249	1.1234679764204996
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.029886519000000004	1.1212271367670392
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.029839319000000003	1.1194563744760073
MENKES DISEASE	0.029805691000000002	1.1181947813759479
NORRIE DISEASE	0.029764809000000003	1.1166610461220927
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029690352999999996	1.1138677436402904
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.029625409	1.1114312947795115
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.029624690000000002	1.1114043206674935
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.02962385	1.1113728071012972
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.029589734000000003	1.1100929061199236
EDINBURGH MALFORMATION SYNDROME	0.029589734000000003	1.1100929061199236
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.029532938	1.1079621388512488
2P15P16.1 MICRODELETION SYNDROME	0.029361148000000004	1.1015172394025976
WILLIAMS-BEUREN SYNDROME; WBS	0.029262122000000005	1.0978021651095529
TRISOMY 18P	0.02918545	1.0949257268388328
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.02906504	1.09040840718919
PEDIATRIC-ONSET GRAVES DISEASE	0.02892116	1.0850105834935617
WOLF-HIRSCHHORN SYNDROME	0.028888299	1.0837777652807312
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.028853559	1.0824744542216118
MCCUNE-ALBRIGHT SYNDROME	0.0287139	1.0772349861961203
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0285948	1.0727668127032837
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0285714	1.0718889347878144
SILLENCE SYNDROME	0.0285714	1.0718889347878144
CAMURATI-ENGELMANN DISEASE	0.0285714	1.0718889347878144
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0285714	1.0718889347878144
THORACOLARYNGOPELVIC DYSPLASIA	0.0285714	1.0718889347878144
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.028529956999999998	1.0703341529736783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.028513472	1.0697156992370753
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.028410660000000004	1.065858588799246
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.028302734000000003	1.061809620769121
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.028302734000000003	1.061809620769121
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028302734000000003	1.061809620769121
MAPLE SYRUP URINE DISEASE; MSUD	0.028254881000000003	1.0600143604319867
MENKES DISEASE	0.028014473	1.0509951777865976
FUMARASE DEFICIENCY; FMRD	0.027993177999999997	1.0501962713673703
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.027952124	1.048656083335675
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.027946943000000002	1.0484617121613142
COHEN SYNDROME	0.027802043000000002	1.0430256219924476
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.0421161179623315
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.027759599000000003	1.0414332865119276
XP22.13P22.2 DUPLICATION SYNDROME	0.027698308999999997	1.0391339216641025
MGAT2-CDG	0.02769079	1.038851837730495
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027551934	1.0336424951736412
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027551934	1.0336424951736412
BOHRING-OPITZ SYNDROME	0.027512797	1.032174225601944
PERMANENT NEONATAL DIABETES MELLITUS	0.02712942	1.0177913964737895
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.02697144	1.011864595059866
SLC39A8-CDG	0.026741618999999998	1.0032425958970013
1P36 DELETION SYNDROME	0.026717393	1.002333729641439
PITT-HOPKINS SYNDROME	0.026592547000000005	0.9976499883493597
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.026549693	0.9960422712472435
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.026529050000000002	0.995267825357969
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.026475841	0.9932716285201827
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.026471319	0.9931019804888258
L-2-HYDROXYGLUTARIC ACIDURIA	0.026466429	0.9929185265141829
ANGELMAN SYNDROME	0.026466429	0.9929185265141829
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.026430930000000002	0.991586740697036
JACOBSEN SYNDROME	0.026418913000000002	0.9911359091196774
CARDIOFACIOCUTANEOUS SYNDROME	0.026390234	0.9900599834471242
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.026066353	0.9779092151932756
RETT SYNDROME; RTT	0.025924619	0.972591901156049
6Q16 MICRODELETION SYNDROME	0.02589309	0.97140905445533
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.025885880000000003	0.971138563012145
SMITH-KINGSMORE SYNDROME; SKS	0.025837391	0.9693194424034619
3Q27.3 MICRODELETION SYNDROME	0.025832889999999997	0.9691505822112596
HYPOTONIA-CYSTINURIA SYNDROME	0.025811918	0.9683637935085581
SECONDARY SHORT BOWEL SYNDROME	0.02572613	0.9651453580123074
8Q24.3 MICRODELETION SYNDROME	0.025676167	0.9632709385981798
HOOFT DISEASE	0.025524934000000003	0.9575972586498832
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.025517256999999998	0.9573092471645388
TURNER SYNDROME	0.0255087	0.9569882214669888
MOSAIC MONOSOMY X	0.0255087	0.9569882214669888
MONOSOMY X	0.0255087	0.9569882214669888
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0255087	0.9569882214669888
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.0254346	0.9542082747346701
CLASSIC HOMOCYSTINURIA	0.025322703	0.9500103300719669
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.025193619	0.945167595335197
MICROHYDRANENCEPHALY; MHAC	0.025185350000000002	0.9448573742889145
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.025185350000000002	0.9448573742889145
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.9379037558430937
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.9379037558430937
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.9379037558430937
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.9379037558430937
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.9379037558430937
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.9379037558430937
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.9379037558430937
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.9379037558430937
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.9379037558430937
ALKAPTONURIA	0.025	0.9379037558430937
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.9379037558430937
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.9379037558430937
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.9379037558430937
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.9379037558430937
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.9379037558430937
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	0.9379037558430937
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.9379037558430937
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.9379037558430937
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02498774	0.9374438078412283
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.024942269000000003	0.9357379109739506
WITTEVEEN-KOLK SYNDROME	0.024934141000000003	0.9354329797048508
CONGENITAL TOXOPLASMOSIS	0.024877668999999998	0.9333143676688518
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.024875853	0.9332462383400275
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.024875853	0.9332462383400275
FRYNS SYNDROME; FRNS	0.024875853	0.9332462383400275
JUVENILE POLYPOSIS OF INFANCY	0.024805088000000003	0.9305914079687382
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.024718093	0.9273276904791553
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.024589431000000005	0.922500787557784
TRANSIENT NEONATAL DIABETES MELLITUS	0.024548764	0.920975118276229
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02443913	0.916862072661505
XYLT1-CDG	0.02440085	0.9154259544305581
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024350919000000002	0.9135527355332381
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024350919000000002	0.9135527355332381
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024350919000000002	0.9135527355332381
FACIOCARDIOMELIC SYNDROME	0.024334434000000002	0.9129342817966352
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.02425635	0.9100048707217849
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.02425635	0.9100048707217849
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217849
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217849
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.02425635	0.9100048707217849
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.02425635	0.9100048707217849
CRANIOPHARYNGIOMA	0.024203403	0.9080185031153598
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.024203403	0.9080185031153598
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.9073153379115292
2Q23.1 MICRODELETION SYNDROME	0.024104799	0.9043192606377138
XQ27.3Q28 DUPLICATION SYNDROME	0.024090590000000002	0.903786193659043
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.024081759	0.9034548885363289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.023950138	0.8985169753264158
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.023950138	0.8985169753264158
SALT-AND-PEPPER SYNDROME	0.023890678	0.8962862650335187
ALLAN-HERNDON-DUDLEY SYNDROME	0.023862600000000005	0.8952328865672564
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.023850450000000002	0.8947770653419165
ABCD SYNDROME	0.0238095	0.8932407789898456
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0238095	0.8932407789898456
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0238095	0.8932407789898456
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.0238095	0.8932407789898456
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0238095	0.8932407789898456
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.02372683	0.8901393188500235
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.023678469	0.8883250003085704
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.023584998	0.8848183282300739
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.023549918000000003	0.8835022616798751
CARTILAGE-HAIR HYPOPLASIA	0.02352823	0.8826886114136061
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.023447044	0.8796428252407309
ATKIN-FLAITZ SYNDROME	0.023335509000000004	0.8754584614244127
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.023252234	0.8723343040136993
SCLERODERMA	0.023202249	0.8704590592442666
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02313705	0.8680130437651778
OBESITY DUE TO SIM1 DEFICIENCY	0.02313705	0.8680130437651778
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.02313705	0.8680130437651778
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.02313705	0.8680130437651778
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.02313705	0.8680130437651778
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.023118270000000003	0.8673084904637887
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.023108474	0.8669409822560991
PIERPONT SYNDROME	0.023027553000000003	0.863905137863036
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.022995464	0.8627012821181859
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.022968340000000004	0.8616836940592466
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022929188	0.8602148617452956
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.022801371	0.8554196599708719
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.022756819	0.8537482404456589
BRITTLE CORNEA SYNDROME	0.0227273	0.8526408012069097
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.0227273	0.8526408012069097
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0227273	0.8526408012069097
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0227273	0.8526408012069097
MARFANOID HABITUS WITH SITUS INVERSUS	0.0227273	0.8526408012069097
STICKLER SYNDROME, TYPE I	0.0227273	0.8526408012069097
19P13.3 MICRODUPLICATION SYNDROME	0.022686539999999998	0.851111642923383
DIENCEPHALIC SYNDROME	0.02266083	0.8501471027008741
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.022586379000000004	0.8473539877998232
ANGELMAN SYNDROME	0.022562287000000004	0.8464501487083923
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.8430077793113963
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.022462817	0.8427184172446436
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02244973	0.842227443386535
11Q22.2Q22.3 MICRODELETION SYNDROME	0.022338829	0.8380668648094648
TETRASOMY 12P	0.02228652	0.8361044325068888
HALLERMANN-STREIFF SYNDROME; HSS	0.022282094000000002	0.8359383860259546
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.02224123	0.8344053260628035
PALLISTER-KILLIAN SYNDROME	0.022195537	0.832691100610174
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.022178639	0.8320571527035245
MELAS	0.022158140000000003	0.8312881091398836
WEAVER-WILLIAMS SYNDROME	0.02214584	0.8308266604920086
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.022118019000000003	0.8297829236763563
GAUCHER DISEASE, PERINATAL LETHAL	0.022102679	0.8292074259317708
AL KAISSI SYNDROME; ALKAS	0.022082341	0.8284444224683173
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.022075441	0.8281855610317048
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.022072257	0.8280661096093606
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022012077999999997	0.8258084252044452
LYSINURIC PROTEIN INTOLERANCE; LPI	0.021994028	0.8251312586927265
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.021916131000000002	0.8222088631379703
RENPENNING SYNDROME	0.021851803000000003	0.8197955242257353
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02174815	0.815906862705559
HYPOTONIA-CYSTINURIA SYNDROME	0.02174479	0.8157808084407737
6P22 MICRODELETION SYNDROME	0.021234290000000003	0.7966288137464578
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02118466	0.794766887210358
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021111063	0.7920058111016067
SIMPSON-GOLABI-BEHMEL SYNDROME	0.020954593	0.7861356590745359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.020940518	0.7856076192599963
PEHO SYNDROME; PEHO	0.020933767000000002	0.7853543477297685
SMITH-MAGENIS SYNDROME	0.020905493	0.78429361609806
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.020861110000000002	0.7826285368022369
CHUDLEY-LOWRY-HOAR SYNDROME	0.0208307	0.7814876706736291
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.020811843	0.7807802286286718
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.02080775	0.7806266750257652
CLARK-BARAITSER SYNDROME	0.020802343000000004	0.7804238252014517
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.020753559999999997	0.7785936748445996
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.020753559999999997	0.7785936748445996
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
PHELAN-MCDERMID SYNDROME	0.020679057	0.7757986091037367
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.020596209	0.7726904710891731
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020582497	0.7721760496371682
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020558749	0.7712851161014178
48,XXXY SYNDROME	0.020497459000000006	0.768985751253593
HIRSCHSPRUNG DISEASE	0.020439164	0.766798747275718
HEART AND BRAIN MALFORMATION SYNDROME	0.020401057	0.7653691193387614
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.020392347999999998	0.7650423911863758
WILLIAMS SYNDROME	0.020364074000000003	0.7639816595546677
GROWTH HORMONE INSENSITIVITY SYNDROME	0.020330434	0.7627196162608052
PRADER-WILLI SYNDROME (TYPE 1)	0.020270424000000002	0.7604682720852795
PRADER-WILLI SYNDROME (TYPE 2)	0.020270424000000002	0.7604682720852795
DISTAL MONOSOMY 10Q	0.020222273000000002	0.7586618319353754
OLIVER SYNDROME	0.0200656	0.7527840641298071
OROFACIODIGITAL SYNDROME XVII	0.02005445	0.7523657590547012
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.02004755	0.7521068976180885
MYHRE SYNDROME	0.020033843	0.7515926637468348
PRIMROSE SYNDROME; PRIMS	0.020004972	0.7505095349734369
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020004972	0.7505095349734369
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.019954369	0.7486111052231598
GABRIELE-DE VRIES SYNDROME	0.0198644	0.745235814702782
20P13 MICRODELETION SYNDROME	0.019837293	0.7442188644183962
CUSHING DISEASE	0.0198055	0.7430261134540156
ACTH-INDEPENDENT CUSHING SYNDROME	0.0198055	0.7430261134540156
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0198055	0.7430261134540156
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.019772219	0.741777538458087
6Q TERMINAL DELETION SYNDROME	0.019754359	0.7411075000149127
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.019651229000000003	0.737238459441309
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.019584853000000003	0.7347482874533953
WILSON-TURNER SYNDROME	0.019584853	0.7347482874533952
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.019584853	0.7347482874533952
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.019584853	0.7347482874533952
ALSTRM SYNDROME	0.019584853	0.7347482874533952
LOEYS-DIETZ SYNDROME 5	0.019583060000000003	0.7346810209960262
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.019581669	0.7346288360310509
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.019560039999999997	0.7338173992176457
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.019386681	0.7273136369292776
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01935961	0.7262980372263005
KLEINE-LEVIN HIBERNATION SYNDROME	0.0192308	0.7214655819146945
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0192308	0.7214655819146945
FRONTOTEMPORAL DEMENTIA; FTD	0.0192308	0.7214655819146945
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.0192308	0.7214655819146945
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0192308	0.7214655819146945
EARLY-ONSET SCHIZOPHRENIA	0.0192308	0.7214655819146945
MOSAIC TRISOMY 8	0.0191761	0.7194134484969099
MEGALENCEPHALY	0.019043434	0.7144363309100028
LARON SYNDROME	0.019043434	0.7144363309100028
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.019043434	0.7144363309100028
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.019043434	0.7144363309100028
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.019022779	0.7136614348269251
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.019009751000000002	0.7131726744216802
TEEBI-SHALTOUT SYNDROME; TBSH	0.0188981	0.7089839587319348
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018845438	0.7070082832283262
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.018717609	0.7022126312600996
NEONATAL ADRENOLEUKODYSTROPHY	0.018717609	0.7022126312600996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.018716047	0.7021540310334345
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.018701124000000003	0.7015941775234967
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.018701124000000003	0.7015941775234967
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.018701124	0.7015941775234967
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.01866125	0.7000982585490773
TEMPLE-BARAITSER SYNDROME; TMBTS	0.018656037000000004	0.6999026868579089
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
C SYNDROME	0.018528293	0.695110223762452
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0185185	0.6947428281032131
ALSTROM SYNDROME; ALMS	0.0185185	0.6947428281032131
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0185185	0.6947428281032131
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0185185	0.6947428281032131
CUSHING SYNDROME	0.0185185	0.6947428281032131
BARATELA-SCOTT SYNDROME	0.0185185	0.6947428281032131
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0185185	0.6947428281032131
SHORT STATURE DUE TO PRIMARY ACID-LABILE SUBUNIT DEFICIENCY	0.0185185	0.6947428281032131
MOSAIC TRISOMY 15	0.01846839	0.6928628938150012
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01845865	0.6924974865117247
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.01839085	0.6899538915258783
TYSHCHENKO SYNDROME	0.01835801	0.6887218611522029
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018333239999999997	0.6877925861109133
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.018289286999999998	0.6861436387596905
CORNELIA DE LANGE SYNDROME 1	0.018263883	0.6851905784791531
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.01820002	0.6827946845767768
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.018184478	0.6822116085698443
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.018184478	0.6822116085698443
TRISOMY 20P	0.018176190000000002	0.6819006747167072
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.018176190000000002	0.6819006747167072
TRISOMY 4P	0.018176190000000002	0.6819006747167072
GRANT SYNDROME	0.018176190000000002	0.6819006747167072
ARIMA SYNDROME	0.018114618000000002	0.6795907303145163
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.018114618000000002	0.6795907303145163
MYOTONIC DYSTROPHY 1	0.018114618000000002	0.6795907303145163
KOOLEN-DE VRIES SYNDROME; KDVS	0.018029801	0.6764087230001427
FOUNTAIN SYNDROME	0.018015553	0.6758741928916125
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.018015553	0.6758741928916125
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.0179835	0.6746716877281709
48,XXYY SYNDROME	0.017964293000000006	0.6739511150306321
CHROMOSOME 18Q DELETION SYNDROME	0.017960781000000002	0.673819358311011
COFFIN-LOWRY SYNDROME; CLS	0.017941831000000002	0.6731084272640819
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.017910738000000002	0.6719419376048648
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.017879489	0.670769595426211
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.017872829	0.6705197378656544
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.017848582	0.6696100837709374
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.017766447	0.6665286947714905
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017764	0.6664368927518686
LESCH-NYHAN SYNDROME	0.01771238	0.6645003090768037
8P INVERTED DUPLICATION/DELETION SYNDROME	0.017666699	0.662786533817977
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01755924	0.6587550858300113
GAUCHER DISEASE	0.017528500000000002	0.6576018393718267
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.017490619000000002	0.656180690084823
ENDOCARDIAL FIBROELASTOSIS	0.017490619000000002	0.656180690084823
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.017482627	0.655880861012155
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.6555622363482201
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.017474134000000002	0.6555622363482201
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.017474134000000002	0.6555622363482201
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.017474134000000002	0.6555622363482201
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.6555622363482201
RING CHROMOSOME 8 SYNDROME	0.017474134000000002	0.6555622363482201
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.017474134000000002	0.6555622363482201
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.017474134000000002	0.6555622363482201
TEMTAMY SYNDROME	0.017474134000000002	0.6555622363482201
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.017474134000000002	0.6555622363482201
HEART-HAND SYNDROME TYPE 2	0.017474134000000002	0.6555622363482201
20Q11.2 MICRODUPLICATION SYNDROME	0.017465869000000002	0.6552521653665383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.01746194	0.65510476441227
MARTSOLF SYNDROME	0.017455140000000004	0.6548496545906809
DESMOSTEROLOSIS	0.017371274	0.6517033251351791
RUBINSTEIN-TAYBI SYNDROME	0.017301303	0.6490782825871754
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.017264744000000002	0.6477067296507807
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.017263048	0.6476431022599841
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
FG SYNDROME 2; FGS2	0.01722294	0.64613840450641
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.01722294	0.64613840450641
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01721309	0.6457688704266078
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.017203791	0.6454200077455844
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.017173907000000006	0.644298875112
STEINERT MYOTONIC DYSTROPHY	0.017153080000000005	0.6435175262510823
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.017046023	0.6395011597555104
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.016999292	0.6377479925389382
FREE SIALIC ACID STORAGE DISEASE	0.016999243	0.6377461542475767
GALACTOSEMIA	0.016999243	0.6377461542475767
MULTIPLE MYELOMA	0.01697303	0.6367627434015001
JACKSON-WEISS SYNDROME	0.0169492	0.6358687335414305
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0169492	0.6358687335414305
WHITE FORELOCK WITH MALFORMATIONS	0.0169492	0.6358687335414305
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0169492	0.6358687335414305
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0169492	0.6358687335414305
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.0169492	0.6358687335414305
GAPO SYNDROME	0.0169492	0.6358687335414305
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0169492	0.6358687335414305
DEAFNESS-CRANIOFACIAL SYNDROME	0.0169492	0.6358687335414305
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0169492	0.6358687335414305
GAMMA-HEAVY CHAIN DISEASE	0.0169492	0.6358687335414305
MUCKLE-WELLS SYNDROME	0.0169492	0.6358687335414305
DYSOSTOSIS, STANESCU TYPE	0.0169492	0.6358687335414305
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414305
FAMILIAL TUMORAL CALCINOSIS	0.0169492	0.6358687335414305
XFE PROGEROID SYNDROME; XFEPS	0.016947	0.6357861980109163
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.016837447000000002	0.6316761912043612
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.016837447000000002	0.6316761912043612
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016826444	0.6312634010033394
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.016821223	0.6310675291829693
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.016804909	0.6304554907080562
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.016759884	0.6287663260437828
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.016757419	0.6286738487334567
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.0165749	0.6218264385089477
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.016493709	0.6187804647553213
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.016474309	0.6180526514407871
HYPOPHOSPHATASIA	0.016474309	0.6180526514407871
HOLOPROSENCEPHALY	0.016474309	0.6180526514407871
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.016474309	0.6180526514407871
MUCOPOLYSACCHARIDOSIS TYPE 3	0.016467509	0.6177975416191979
KAPUR-TORIELLO SYNDROME	0.016467509	0.6177975416191979
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.016467509	0.6177975416191979
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.016467509	0.6177975416191979
LAMBERT SYNDROME	0.016457824	0.6174341977041842
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.016428309	0.6163269085300358
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.016420391	0.6160298556524852
HAREL-YOON SYNDROME; HAYOS	0.016411871999999997	0.6157102555686441
MENTAL RETARDATION, X-LINKED 41	0.016411871999999997	0.6157102555686441
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.016368299	0.6140755643545102
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.016366263	0.6139991814726342
48,XYYY SYNDROME	0.01635185	0.6134584611993156
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
DUPLICATION OF THE PITUITARY GLAND	0.01626349	0.6101435341646637
ALAZAMI SYNDROME; ALAZS	0.01626349	0.6101435341646637
BALLER-GEROLD SYNDROME	0.016234949999999998	0.6090728232369933
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.016216	0.6083618921900642
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0162124	0.6082268340492227
SUMMITT SYNDROME	0.016195884000000004	0.6076072173119628
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.016182243000000002	0.6070954595066246
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.016182243000000002	0.6070954595066246
RING CHROMOSOME 10 SYNDROME	0.016182243000000002	0.6070954595066246
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.016173422	0.6067645295454127
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.016102847	0.6041168272426677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.016102846999999997	0.6041168272426676
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.016084987	0.6034467887994933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016055357	0.6023351852680681
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.016036180999999997	0.6016157755711862
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.016023697	0.6011474239516684
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.015992784	0.5999876871994934
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01597967	0.5994957004053283
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015959369	0.5987340850394335
SCHWARTZ-JAMPEL SYNDROME	0.015942884	0.5981156313028305
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.015932889999999998	0.5977406948973947
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.015932889999999998	0.5977406948973947
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.015926090000000004	0.5974855850758055
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.015926090000000004	0.5974855850758055
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.015926090000000004	0.5974855850758055
%203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;AMR SYNDROME	0.015926090000000004	0.5974855850758055
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.015926090000000004	0.5974855850758055
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.015926090000000004	0.5974855850758055
FACIOCARDIORENAL SYNDROME	0.015926090000000004	0.5974855850758055
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.015926090000000004	0.5974855850758055
ALLAN-HERNDON-DUDLEY SYNDROME	0.015926090000000004	0.5974855850758055
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.015926090000000004	0.5974855850758055
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.015926090000000004	0.5974855850758055
260150 PALANT CLEFT PALATE SYNDROME	0.015926090000000004	0.5974855850758055
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.015926090000000004	0.5974855850758055
MACS SYNDROME	0.01591394	0.5970297638504657
EPILEPSY, HOT WATER, 1	0.015887128	0.596023880830399
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015886938	0.5960167527618546
MICROPHTHALMIA WITH LIMB ANOMALIES	0.01586903	0.5953449135434691
CRANIOFACIOFRONTODIGITAL SYNDROME	0.015829740000000002	0.5938709040007862
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.015794598000000003	0.5925525114492727
OGDEN SYNDROME	0.015794598000000003	0.5925525114492727
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.015772253	0.5917142130723
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015772253	0.5917142130723
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.015717319	0.5896533008753606
19Q13.11 MICRODELETION SYNDROME	0.015700834	0.5890348471387576
INFANTILE NEUROAXONAL DYSTROPHY	0.015657309	0.5874019566998349
DISTAL TRISOMY 15Q	0.015587093000000002	0.5847677226950238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015561427999999999	0.5838048706992752
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.015550447000000002	0.5833929058535587
SIALURIA	0.015522646999999999	0.5823499568770611
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015510533999999998	0.58189552374928
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015450523999999998	0.5796441795737542
MYOCLONIC-ATONIC EPILEPSY	0.015450333999999998	0.5796370515052098
NIEMANN-PICK DISEASE TYPE B	0.015450333999999998	0.5796370515052098
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.015374479000000002	0.5767912639292309
NEUROFIBROMATOSIS TYPE 1	0.015364219	0.5764063482278328
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.015346428	0.5757388983990247
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015313617	0.5745079559937059
VELO-FACIAL-SKELETAL SYNDROME	0.01529991	0.5739937221224523
INTERMEDIATE NEMALINE MYOPATHY	0.01529991	0.5739937221224523
VASCULAR EHLERS-DANLOS SYNDROME	0.01529991	0.5739937221224523
OSTEOGLOSPHONIC DYSPLASIA	0.015230833999999999	0.5714022565289075
COSTELLO SYNDROME	0.015230833999999999	0.5714022565289075
MENTAL RETARDATION, X-LINKED 102	0.015185791	0.5697124165739299
MAJEED SYNDROME	0.0151759	0.5693413443319681
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0151759	0.5693413443319681
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.015141308999999999	0.5680436231792333
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.015115890000000002	0.5670900001564424
TRISOMY 18	0.015115890000000002	0.5670900001564424
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.015115890000000002	0.5670900001564424
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.015079591	0.5657282014191084
GENITOPATELLAR SYNDROME; GTPTS	0.015009028000000002	0.5630809493101663
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014985599999999998	0.5622020209424905
MOYNAHAN SYNDROME	0.014955253000000002	0.5610635183313477
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984203
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.014890969000000002	0.5586518301297231
ACROCALLOSAL SYNDROME	0.014870290000000001	0.5578760336590399
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014851768999999999	0.557181197040561
HYPERPROLINEMIA, TYPE I	0.014749180999999998	0.5533324902203837
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.014732164000000002	0.5526940778918566
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.014714910000000001	0.5520467742357239
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0147059	0.5517087537221179
CONGENITAL ADRENAL HYPERPLASIA	0.0147059	0.5517087537221179
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.0147059	0.5517087537221179
GLYCOGEN STORAGE DISEASE VI	0.0147059	0.5517087537221179
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0147059	0.5517087537221179
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0147059	0.5517087537221179
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0147059	0.5517087537221179
COMMON VARIABLE IMMUNODEFICIENCY	0.0147059	0.5517087537221179
CYSTINOSIS, NEPHROPATHIC; CTNS	0.0147059	0.5517087537221179
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0147059	0.5517087537221179
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0147059	0.5517087537221179
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.014692670000000001	0.5512124150545259
SCHISIS ASSOCIATION	0.014692670000000001	0.5512124150545259
DIETHYLSTILBESTROL SYNDROME	0.014692670000000001	0.5512124150545259
BRONCHOPULMONARY DYSPLASIA	0.014692670000000001	0.5512124150545259
RETINOPATHY OF PREMATURITY	0.014692670000000001	0.5512124150545259
MEIER-GORLIN SYNDROME 7	0.01468695	0.5509978226751889
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.01468695	0.5509978226751889
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.014660857	0.5500189137671404
N-ACETYLASPARTATE DEFICIENCY; NACED	0.014660857	0.5500189137671404
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.014660857	0.5500189137671404
XERODERMA PIGMENTOSUM	0.014648919000000002	0.5495710459656502
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.014644372	0.5494004600305374
TAY-SACHS DISEASE	0.014588909000000002	0.5473197017901245
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014547309000000001	0.5457590299404016
17P13.3 MICRODUPLICATION SYNDROME	0.014520740000000002	0.5447622633448418
RING CHROMOSOME 14 SYNDROME	0.014509821999999999	0.5443526620165898
KRABBE DISEASE	0.014467589999999999	0.5427682799599192
MICROSPORIDIOSIS	0.014430319	0.5413700155245582
WHIPPLE DISEASE	0.014430319	0.5413700155245582
CRONKHITE-CANADA SYNDROME	0.014430319	0.5413700155245582
SYSTEMIC SCLEROSIS	0.014430319	0.5413700155245582
FLYNN-AIRD SYNDROME	0.014430319	0.5413700155245582
SECKEL SYNDROME	0.014413834	0.5407515617879552
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.014413834	0.5407515617879552
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.014413834	0.5407515617879552
NEONATAL MARFAN SYNDROME	0.014412850000000001	0.5407146458961254
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014267771999999998	0.535271877852517
8P23.1 MICRODELETION SYNDROME	0.014243148999999998	0.5343481176853121
SECKEL SYNDROME 2; SCKL2	0.01422582	0.5336980003179119
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.01422582	0.5336980003179119
RAMON SYNDROME	0.014224253	0.5336392125104956
FILIPPI SYNDROME; FLPIS	0.014224253	0.5336392125104956
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.014224246999999999	0.5336389874135942
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014223533999999998	0.5336122383984775
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014223533999999998	0.5336122383984775
MENTAL RETARDATION, X-LINKED 77	0.014223533999999998	0.5336122383984775
AYM-GRIPP SYNDROME	0.014223533999999998	0.5336122383984775
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.014223533999999998	0.5336122383984775
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.014119438	0.5297069572237478
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.014117691	0.5296414165092896
COG5-CDG	0.014116509	0.5295970724197133
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.014029441	0.5263306162511635
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014029441	0.5263306162511635
INFANTILE SIALIC ACID STORAGE DISEASE	0.013949356999999999	0.5233261728758459
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.013947852	0.5232697110697442
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013896744000000003	0.5213523356635991
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.013888900000000001	0.5210580589811658
NIJMEGEN BREAKAGE SYNDROME	0.013888900000000001	0.5210580589811658
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.5210580589811658
BETHLEM MYOPATHY	0.013888900000000001	0.5210580589811658
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.013888900000000001	0.5210580589811658
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.5210580589811658
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.013888900000000001	0.5210580589811658
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.5210580589811658
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.5210580589811658
WOLMAN DISEASE	0.013888900000000001	0.5210580589811658
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.5210580589811658
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.013888900000000001	0.5210580589811658
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.013888900000000001	0.5210580589811658
PRIMARY MYELOFIBROSIS	0.013888900000000001	0.5210580589811658
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.013888900000000001	0.5210580589811658
AREDYLD SYNDROME	0.013888900000000001	0.5210580589811658
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.013888900000000001	0.5210580589811658
MULIBREY NANISM	0.013888900000000001	0.5210580589811658
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.0138609	0.5200076067746214
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.013818684000000001	0.5184238249763545
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.013792591	0.517444916068306
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.013744533	0.5156419649203736
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013742837999999999	0.5155783750457275
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.013742837999999999	0.5155783750457275
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013742837999999999	0.5155783750457275
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013699319	0.5139457097037061
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013699319	0.5139457097037061
MIRAGE SYNDROME; MIRAGE	0.013699319	0.5139457097037061
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.013699319	0.5139457097037061
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.513918735591688
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.013682834	0.5133272559671032
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.013682834	0.5133272559671032
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.013682834	0.5133272559671032
GRANGE SYNDROME; GRNG	0.013682834	0.5133272559671032
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.013682828	0.5133270308702018
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.013682828	0.5133270308702018
POTOCKI-LUPSKI SYNDROME	0.013666417	0.5127113533287162
ROIFMAN SYNDROME; RFMN	0.013649988	0.5120950004965262
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.013556993	0.5086061861055411
TRISOMY X	0.013533109000000001	0.5077101503733589
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0135306	0.5076160223524225
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.013516624000000001	0.507091696636756
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.013516624000000001	0.507091696636756
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013435609	0.5040523257255708
SYNDROMIC DIARRHEA	0.01341245	0.503183489202308
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.013361919000000002	0.5012877606148478
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.013345434000000002	0.5006693068782448
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013332987	0.5002023433562857
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01333156	0.500148807809902
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.013306233999999998	0.4991986737890828
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.013306233999999998	0.4991986737890828
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.013293750000000002	0.4987303221695651
LOEYS-DIETZ SYNDROME	0.013293750000000002	0.4987303221695651
MARFAN SYNDROME; MFS	0.013293750000000002	0.4987303221695651
THANATOPHORIC DYSPLASIA TYPE 1	0.013262709	0.49756578335016
THANATOPHORIC DYSPLASIA	0.013262709	0.49756578335016
COHEN-GIBSON SYNDROME; COGIS	0.013251172	0.49713295952491354
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013246224	0.49694732961355703
PYRIDOXINE-DEPENDENT EPILEPSY	0.013246224	0.49694732961355703
RING CHROMOSOME 12 SYNDROME	0.01318586	0.4946827047208485
SPONDYLOOCULAR SYNDROME; SOS	0.0131579	0.49363375316031366
SHORT STATURE DUE TO GHSR DEFICIENCY	0.0131579	0.49363375316031366
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0131579	0.49363375316031366
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0131579	0.49363375316031366
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.49363375316031366
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0131579	0.49363375316031366
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.49363375316031366
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.49363375316031366
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0131579	0.49363375316031366
SECKEL SYNDROME 4	0.0131579	0.49363375316031366
FORSYTHE-WAKELING SYNDROME; FWS	0.0131579	0.49363375316031366
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.49363375316031366
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0131579	0.49363375316031366
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.49363375316031366
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.49363375316031366
RUIJS-AALFS SYNDROME; RJALS	0.0131579	0.49363375316031366
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.013112569000000001	0.49193310855406874
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.013067902999999999	0.49025741218772917
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.01305298	0.4896975586777914
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012997256999999998	0.48760704623831747
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.012997256999999998	0.48760704623831747
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.012997256999999998	0.48760704623831747
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.012997256999999998	0.48760704623831747
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.012989481	0.4873153206541001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012980771999999998	0.48698859250171456
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012980771999999998	0.48698859250171456
OSTEOGENESIS IMPERFECTA, TYPE X	0.012963088000000001	0.4863251569009815
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.012963088000000001	0.4863251569009815
PELGER-HUET ANOMALY; PHA	0.012919224	0.4846795484871294
1Q44 MICRODELETION SYNDROME	0.01290388	0.4841039006779431
DIGEORGE SYNDROME; DGS	0.012873269	0.48295549380313857
BARDET-BIEDL SYNDROME 1; BBS1	0.012856784000000001	0.4823370400665357
AUTISM, SUSCEPTIBILITY TO, 18	0.012831053	0.4813717120048718
47,XYY SYNDROME	0.012831053	0.4813717120048718
CHIME SYNDROME	0.012831053	0.4813717120048718
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012820607	0.48097981829953024
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.012820500000000002	0.4809758040714553
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.012820500000000002	0.4809758040714553
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012781299999999999	0.4795051709822932
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012781299999999999	0.4795051709822932
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012780451	0.4794733197707448
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012780451	0.4794733197707448
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.012772392	0.4791709771160113
THANATOPHORIC DYSPLASIA, TYPE I	0.01272129	0.4772538268067675
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.01272129	0.4772538268067675
LATHOSTEROLOSIS	0.012720441	0.47722197559521906
COG1-CDG	0.012718038	0.47713182428620743
LATHOSTEROLOSIS	0.012520969000000002	0.46973855407579784
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012455837999999999	0.46729508969492506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.012455837999999999	0.46729508969492506
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.012455837999999999	0.46729508969492506
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.012455837999999999	0.46729508969492506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012455837999999999	0.46729508969492506
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.012455837999999999	0.46729508969492506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012455837999999999	0.46729508969492506
9Q33.3Q34.11 MICRODELETION SYNDROME	0.012418939	0.46591078126745095
ARGININEMIA	0.012418939	0.46591078126745095
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822	0.4653436496243677
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822	0.4653436496243677
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.01236485	0.463881570217459
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.012352273	0.46340972959596954
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012328871000000002	0.4625317766482
MENTAL RETARDATION, X-LINKED 90	0.012328871	0.4625317766481999
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.012306119	0.4616782091980822
GABA-TRANSAMINASE DEFICIENCY	0.012306119	0.4616782091980822
KLIPPEL-TRNAUNAY SYNDROME	0.012289634	0.46105975546147926
WEAVER SYNDROME	0.012289634	0.46105975546147926
MEHMO SYNDROME; MEHMO	0.012223451	0.45857682409056066
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.012179022000000001	0.45691001905182665
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01217166	0.456633825153806
OCULOPHARYNGODISTAL MYOPATHY	0.01210488	0.45412849664119787
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012050369	0.4520834537758074
MUCOPOLYSACCHARIDOSIS, TYPE II	0.012035718999999999	0.4515338421748833
AICARDI-GOUTIRES SYNDROME	0.012035718999999999	0.4515338421748833
LISSENCEPHALY 4	0.012035718999999999	0.4515338421748833
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.012035718999999999	0.4515338421748833
WARBURG MICRO SYNDROME 3; WARBM3	0.012035718999999999	0.4515338421748833
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.012035718999999999	0.4515338421748833
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.012035718999999999	0.4515338421748833
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.012035718999999999	0.4515338421748833
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012035718999999999	0.4515338421748833
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.012035718999999999	0.4515338421748833
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.012035718999999999	0.4515338421748833
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.012035718999999999	0.4515338421748833
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.45142178143413525
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.45142178143413525
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012032732	0.45142178143413525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.012026811000000002	0.4511996483086014
WEAVER SYNDROME	0.012026811000000002	0.4511996483086014
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012019233999999998	0.45091538843828033
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012019233999999998	0.45091538843828033
BETA-UREIDOPROPIONASE DEFICIENCY	0.012019233999999998	0.45091538843828033
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012019233999999998	0.45091538843828033
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012019233999999998	0.45091538843828033
JOUBERT SYNDROME 10	0.012019233999999998	0.45091538843828033
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.012019233999999998	0.45091538843828033
ACROCALLOSAL SYNDROME; ACLS	0.012014571000000002	0.45074045062974055
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.011923128000000002	0.4473098613039182
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01184276	0.44429476334193424
MENTAL RETARDATION, X-LINKED 19	0.011840822	0.4442220570427813
INFANTILE REFSUM DISEASE	0.011827339000000001	0.44371622678917993
TRISOMY 13	0.011770549000000002	0.4415856846174068
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.011764700000000001	0.44136625265468976
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.011764700000000001	0.44136625265468976
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.011764700000000001	0.44136625265468976
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.011764700000000001	0.44136625265468976
SOMATOMAMMOTROPINOMA	0.011764700000000001	0.44136625265468976
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.011764700000000001	0.44136625265468976
SCLEROSTEOSIS	0.011764700000000001	0.44136625265468976
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.011764700000000001	0.44136625265468976
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.011764700000000001	0.44136625265468976
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.011764700000000001	0.44136625265468976
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.011764700000000001	0.44136625265468976
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.011764700000000001	0.44136625265468976
46,XY SEX REVERSAL 1; SRXY1	0.011764700000000001	0.44136625265468976
46,XX SEX REVERSAL 1; SRXX1	0.011764700000000001	0.44136625265468976
PREMATURE OVARIAN FAILURE 2B	0.011764700000000001	0.44136625265468976
ACROMEGALY	0.011764700000000001	0.44136625265468976
DIABETIC EMBRYOPATHY	0.011764700000000001	0.44136625265468976
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.011764700000000001	0.44136625265468976
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.011764700000000001	0.44136625265468976
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.011764338000000001	0.4413526718083051
ZELLWEGER SYNDROME	0.011760829	0.441221027637135
DIAMOND-BLACKFAN ANEMIA 1	0.011744344	0.44060257390053204
MARDEN-WALKER SYNDROME	0.011680481000000001	0.4382066799981558
TRICHOHEPATOENTERIC SYNDROME 2	0.01164135	0.43673863552335984
TRICHOHEPATOENTERIC SYNDROME 1	0.01164135	0.43673863552335984
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.011583519	0.4345690390391934
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.011561887	0.43375748967733746
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.01149764	0.43134718957327145
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.011494299999999999	0.4312218856314908
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.011494299999999999	0.4312218856314908
DPM3-CDG	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.011494299999999999	0.4312218856314908
RICHIERI COSTA-DA SILVA SYNDROME	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.011494299999999999	0.4312218856314908
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.011494299999999999	0.4312218856314908
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.011494299999999999	0.4312218856314908
SPINOCEREBELLAR ATAXIA 47; SCA47	0.011493451	0.43119003441994236
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011493451	0.43119003441994236
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011486524000000001	0.43093016004727347
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.011486524000000001	0.43093016004727347
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.011486524000000001	0.43093016004727347
2Q33.1 DELETION SYNDROME	0.011367333	0.42645857258476566
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011315888	0.42452855423599173
17Q23.1Q23.2 MICRODELETION SYNDROME	0.011285920000000001	0.42340427024578753
JABERI-ELAHI SYNDROME; JABELS	0.011251401	0.42210925025586954
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.011125283	0.41737778842069273
W SYNDROME	0.011107289999999999	0.4167027603295373
13Q12.3 MICRODELETION SYNDROME	0.0110756	0.4155138735286307
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011073241000000001	0.4154253729302294
NEURONAL CEROID LIPOFUSCINOSIS	0.011065273	0.4151264442451671
METACHROMATIC LEUKODYSTROPHY	0.011065273	0.4151264442451671
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.011042100000000001	0.41425708249580095
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.010968517	0.4114965316131529
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.010968517	0.4114965316131529
VAN MALDERGEM SYNDROME 2; VMLDS2	0.010952032	0.41087807787654995
VAN MALDERGEM SYNDROME 1; VMLDS1	0.010952032	0.41087807787654995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010913497000000001	0.4094323930272934
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.010895769	0.4087673067159499
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010893948	0.4086989898063743
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.010893948	0.4086989898063743
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.010799821	0.40516770713332456
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01078831	0.4047358587279842
ADAMS-OLIVER SYNDROME	0.010756713000000001	0.4035504609290493
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.010745732000000001	0.40313849608333274
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010745732000000001	0.40313849608333274
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010726467	0.40241574744908004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010726467	0.40241574744908004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010651898	0.3996182056423015
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.010651898	0.3996182056423015
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.01063441	0.39896212320701413
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.010600349	0.39768428561390323
HEREDITARY FOLATE MALABSORPTION	0.010600349	0.39768428561390323
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.010540339000000001	0.3954329414383775
FAMILIAL DYSAUTONOMIA	0.010540339000000001	0.3954329414383775
ISOLATED CEREBELLAR AGENESIS	0.010540339000000001	0.3954329414383775
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010531913	0.3951168303565082
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.010523854000000001	0.3948144877017746
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.010523854000000001	0.3948144877017746
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010523854000000001	0.3948144877017746
MONOSOMY 18P	0.010523854000000001	0.3948144877017746
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.010517778	0.3945865395729544
BIOTINIDASE DEFICIENCY	0.01048625	0.3934037303883856
ROBERTS SYNDROME	0.010457344	0.3923192885497296
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010431251	0.391340379641681
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010425511	0.3911250369393395
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01035435	0.38845535017255745
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01035435	0.38845535017255745
SHORT SYNDROME	0.01035435	0.38845535017255745
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.01035435	0.38845535017255745
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.010330019	0.3875425447212207
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010330019	0.3875425447212207
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.010330019	0.3875425447212207
MENTAL RETARDATION, X-LINKED 97; MRX97	0.010313534	0.3869240909846178
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.010308948	0.3867520419196459
JOHANSON-BLIZZARD SYNDROME; JBS	0.010289772	0.38603263222276407
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.010274887	0.38547420432653506
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010258402	0.3848557505899321
601095 HARROD SYNDROME	0.010237534000000001	0.3840728635668548
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.010231779	0.3838569581222597
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.010231779	0.3838569581222597
FUCOSIDOSIS	0.010226039	0.3836416154199181
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.010220798	0.38344499327654313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.010185048	0.3821037909056876
GALLOWAY-MOWAT SYNDROME	0.010171769	0.381605613946734
X SMALL RINGS	0.01014784	0.38070788998779115
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010111703000000001	0.3793521688667951
SARCOSINEMIA	0.01010035	0.3789262480131916
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01010035	0.3789262480131916
CHROMOSOME 16Q22 DELETION SYNDROME	0.010066898000000001	0.37767125775557314
22Q11.2 DELETION SYNDROME	0.010019759	0.37590278394970555
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010006979000000001	0.37542332754971863
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.01000214	0.3752417868987376
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009999181	0.375130776610196
HELSMOORTEL-VAN DER AA SYNDROME	0.009999181	0.375130776610196
20Q11.2 MICRODELETION SYNDROME	0.009998920000000001	0.3751209848949851
HOLOPROSENCEPHALY 5; HPE5	0.009990494	0.37480487381311567
ELSAHY-WATERS SYNDROME; ESWS	0.009990494	0.37480487381311567
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009964401	0.3738259649050671
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009964401	0.3738259649050671
ACROPECTOROVERTEBRAL DYSPLASIA	0.00995465	0.3734601449241381
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00994739	0.37318777767344125
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00994739	0.37318777767344125
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009936319	0.3727724363742037
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.009936319	0.3727724363742037
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.009936319	0.3727724363742037
HEREDITARY METHEMOGLOBINEMIA	0.009936319	0.3727724363742037
SHPRINTZEN-GOLDBERG SYNDROME	0.009935474000000001	0.3727407352272562
KAGAMI-OGATA SYNDROME	0.009906317000000001	0.37164687683489156
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.009901987999999999	0.37148446942052965
HADDAD SYNDROME	0.009869653	0.37027138470272225
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009846251	0.36939343175495265
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.009838283	0.36909450306989033
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.009838283	0.36909450306989033
NEUROCUTANEOUS MELANOCYTOSIS	0.009838283	0.36909450306989033
LANDAU-KLEFFNER SYNDROME	0.009838283	0.36909450306989033
1Q41Q42 MICRODELETION SYNDROME	0.009838283	0.36909450306989033
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.009838283	0.36909450306989033
5Q35 MICRODUPLICATION SYNDROME	0.009838283	0.36909450306989033
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.009815721999999999	0.36824810120446727
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0097886	0.3672305881778282
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.0097886	0.3672305881778282
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.009784194	0.3670652920198984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.009784194	0.3670652920198984
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.009784194	0.3670652920198984
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009784194	0.3670652920198984
CARNOSINEMIA	0.009784194	0.3670652920198984
HYDROXYLYSINURIA	0.009784194	0.3670652920198984
CARNOSINASE DEFICIENCY	0.009784194	0.3670652920198984
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.009784194	0.3670652920198984
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009764929	0.36634254338564576
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.009764838000000001	0.3663391294159745
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009741787	0.3654743446369369
PEMPHIGOID GESTATIONIS	0.00969036	0.3635450015788672
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.3635450015788672
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009630350000000001	0.36129365740334146
CHROMOSOME 9P DELETION SYNDROME	0.009610012000000001	0.36053065393988803
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009586769000000002	0.3596586660600056
CHROMOSOME 10Q26 DELETION SYNDROME	0.009544191	0.358061303415354
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.009544191	0.358061303415354
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.009529359	0.3575048638750874
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009529359	0.3575048638750874
MUENKE SYNDROME	0.009491953000000001	0.35610153475944484
PARTINGTON SYNDROME	0.009481868999999999	0.35572322190048783
MICROFORM HOLOPROSENCEPHALY	0.009469713000000001	0.35526717557824683
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.009465560000000001	0.35511137100632617
DISTAL 17P13.1 MICRODELETION SYNDROME	0.009465560000000001	0.35511137100632617
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.009465560000000001	0.35511137100632617
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009465560000000001	0.35511137100632617
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.009465560000000001	0.35511137100632617
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.009465560000000001	0.35511137100632617
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009457762000000002	0.3548188200668036
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009439467	0.35413246209827753
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.009439467	0.35413246209827753
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.009422982	0.3535140083616746
LEGIUS SYNDROME	0.009387138000000001	0.35216927947269705
ADDUCTED THUMBS SYNDROME	0.009387138	0.35216927947269705
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009364898	0.35133492029149904
NEMALINE MYOPATHY 10	0.009364898	0.35133492029149904
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.35133492029149904
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00934741	0.3506788378562117
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00934741	0.3506788378562117
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00934741	0.3506788378562117
DYSTONIA, JUVENILE-ONSET	0.00934741	0.3506788378562117
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3494010002631008
SNEDDON SYNDROME	0.009313349	0.3494010002631008
PINEOBLASTOMA	0.009313349	0.3494010002631008
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.009313349	0.3494010002631008
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3494010002631008
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3494010002631008
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3494010002631008
CRYPTOCOCCOSIS	0.009313349	0.3494010002631008
MENTAL RETARDATION, X-LINKED 93	0.009311668	0.3493379356145579
HSD10 DISEASE, ATYPICAL TYPE	0.009296864	0.3487825465264978
NANCE-HORAN SYNDROME	0.009296864	0.3487825465264978
FAMILIAL PAROXYSMAL ATAXIA	0.009296864	0.3487825465264978
FETAL ALCOHOL SYNDROME	0.009296864	0.3487825465264978
ADULT POLYGLUCOSAN BODY DISEASE	0.009296864	0.3487825465264978
MENTAL RETARDATION, X-LINKED 105; MRX105	0.009296864	0.3487825465264978
ABETAL34V AMYLOIDOSIS	0.009296864	0.3487825465264978
NEUROFERRITINOPATHY	0.009296864	0.3487825465264978
HISTIDINEMIA	0.009296864	0.3487825465264978
SPINOCEREBELLAR ATAXIA TYPE 21	0.009296864	0.3487825465264978
SHORT SYNDROME	0.00927337	0.34790114209290673
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 3	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
PGM3-CDG	0.009239819	0.34664243773641507
LIG4 SYNDROME	0.00922351	0.3460305868422533
KOOLEN-DE VRIES SYNDROME	0.009189893000000001	0.3447694064198462
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.009163500000000002	0.34377924266672755
FONTAINE PROGEROID SYNDROME; FPS	0.009145088000000001	0.34308849530862423
THYROTOXIC PERIODIC PARALYSIS	0.00911458	0.34194395259729377
CARCINOMA OF ESOPHAGUS	0.00911458	0.34194395259729377
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009079267	0.3406191447840903
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.009079267	0.3406191447840903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.009079267	0.3406191447840903
MENTAL RETARDATION, X-LINKED 91; MRX91	0.009034819	0.33895162693850167
CHROMOSOME 16P13.3 DELETION SYNDROME	0.009015643	0.33823221724161984
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.009002863	0.3377527608416328
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009002863	0.3377527608416328
15Q14 MICRODELETION SYNDROME	0.009002863	0.3377527608416328
CEREBROFACIOARTICULAR SYNDROME	0.00898794	0.337192907331695
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.337192907331695
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.337192907331695
ISOLATED OXYCEPHALY	0.00898794	0.337192907331695
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00898794	0.337192907331695
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3355736727714572
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
SCARF SYNDROME	0.008940449999999999	0.3354112653570954
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.008940449999999999	0.3354112653570954
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.008940449999999999	0.3354112653570954
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.008940449999999999	0.3354112653570954
2P21 MICRODELETION SYNDROME	0.008937759	0.3353103093968165
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008932828	0.335125317260014
GMS SYNDROME	0.008928294	0.3349552190348543
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008928294	0.3349552190348543
CINCA SYNDROME	0.008928294	0.3349552190348543
MICROPHTHALMIA, SYNDROMIC 1	0.008924441	0.33481066930800374
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008898048	0.3338205055548851
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008898048	0.3338205055548851
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.008884712999999999	0.33332022769151837
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.008780249	0.32940114057350267
MEHMO SYNDROME	0.008780249	0.32940114057350267
KLEEFSTRA SYNDROME	0.008780249	0.32940114057350267
HUNTINGTON DISEASE	0.00877193	0.3290890437197084
HISTIDINEMIA	0.00877193	0.3290890437197084
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.3290890437197084
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.3290890437197084
KEIPERT SYNDROME	0.00877193	0.3290890437197084
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.3290890437197084
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.3290890437197084
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.3290890437197084
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.3290890437197084
RHEUMATIC FEVER	0.00877193	0.3290890437197084
CORTICOBASAL SYNDROME	0.00877193	0.3290890437197084
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.3290890437197084
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.3290890437197084
BREATH-HOLDING SPELLS	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.3290890437197084
LOCKED-IN SYNDROME	0.00877193	0.3290890437197084
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.3290890437197084
CAFFEY DISEASE	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.3290890437197084
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.3290890437197084
MILROY DISEASE	0.00877193	0.3290890437197084
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.3290890437197084
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.3290890437197084
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.3290890437197084
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.008708484	0.3267087940519795
EAR-PATELLA-SHORT STATURE SYNDROME	0.008708484	0.3267087940519795
OROFACIODIGITAL SYNDROME TYPE 4	0.008708484	0.3267087940519795
PETTIGREW SYNDROME	0.008673587	0.3253995929572732
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.008648474000000001	0.32445744987645375
3C SYNDROME	0.008648474000000001	0.32445744987645375
OCCIPITAL HORN SYNDROME	0.008648474000000001	0.32445744987645375
DISTAL MONOSOMY 9P	0.008648474000000001	0.32445744987645375
2Q24 MICRODELETION SYNDROME	0.008642663	0.32423944352744555
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008642663	0.32423944352744555
FRIED SYNDROME	0.00863839	0.3240791370174968
COACH SYNDROME	0.008612297	0.3231002281094483
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.008606921	0.32289854128579176
WOLF-HIRSCHHORN SYNDROME	0.008582653	0.3219880993519198
OROFACIODIGITAL SYNDROME TYPE 2	0.0085713	0.3215621784983163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.008537848	0.3203071882406978
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008528721999999999	0.3199648158536648
KLEEFSTRA SYNDROME	0.008514797	0.3194424034616602
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.008496224	0.31874561600336926
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.008496224	0.31874561600336926
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0084934	0.31863967039510926
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.0084934	0.31863967039510926
KABUKI SYNDROME	0.008490708999999999	0.31853871443483023
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.008477929	0.3180592580348433
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008477929	0.3180592580348433
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.008477929	0.3180592580348433
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.008477838000000001	0.31805584406517207
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.008461444	0.3174408042982404
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.008461444	0.3174408042982404
CRANIOECTODERMAL DYSPLASIA 1	0.0084256	0.31609607540926277
RAPADILINO SYNDROME	0.0084256	0.31609607540926277
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0084256	0.31609607540926277
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0084256	0.31609607540926277
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0084256	0.31609607540926277
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.0084256	0.31609607540926277
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.0084256	0.31609607540926277
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806476
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806476
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
HYDROLETHALUS	0.00840336	0.31526171622806476
RENAL TUBULAR DYSGENESIS	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31526171622806476
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
FATCO SYNDROME	0.00840336	0.31526171622806476
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
COFFIN-SIRIS SYNDROME 6; CSS6	0.008383022	0.3144987127646113
CHROMOSOME 18P DELETION SYNDROME	0.008343294000000001	0.31300827114812596
CRI-DU-CHAT SYNDROME	0.008343294000000001	0.31300827114812596
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.008317201	0.3120293622400773
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.008307552	0.3116673689064721
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008307552	0.3116673689064721
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00826924	0.31023005015871774
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.31023005015871774
AMISH LETHAL MICROCEPHALY	0.00826924	0.31023005015871774
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00826924	0.31023005015871774
MYOPATHIC EHLERS-DANLOS SYNDROME	0.008183550000000001	0.30701529124518995
16P12.1P12.3 TRIPLICATION SYNDROME	0.008183550000000001	0.30701529124518995
LATERAL MENINGOCELE SYNDROME	0.00812354	0.3047639470696642
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00812354	0.3047639470696642
DISTAL MONOSOMY 15Q	0.008117729	0.30454594072065605
MEIER-GORLIN SYNDROME 6; MGORS6	0.008101244	0.3039274869840531
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.008081986999999999	0.3032050384790022
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008081986999999999	0.3032050384790022
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.008041234000000001	0.30167614280852734
HYPERCALCEMIA, INFANTILE, 1	0.007981802	0.29944648296783666
GAPO SYNDROME; GAPOS	0.007962903	0.2987374652445695
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.007962903	0.2987374652445695
16Q24.3 MICRODELETION SYNDROME	0.007952819	0.2983591523856126
PMM2-CDG	0.007947443	0.29815746556195616
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.007947443	0.29815746556195616
HUNTER-MACDONALD SYNDROME	0.00793651	0.29774730149145084
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.00793651	0.29774730149145084
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.007887433	0.2959061213864303
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.007842628	0.2942252102752084
THREE M SYNDROME 2; 3M2	0.00781836	0.29331476834133635
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00781836	0.29331476834133635
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007792267	0.2923358594332878
3Q29 MICRODUPLICATION SYNDROME	0.0077286429999999995	0.2899489318908174
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.0077286429999999995	0.2899489318908174
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0077223199999999995	0.2897117172728895
AICA-RIBOSIDURIA	0.007712049	0.28932638889383894
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.007712049	0.28932638889383894
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007710768999999999	0.2892783682215398
EAST SYNDROME	0.007710768999999999	0.2892783682215398
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007690048999999999	0.288501033588697
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007666647	0.28762308064092745
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.007664559	0.28754474691923937
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007650758999999999	0.287027024046014
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.007650758999999999	0.287027024046014
FRAGILE X SYNDROME	0.007650758999999999	0.287027024046014
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
TRANSALDOLASE DEFICIENCY	0.00757631	0.28423398417726353
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.007567184	0.2838916117902306
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.007567184	0.2838916117902306
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.007567184	0.2838916117902306
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.007567184	0.2838916117902306
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.007553259	0.28336919939822597
XQ21 MICRODELETION SYNDROME	0.007505768999999999	0.2815875574236264
WOLCOTT-RALLISON SYNDROME	0.0075016729999999995	0.2814338912722691
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.007463191	0.27999019477897497
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.007463191	0.27999019477897497
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.007450689999999999	0.2795212053849031
LOWRY-MACLEAN SYNDROME	0.007437969000000001	0.27904396243778
QAZI-MARKOUIZOS SYNDROME	0.007437969000000001	0.27904396243778
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007424596999999999	0.2785422964768546
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.007421484000000001	0.27842550870117705
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.007421484000000001	0.27842550870117705
HALLERMANN-STREIFF SYNDROME	0.007421484000000001	0.27842550870117705
OCULO-PALATO-CEREBRAL SYNDROME	0.007421484000000001	0.27842550870117705
OROFACIODIGITAL SYNDROME TYPE 5	0.007421484000000001	0.27842550870117705
BARBER-SAY SYNDROME; BBRSAY	0.007421484000000001	0.27842550870117705
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.007421484000000001	0.27842550870117705
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.007411399999999999	0.27804719584222015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.007385306999999999	0.2770682869341715
XQ25 MICRODUPLICATION SYNDROME	0.007385306999999999	0.2770682869341715
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.007385306999999999	0.2770682869341715
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007379930999999999	0.27686660011051506
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.007355663	0.2759561581766431
GLYCEROL KINASE DEFICIENCY; GKD	0.007355663	0.2759561581766431
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.007355663	0.2759561581766431
BANGSTAD SYNDROME	0.007355663	0.2759561581766431
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007319921	0.2746152559349893
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.007319921	0.2746152559349893
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.007319921	0.2746152559349893
FANCONI ANEMIA	0.007262314	0.2724540630684752
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.007250848000000001	0.27202390288989536
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.007250848000000001	0.27202390288989536
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00716935	0.2689664116781473
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00714863	0.26818907704530454
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.007125227999999999	0.26731112409753494
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00712314	0.26723279037584696
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00710934	0.26671506750262153
16P11.2P12.2 MICRODELETION SYNDROME	0.00710934	0.26671506750262153
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00710934	0.26671506750262153
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0070970469999999996	0.2662538814677984
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0070970469999999996	0.2662538814677984
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.007036749	0.26399173264100534
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.007036749	0.26399173264100534
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007036749	0.26399173264100534
CENTRAL DIABETES INSIPIDUS	0.007036749	0.26399173264100534
CLASSIC GALACTOSEMIA	0.007020264	0.2633732789044024
TRISOMY 5P	0.00701184	0.2630572428548335
CHOREOACANTHOCYTOSIS	0.006976739	0.26174038846547953
LYNCH SYNDROME	0.006976739	0.26174038846547953
FAMILIAL COLORECTAL CANCER TYPE X	0.006976739	0.26174038846547953
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006976739	0.26174038846547953
GM1 GANGLIOSIDOSIS	0.006976739	0.26174038846547953
MULTIPLE CARBOXYLASE DEFICIENCY	0.006976739	0.26174038846547953
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.006964349999999999	0.26127560088023394
MONOSOMY 13Q34	0.006964349999999999	0.26127560088023394
GALACTOSE EPIMERASE DEFICIENCY	0.006960254	0.2611219347288766
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0069217720000000005	0.25967823823558245
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00689655	0.2587320058943875
CLEIDOCRANIAL DYSPLASIA; CCD	0.00689655	0.2587320058943875
RADIO-RENAL SYNDROME	0.00689655	0.2587320058943875
600736 VELOFACIOSKELETAL SYNDROME	0.00689655	0.2587320058943875
PHOCOMELIA, SCHINZEL TYPE	0.00689655	0.2587320058943875
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00689655	0.2587320058943875
SIMOSA CRANIOFACIAL SYNDROME	0.00689655	0.2587320058943875
FAMILIAL ANETODERMA	0.00689655	0.2587320058943875
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00689655	0.2587320058943875
STICKLER SYNDROME, TYPE II	0.00689655	0.2587320058943875
CHILDHOOD APRAXIA OF SPEECH	0.00689655	0.2587320058943875
CENANI-LENZ SYNDROME	0.00689655	0.2587320058943875
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00689655	0.2587320058943875
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00689655	0.2587320058943875
MESOMELIA-SYNOSTOSES SYNDROME	0.00689655	0.2587320058943875
CLEIDOCRANIAL DYSPLASIA	0.00689655	0.2587320058943875
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00689655	0.2587320058943875
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00689655	0.2587320058943875
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.006883177999999999	0.2582303399334621
ROIFMAN SYNDROME	0.006843887999999999	0.2567563303907791
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006838512	0.2565546435671226
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.006830729000000001	0.2562626553698536
ROTHMUND-THOMSON SYNDROME	0.0068142440000000006	0.25564420163325063
OLIVER-MCFARLANE SYNDROME	0.0068142440000000006	0.25564420163325063
FANCONI ANEMIA	0.0068142440000000006	0.25564420163325063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0068142440000000006	0.25564420163325063
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0068142440000000006	0.25564420163325063
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0068142440000000006	0.25564420163325063
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0068142440000000006	0.25564420163325063
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.006778502	0.25430329939159685
JOUBERT SYNDROME 1	0.006778502	0.25430329939159685
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.006737379999999999	0.25276056026168564
HUNTINGTON DISEASE-LIKE 1	0.006711287	0.2517816513536371
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006705109	0.25154987657749317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006660443	0.2498741802111537
19P13.13 MICRODELETION SYNDROME	0.006660442999999999	0.24987418021115365
DYSOSTEOSCLEROSIS	0.006660442999999999	0.24987418021115365
DESBUQUOIS DYSPLASIA 1	0.006619712000000001	0.24834610989598388
JOUBERT SYNDROME 8	0.006619712000000001	0.24834610989598388
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.006501653	0.24391699071554065
ACRODERMATITIS ENTEROPATHICA	0.00649533	0.24367977609761282
MUCOLIPIDOSIS TYPE II	0.00649533	0.24367977609761282
RETICULAR DYSGENESIS	0.00649533	0.24367977609761282
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00649533	0.24367977609761282
X-LINKED AGAMMAGLOBULINEMIA	0.00649533	0.24367977609761282
CRYPTOSPORIDIOSIS	0.00649533	0.24367977609761282
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.006463058999999999	0.2424690924134203
JUVENILE DERMATOMYOSITIS	0.00643532	0.24142843192208707
POLYMYOSITIS	0.00643532	0.24142843192208707
DERMATOMYOSITIS	0.00643532	0.24142843192208707
FRAGILE X MENTAL RETARDATION SYNDROME	0.006423768999999999	0.24099508287073731
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.006423768999999999	0.24099508287073731
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006423768999999999	0.24099508287073731
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.006423768999999999	0.24099508287073731
HSD10 DISEASE	0.006423768999999999	0.24099508287073731
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.006423768999999999	0.24099508287073731
BRANCHIOSKELETOGENITAL SYNDROME	0.006423768999999999	0.24099508287073731
MENTAL RETARDATION, X-LINKED 21	0.006423768999999999	0.24099508287073731
SAETHRE-CHOTZEN SYNDROME	0.006423768999999999	0.24099508287073731
PACHYGYRIA, FRONTOTEMPORAL	0.006423768999999999	0.24099508287073731
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006423768999999999	0.24099508287073731
MENTAL RETARDATION, X-LINKED 14	0.006423768999999999	0.24099508287073731
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.006423768999999999	0.24099508287073731
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.006418393	0.2407933960470808
6Q25 MICRODELETION SYNDROME	0.0064155689999999994	0.24068745043882075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.006407284	0.2403766291341344
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.006407284	0.2403766291341344
MICRO SYNDROME	0.006403049	0.2402177482378946
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.006403049	0.2402177482378946
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006360471	0.2386203855932431
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.006358383	0.23854205187155506
FILIPPI SYNDROME	0.006358383	0.23854205187155506
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.006358383	0.23854205187155506
SILVER-RUSSELL SYNDROME; SRS	0.00628931	0.23595069882646108
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00628931	0.23595069882646108
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00628931	0.23595069882646108
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00628931	0.23595069882646108
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00628931	0.23595069882646108
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00628931	0.23595069882646108
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00628931	0.23595069882646108
PANCREATIC AGENESIS 2; PAGEN2	0.00628931	0.23595069882646108
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00628931	0.23595069882646108
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00628931	0.23595069882646108
BOWEN-CONRADI SYNDROME	0.00628931	0.23595069882646108
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00628931	0.23595069882646108
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00628931	0.23595069882646108
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00628931	0.23595069882646108
SECKEL SYNDROME 9; SCKL9	0.00628931	0.23595069882646108
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00628931	0.23595069882646108
ISOLATED CLEFT LIP	0.00628931	0.23595069882646108
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00628931	0.23595069882646108
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.006253568	0.2346097965848073
LARSEN-LIKE SYNDROME	0.006253568	0.2346097965848073
2Q37 MICRODELETION SYNDROME	0.006199593	0.23258486237594206
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.006199593	0.23258486237594206
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.0061636899999999994	0.23123792003410065
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0061636899999999994	0.23123792003410065
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0061609989999999995	0.23113696407382175
CONO-SPONDYLAR DYSPLASIA	0.0061609989999999995	0.23113696407382175
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0061609989999999995	0.23113696407382175
TEMPLE-BARAITSER SYNDROME	0.006137597	0.23025901112605213
FETAL TRIMETHADIONE SYNDROME	0.006119024	0.22956222366776116
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776116
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776116
12Q14 MICRODELETION SYNDROME	0.0060970239999999995	0.22873686836261928
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006092930999999999	0.2285833147597126
WIEACKER-WOLFF SYNDROME	0.006090106999999999	0.22847736915145256
WIEDEMANN-STEINER SYNDROME; WDSTS	0.006070931	0.2277579594545707
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.006070931	0.2277579594545707
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.006070931	0.2277579594545707
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.005895547	0.22117822696197934
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.005895546999999999	0.22117822696197928
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005895546999999999	0.22117822696197928
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.005895546999999999	0.22117822696197928
GRACILE BONE DYSPLASIA; GCLEB	0.005893459	0.2210998932402913
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00588235	0.22068312632734485
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00588235	0.22068312632734485
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00588235	0.22068312632734485
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00588235	0.22068312632734485
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734485
MOSAIC TRISOMY 1	0.00588235	0.22068312632734485
CARPENTER-WAZIRI SYNDROME	0.00588235	0.22068312632734485
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11	0.00588235	0.22068312632734485
PROTEUS SYNDROME	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00588235	0.22068312632734485
GMEZ-LPEZ-HERNNDEZ SYNDROME	0.00588235	0.22068312632734485
NANCE-HORAN SYNDROME	0.00588235	0.22068312632734485
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00588235	0.22068312632734485
DISTAL TRISOMY 5Q	0.00588235	0.22068312632734485
X-LINKED INTELLECTUAL DISABILITY-MACROCEPHALY-MACROORCHIDISM SYNDROME	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00588235	0.22068312632734485
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00588235	0.22068312632734485
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00588235	0.22068312632734485
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00588235	0.22068312632734485
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00588235	0.22068312632734485
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734485
MYOPATHY AND DIABETES MELLITUS	0.00588235	0.22068312632734485
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00588235	0.22068312632734485
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00588235	0.22068312632734485
SPINOCEREBELLAR ATAXIA TYPE 35	0.00588235	0.22068312632734485
HYPERTRYPTOPHANEMIA; HYPTRP	0.00588235	0.22068312632734485
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.00588235	0.22068312632734485
OTOFACIOCERVICAL SYNDROME 2	0.00588235	0.22068312632734485
GARDNER SYNDROME	0.00588235	0.22068312632734485
MARSHALL-SMITH SYNDROME	0.005876974	0.22048143950368837
2Q32Q33 MICRODELETION SYNDROME	0.00586163	0.21990579169450208
MONOSOMY 5P	0.00586163	0.21990579169450208
SCHINDLER DISEASE, TYPE I	0.005835537	0.21892688278645356
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005833449	0.21884854906476553
NEUROFACIODIGITORENAL SYNDROME	0.005816964	0.2182300953281626
FAMILIAL LAMBDOID SYNOSTOSIS	0.005816964	0.2182300953281626
NATIVE AMERICAN MYOPATHY	0.00581414	0.21812414971990254
NOCARDIOSIS	0.005749749	0.2157084472902029
MALIGNANT ATROPHIC PAPULOSIS	0.005749749	0.2157084472902029
JUVENILE HUNTINGTON DISEASE	0.005749749	0.2157084472902029
TAKAYASU ARTERITIS	0.005749749	0.2157084472902029
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005749749	0.2157084472902029
ACUTE INTERMITTENT PORPHYRIA	0.005749749	0.2157084472902029
BEHET DISEASE	0.005749749	0.2157084472902029
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005749749	0.2157084472902029
TSH-SECRETING PITUITARY ADENOMA	0.005749749	0.2157084472902029
RIFT VALLEY FEVER	0.005749749	0.2157084472902029
ERYTHROKERATODERMIA VARIABILIS	0.005733264	0.21508999355359992
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.005718184	0.21452425000807537
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.005674658999999999	0.21289135956915253
19P13.12 MICRODELETION SYNDROME	0.005674658999999999	0.21289135956915253
KALLMANN SYNDROME	0.005674658999999999	0.21289135956915253
DOWN SYNDROME	0.005658174	0.21227290583254962
COWDEN SYNDROME 6; CWS6	0.005653502999999999	0.21209766789480783
COWDEN SYNDROME 5; CWS5	0.005653502999999999	0.21209766789480783
RING CHROMOSOME 13 SYNDROME	0.005596177999999999	0.20994705458265966
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0055940899999999995	0.20986872086097164
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0055940899999999995	0.20986872086097164
FRANK-TER HAAR SYNDROME; FTHS	0.0055940899999999995	0.20986872086097164
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0055940899999999995	0.20986872086097164
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0055940899999999995	0.20986872086097164
NASODIGITOACOUSTIC SYNDROME	0.0055940899999999995	0.20986872086097164
OGDEN SYNDROME; OGDNS	0.0055940899999999995	0.20986872086097164
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0055940899999999995	0.20986872086097164
17P11.2 MICRODUPLICATION SYNDROME	0.00557209	0.20904336555582972
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00557209	0.20904336555582972
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00557209	0.20904336555582972
DESANTO-SHINAWI SYNDROME	0.005567997	0.20888981195292308
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005567997	0.20888981195292308
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.005567997	0.20888981195292308
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.005567997	0.20888981195292308
COFFIN-SIRIS SYNDROME 7; CSS7	0.005551512	0.20827135821632017
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.005551512	0.20827135821632017
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.005551512	0.20827135821632017
MENTAL RETARDATION, X-LINKED 99	0.005551512	0.20827135821632017
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0055486879999999995	0.20816541260806012
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0055486879999999995	0.20816541260806012
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0055486879999999995	0.20816541260806012
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0055486879999999995	0.20816541260806012
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0055486879999999995	0.20816541260806012
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0055486879999999995	0.20816541260806012
C SYNDROME	0.0055459969999999996	0.20806445664778117
OROFACIODIGITAL SYNDROME VI	0.0055295119999999994	0.2074460029111782
HADZISELIMOVIC SYNDROME	0.0055295119999999994	0.2074460029111782
JOUBERT SYNDROME 2	0.0055295119999999994	0.2074460029111782
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0055295119999999994	0.2074460029111782
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005458943	0.2047985257053346
SHOX-RELATED SHORT STATURE	0.0054353	0.20391153136535864
NON-DISTAL MONOSOMY 20Q	0.005409206999999999	0.20293262245731006
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005409206999999999	0.20293262245731006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005409206999999999	0.20293262245731006
MICROTRIPLICATION 11Q24.1	0.005392722000000001	0.2023141687207072
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.005392722000000001	0.2023141687207072
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005354128	0.20086627041858682
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00535204	0.2007879366968988
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00535204	0.2007879366968988
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00535204	0.2007879366968988
HYPERLYSINEMIA, TYPE I	0.005351442999999999	0.20076553955520926
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00529203	0.19853659252137304
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00529203	0.19853659252137304
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00529203	0.19853659252137304
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.005246628	0.19683328426846153
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.005246628	0.19683328426846153
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.005246628	0.19683328426846153
HEPATOCELLULAR CARCINOMA	0.00520833	0.19539649074681037
MANTLE CELL LYMPHOMA	0.00520833	0.19539649074681037
PERITONEAL CYSTIC MESOTHELIOMA	0.00520833	0.19539649074681037
MALIGNANT PERITONEAL MESOTHELIOMA	0.00520833	0.19539649074681037
GIANT CELL ARTERITIS	0.00520833	0.19539649074681037
MALT LYMPHOMA	0.00520833	0.19539649074681037
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.19539649074681037
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.19539649074681037
EOSINOPHILIC GASTROENTERITIS	0.00520833	0.19539649074681037
NON-FUNCTIONING PARAGANGLIOMA	0.00520833	0.19539649074681037
PSEUDOMYXOMA PERITONEI	0.00520833	0.19539649074681037
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681037
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.19539649074681037
PLEURAL MESOTHELIOMA	0.00520833	0.19539649074681037
FELTY SYNDROME	0.00520833	0.19539649074681037
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00520833	0.19539649074681037
PERRY SYNDROME	0.00520833	0.19539649074681037
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00520833	0.19539649074681037
SYSTEMIC CAPILLARY LEAK SYNDROME	0.00520833	0.19539649074681037
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.19539649074681037
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.19539649074681037
FOCAL MYOSITIS	0.00520833	0.19539649074681037
GRFOMA	0.00520833	0.19539649074681037
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00520833	0.19539649074681037
CLASSIC HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
THYMIC CARCINOMA	0.00520833	0.19539649074681037
ACUTE MONOBLASTIC LEUKEMIA	0.00520833	0.19539649074681037
LEISHMANIASIS	0.00520833	0.19539649074681037
PRIMARY SCLEROSING CHOLANGITIS	0.00520833	0.19539649074681037
RIDDLE SYNDROME	0.00520833	0.19539649074681037
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.19539649074681037
HERMANSKY-PUDLAK SYNDROME	0.00520833	0.19539649074681037
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.19539649074681037
MARBURG HEMORRHAGIC FEVER	0.00520833	0.19539649074681037
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.19539649074681037
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.19539649074681037
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.19539649074681037
BUDD-CHIARI SYNDROME	0.00520833	0.19539649074681037
OROMANDIBULAR DYSTONIA	0.00520833	0.19539649074681037
STEVENS-JOHNSON SYNDROME	0.00520833	0.19539649074681037
YAO SYNDROME	0.00520833	0.19539649074681037
MU-HEAVY CHAIN DISEASE	0.00520833	0.19539649074681037
THYMIC NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.19539649074681037
BRONCHIAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.19539649074681037
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00520833	0.19539649074681037
NEPHROBLASTOMA	0.00520833	0.19539649074681037
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.19539649074681037
MAST CELL SARCOMA	0.00520833	0.19539649074681037
KAPOSI SARCOMA	0.00520833	0.19539649074681037
PULMONARY BLASTOMA	0.00520833	0.19539649074681037
REACTIVE ARTHRITIS	0.00520833	0.19539649074681037
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF STOMACH	0.00520833	0.19539649074681037
JEJUNAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00520833	0.19539649074681037
OSTEOSARCOMA	0.00520833	0.19539649074681037
MEDULLARY THYROID CARCINOMA	0.00520833	0.19539649074681037
BULLOUS PEMPHIGOID	0.00520833	0.19539649074681037
ANAPLASTIC THYROID CARCINOMA	0.00520833	0.19539649074681037
PARATHYROID CARCINOMA	0.00520833	0.19539649074681037
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.00520833	0.19539649074681037
RAT-BITE FEVER	0.00520833	0.19539649074681037
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.19539649074681037
POLYCYTHEMIA VERA	0.00520833	0.19539649074681037
EOSINOPHILIC FASCIITIS	0.00520833	0.19539649074681037
PANCREATOBLASTOMA	0.00520833	0.19539649074681037
LIPOSARCOMA	0.00520833	0.19539649074681037
ISAAC SYNDROME	0.00520833	0.19539649074681037
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.19539649074681037
RHABDOID TUMOR	0.00520833	0.19539649074681037
MNTRIER DISEASE	0.00520833	0.19539649074681037
HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
CARNEY-STRATAKIS SYNDROME	0.00520833	0.19539649074681037
ILEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
TUBERCULOSIS	0.00520833	0.19539649074681037
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00520833	0.19539649074681037
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681037
VIPOMA	0.00520833	0.19539649074681037
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681037
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.00520833	0.19539649074681037
POEMS SYNDROME	0.00520833	0.19539649074681037
FAMILIAL PANCREATIC CARCINOMA	0.00520833	0.19539649074681037
ZOLLINGER-ELLISON SYNDROME	0.00520833	0.19539649074681037
THYMIC EPITHELIAL NEOPLASM	0.00520833	0.19539649074681037
FOLLICULAR LYMPHOMA	0.00520833	0.19539649074681037
GLUCAGONOMA	0.00520833	0.19539649074681037
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00520833	0.19539649074681037
PPOMA	0.00520833	0.19539649074681037
POLYARTERITIS NODOSA	0.00520833	0.19539649074681037
TOXIC EPIDERMAL NECROLYSIS	0.00520833	0.19539649074681037
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00520833	0.19539649074681037
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00520833	0.19539649074681037
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.19539649074681037
GALLBLADDER NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00520833	0.19539649074681037
CAP POLYPOSIS	0.00520833	0.19539649074681037
ATTRV30M AMYLOIDOSIS	0.00520833	0.19539649074681037
ERDHEIM-CHESTER DISEASE	0.00520833	0.19539649074681037
LARYNGEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681037
CASTLEMAN DISEASE	0.00520833	0.19539649074681037
SARCOIDOSIS	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00520833	0.19539649074681037
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00520833	0.19539649074681037
ALPORT SYNDROME	0.00520833	0.19539649074681037
SOMATOSTATINOMA	0.00520833	0.19539649074681037
NEUROENDOCRINE TUMOR OF THE COLON	0.00520833	0.19539649074681037
PYOMYOSITIS	0.00520833	0.19539649074681037
KLATSKIN TUMOR	0.00520833	0.19539649074681037
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.19539649074681037
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.19539649074681037
PERRY SYNDROME	0.00520833	0.19539649074681037
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.19539649074681037
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.19539649074681037
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.19539649074681037
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681037
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.19539649074681037
DISTAL TRISOMY 17Q	0.005176059	0.19418580706261787
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.005176059	0.19418580706261787
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576007
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576007
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576007
ACHONDROPLASIA	0.00513324	0.19257940302576007
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576007
DISTAL MONOSOMY 1Q	0.005131393	0.19251011069627838
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.005131393	0.19251011069627838
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0051285689999999995	0.19240416508801833
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.005112083999999999	0.1917857113514154
1Q21.1 MICRODELETION SYNDROME	0.005109392999999999	0.19168475539113644
WIEDEMANN-STEINER SYNDROME	0.005109392999999999	0.19168475539113644
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.005109392999999999	0.19168475539113644
HENNEKAM-BEEMER SYNDROME	0.005109392999999999	0.19168475539113644
ALEXANDER DISEASE	0.005109392999999999	0.19168475539113644
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.005026578	0.18857785540953065
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005026578	0.18857785540953065
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.005026578	0.18857785540953065
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.005026578	0.18857785540953065
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.005026578	0.18857785540953065
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005026578	0.18857785540953065
RIGID SPINE MUSCULAR DYSTROPHY 1	0.005004578	0.1877525001043887
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.005004578	0.1877525001043887
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005004578	0.1877525001043887
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.004972603	0.18655292120066538
11P15.4 MICRODUPLICATION SYNDROME	0.004972603	0.18655292120066538
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.004972603	0.18655292120066538
MONOSOMY 22Q13.3	0.004972603	0.18655292120066538
CHROMOSOME 2Q37 DELETION SYNDROME	0.004972603	0.18655292120066538
DISTAL 16P11.2 MICRODELETION SYNDROME	0.004972603	0.18655292120066538
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004972603	0.18655292120066538
BOHRING-OPITZ SYNDROME	0.004934009	0.18510502289854502
XQ28 (MECP2) DUPLICATION	0.004934009	0.18510502289854502
RETT SYNDROME	0.004934009	0.18510502289854502
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004934009	0.18510502289854502
PITT-HOPKINS-LIKE SYNDROME	0.004934009	0.18510502289854502
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004934009	0.18510502289854502
HALL-RIGGS SYNDROME	0.004934009	0.18510502289854502
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004886519	0.1833233809239455
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.004873999	0.1828536787230193
4Q21 MICRODELETION SYNDROME	0.004873999	0.1828536787230193
5Q14.3 MICRODELETION SYNDROME	0.004873999	0.1828536787230193
14Q12 MICRODELETION SYNDROME	0.004873999	0.1828536787230193
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004873999	0.1828536787230193
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.004873999	0.1828536787230193
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004873999	0.1828536787230193
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004873999	0.1828536787230193
MEND SYNDROME	0.004843941	0.18172601827929402
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004843941	0.18172601827929402
OROFACIODIGITAL SYNDROME TYPE 6	0.004843941	0.18172601827929402
ZTTK SYNDROME; ZTTKS	0.004843941	0.18172601827929402
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004783931	0.17947467410376827
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004783931	0.17947467410376827
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004783931	0.17947467410376827
EMANUEL SYNDROME	0.004783931	0.17947467410376827
KABUKI SYNDROME 1	0.004783931	0.17947467410376827
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00463464	0.1738738505192254
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00463464	0.1738738505192254
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004608547	0.17289494161117686
TRISOMY 8P	0.004608547	0.17289494161117686
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004608547	0.17289494161117686
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.004608547	0.17289494161117686
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004608547	0.17289494161117686
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.004608547	0.17289494161117686
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004608547	0.17289494161117686
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004608547	0.17289494161117686
LISSENCEPHALY 3; LIS3	0.004608547	0.17289494161117686
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.004608547	0.17289494161117686
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.004608547	0.17289494161117686
MOWAT-WILSON SYNDROME; MOWS	0.004608547	0.17289494161117686
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004608547	0.17289494161117686
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004606459	0.17281660788948883
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004606459	0.17281660788948883
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004606459	0.17281660788948883
WEBB-DATTANI SYNDROME; WEDAS	0.004606459	0.17281660788948883
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.17219815415288592
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004589974	0.17219815415288592
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.17219815415288592
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004589974	0.17219815415288592
PETERS PLUS SYNDROME	0.004589974	0.17219815415288592
ZECHI-CEIDE SYNDROME	0.004589974	0.17219815415288592
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.004589974	0.17219815415288592
ZECHI-CEIDE SYNDROME	0.004589974	0.17219815415288592
KEIPERT SYNDROME; KPTS	0.004589974	0.17219815415288592
LARSEN SYNDROME	0.004589974	0.17219815415288592
NOONAN SYNDROME 5; NS5	0.004589974	0.17219815415288592
OPITZ G/BBB SYNDROME	0.004589974	0.17219815415288592
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00458715	0.17209220854462587
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00458715	0.17209220854462587
FRONTOOCULAR SYNDROME	0.00458715	0.17209220854462587
14Q11.2 MICRODELETION SYNDROME	0.00458715	0.17209220854462587
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00458715	0.17209220854462587
MOEBIUS SYNDROME; MBS	0.00458715	0.17209220854462587
17Q21.31 MICRODUPLICATION SYNDROME	0.004567974	0.17137279884774398
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.004567974	0.17137279884774398
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.004567974	0.17137279884774398
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004561057	0.17111329963657732
SPINOCEREBELLAR ATAXIA TYPE 13	0.004561057	0.17111329963657732
TEMTAMY SYNDROME; TEMTYS	0.004561057	0.17111329963657732
PELIZAEUS-MERZBACHER DISEASE	0.004541881	0.17039388993969543
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004541881	0.17039388993969543
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004541881	0.17039388993969543
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.004541881	0.17039388993969543
LEIGH SYNDROME; LS	0.004541881	0.17039388993969543
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004541881	0.17039388993969543
FOLATE MALABSORPTION, HEREDITARY	0.004541881	0.17039388993969543
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004541881	0.17039388993969543
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004541881	0.17039388993969543
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.004541881	0.17039388993969543
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004541881	0.17039388993969543
ADIPOSIS DOLOROSA	0.004447669	0.16685941839387583
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.004447669	0.16685941839387583
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.004447669	0.16685941839387583
BARDET-BIEDL SYNDROME 14; BBS14	0.004431184	0.16624096465727292
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.004431184	0.16624096465727292
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 13; BBS13	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 9; BBS9	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 8; BBS8	0.004431184	0.16624096465727292
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004431184	0.16624096465727292
URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.16624096465727292
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.004431184	0.16624096465727292
CARPENTER SYNDROME	0.004431184	0.16624096465727292
BIEMOND SYNDROME TYPE 2	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 16; BBS16	0.004431184	0.16624096465727292
LAURENCE-MOON SYNDROME	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 4; BBS4	0.004431184	0.16624096465727292
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.004431184	0.16624096465727292
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.004431184	0.16624096465727292
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.004431184	0.16624096465727292
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 3; BBS3	0.004431184	0.16624096465727292
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME	0.004431184	0.16624096465727292
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.004431184	0.16624096465727292
RETINITIS PIGMENTOSA	0.004431184	0.16624096465727292
WAGR SYNDROME	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 6; BBS6	0.004431184	0.16624096465727292
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.004431184	0.16624096465727292
MACROCEPHALY/AUTISM SYNDROME	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 2	0.004431184	0.16624096465727292
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 19; BBS19	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 7; BBS7	0.004431184	0.16624096465727292
BARDET-BIEDL SYNDROME 20	0.004431184	0.16624096465727292
ATKIN-FLAITZ SYNDROME	0.004431184	0.16624096465727292
CHOPS SYNDROME; CHOPS	0.004431184	0.16624096465727292
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00439259	0.16479306635515256
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.004345099999999999	0.163011424380553
ALAGILLE SYNDROME	0.004345099999999999	0.163011424380553
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.004345099999999999	0.163011424380553
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.004345099999999999	0.163011424380553
DOUBLE OUTLET RIGHT VENTRICLE	0.004345099999999999	0.163011424380553
CYSTINOSIS	0.004345099999999999	0.163011424380553
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.004345099999999999	0.163011424380553
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.004345099999999999	0.163011424380553
AARSKOG-SCOTT SYNDROME	0.004345099999999999	0.163011424380553
ALAGILLE SYNDROME 1; ALGS1	0.004345099999999999	0.163011424380553
JUVENILE POLYPOSIS SYNDROME	0.004345099999999999	0.163011424380553
CONGENITAL HYPOTHYROIDISM	0.00433258	0.1625417221796268
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00433258	0.1625417221796268
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00433258	0.1625417221796268
ATHYREOSIS	0.00433258	0.1625417221796268
THYROID ECTOPIA	0.00433258	0.1625417221796268
THYROID HYPOPLASIA	0.00433258	0.1625417221796268
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00433258	0.1625417221796268
REFSUM DISEASE	0.00433258	0.1625417221796268
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004319007	0.16203251547250447
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004302522	0.16141406173590153
ERMINE PHENOTYPE	0.00428509	0.16076008020502727
CAT-EYE SYNDROME	0.00428509	0.16076008020502727
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00428509	0.16076008020502727
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00428509	0.16076008020502727
TRANSKETOLASE DEFICIENCY	0.00428509	0.16076008020502727
GERODERMA OSTEODYSPLASTICA	0.00428509	0.16076008020502727
DENT DISEASE	0.00428509	0.16076008020502727
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004258997	0.15978117129697872
LISSENCEPHALY, X-LINKED, 2	0.004258997	0.15978117129697872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004258997	0.15978117129697872
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0042425119999999995	0.15916271756037575
ARTERIAL TORTUOSITY SYNDROME	0.0042425119999999995	0.15916271756037575
DUBOWITZ SYNDROME	0.0042425119999999995	0.15916271756037575
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004171943	0.15651524035453213
OROFACIODIGITAL SYNDROME XVI; OFD16	0.004067128	0.15258298506778437
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004067128	0.15258298506778437
SCHOLTE SYNDROME; SHLTS	0.004067128	0.15258298506778437
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.004067128	0.15258298506778437
JOUBERT SYNDROME 14	0.004067128	0.15258298506778437
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.004067128	0.15258298506778437
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.004067128	0.15258298506778437
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004067128	0.15258298506778437
SAUL-WILSON SYNDROME; SWILS	0.00406504	0.15250465134609636
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.15250465134609636
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.15250465134609636
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00406504	0.15250465134609636
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00406504	0.15250465134609636
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.15250465134609636
CRANIOSYNOSTOSIS 4; CRS4	0.00406504	0.15250465134609636
STEEL SYNDROME; STLS	0.00406504	0.15250465134609636
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00406504	0.15250465134609636
HYPERTELORISM, TEEBI TYPE	0.00406504	0.15250465134609636
AXENFELD-RIEGER SYNDROME	0.00406504	0.15250465134609636
268650 RUDIGER SYNDROME	0.00406504	0.15250465134609636
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00406504	0.15250465134609636
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.15250465134609636
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00406504	0.15250465134609636
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00406504	0.15250465134609636
HYPERTELORISM, TEEBI TYPE; TBHS	0.00406504	0.15250465134609636
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00406504	0.15250465134609636
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.15250465134609636
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00406504	0.15250465134609636
ODONTOCHONDRODYSPLASIA; ODCD	0.00406504	0.15250465134609636
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.15250465134609636
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00406504	0.15250465134609636
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.15250465134609636
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00406504	0.15250465134609636
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00406504	0.15250465134609636
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0040430399999999995	0.15167929604095443
NEUTRAL LIPID STORAGE MYOPATHY	0.004019638	0.15080134309318483
NOONAN SYNDROME 6; NS6	0.004019638	0.15080134309318483
VERVERI-BRADY SYNDROME; VERBRAS	0.004019638	0.15080134309318483
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.004019638	0.15080134309318483
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.004019638	0.15080134309318483
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.004019638	0.15080134309318483
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.004019638	0.15080134309318483
VICI SYNDROME; VICIS	0.004016947	0.15070038713290587
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004016947	0.15070038713290587
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004016947	0.15070038713290587
GLUTARIC ACIDEMIA I; GA1	0.004016947	0.15070038713290587
HYPOPHOSPHATASIA, INFANTILE	0.004016947	0.15070038713290587
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004016947	0.15070038713290587
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004016947	0.15070038713290587
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004016947	0.15070038713290587
PEROXISOME BIOGENESIS DISORDER 3B	0.004000462	0.15008193339630294
WARBURG MICRO SYNDROME 1	0.004000462	0.15008193339630294
NIEMANN-PICK DISEASE, TYPE A	0.004000462	0.15008193339630294
GALACTOSE EPIMERASE DEFICIENCY	0.004000462	0.15008193339630294
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00390625	0.14654746185048337
ACROCEPHALOSYNDACTYLY	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 5; BBS5	0.00390625	0.14654746185048337
ULNAR-MAMMARY SYNDROME	0.00390625	0.14654746185048337
SHEEHAN SYNDROME	0.00390625	0.14654746185048337
HALOTHANE HEPATITIS	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 11; BBS11	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 10; BBS10	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 17; BBS17	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 18; BBS18	0.00390625	0.14654746185048337
SERTOLI CELL-ONLY SYNDROME	0.00390625	0.14654746185048337
BARDET-BIEDL SYNDROME 12; BBS12	0.00390625	0.14654746185048337
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00390625	0.14654746185048337
PERIPARTUM CARDIOMYOPATHY	0.00390625	0.14654746185048337
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00390625	0.14654746185048337
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00390625	0.14654746185048337
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00390625	0.14654746185048337
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00390625	0.14654746185048337
IMMUNODEFICIENCY 61; IMD61	0.00390625	0.14654746185048337
ADENOCARCINOMA OF THE ESOPHAGUS	0.00390625	0.14654746185048337
MLLERIAN APLASIA AND HYPERANDROGENISM	0.00390625	0.14654746185048337
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00390625	0.14654746185048337
POLYCYSTIC OVARY SYNDROME 1	0.00390625	0.14654746185048337
SECONDARY POLYCYTHEMIA	0.00390625	0.14654746185048337
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00390625	0.14654746185048337
RING CHROMOSOME Y SYNDROME	0.00390625	0.14654746185048337
NARCOLEPSY 7; NRCLP7	0.00390625	0.14654746185048337
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00390625	0.14654746185048337
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00390625	0.14654746185048337
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.00390625	0.14654746185048337
SUMMITT SYNDROME	0.00390625	0.14654746185048337
RETINITIS PIGMENTOSA 71; RP71	0.00390625	0.14654746185048337
ADIPOSIS DOLOROSA	0.00390625	0.14654746185048337
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00390625	0.14654746185048337
DYSBETALIPOPROTEINEMIA	0.00390625	0.14654746185048337
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00390625	0.14654746185048337
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.00390625	0.14654746185048337
OBESITY-HYPOVENTILATION SYNDROME	0.00390625	0.14654746185048337
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.00390625	0.14654746185048337
SENIOR-LOKEN SYNDROME 9	0.00390625	0.14654746185048337
NARCOLEPSY TYPE 1	0.00390625	0.14654746185048337
ULNAR-MAMMARY SYNDROME; UMS	0.00390625	0.14654746185048337
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0038824029999999995	0.14565281421585974
MOSAIC TRISOMY 14	0.0038824029999999995	0.14565281421585974
HARROD SYNDROME	0.0038824029999999995	0.14565281421585974
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0038824029999999995	0.14565281421585974
COWDEN SYNDROME	0.0038824029999999995	0.14565281421585974
COFFIN-SIRIS SYNDROME 1; CSS1	0.0038223930000000003	0.14340147004033402
MONOSOMY 9P	0.0038223929999999995	0.143401470040334
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0038223929999999995	0.143401470040334
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0038223929999999995	0.143401470040334
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0038223929999999995	0.143401470040334
COFFIN-LOWRY SYNDROME	0.0038223929999999995	0.143401470040334
VICI SYNDROME	0.0038223929999999995	0.143401470040334
TARP SYNDROME; TARPS	0.003777588	0.141720558929112
CLASSIC MULTIMINICORE MYOPATHY	0.003777588	0.141720558929112
NEMALINE MYOPATHY 7; NEM7	0.003717578	0.13946921475358626
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.003717578	0.13946921475358626
NEMALINE MYOPATHY 4	0.003717578	0.13946921475358626
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.003647009	0.1368217375477426
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.003647009	0.1368217375477426
CHILDHOOD DISINTEGRATIVE DISORDER	0.003647009	0.1368217375477426
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.003647009	0.1368217375477426
RENIER-GABREELS-JASPER SYNDROME	0.003647009	0.1368217375477426
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.003647009	0.1368217375477426
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.003647009	0.1368217375477426
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.003647009	0.1368217375477426
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.003647009	0.1368217375477426
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003647009	0.1368217375477426
INTELLECTUAL DISABILITY, WOLFF TYPE	0.003647009	0.1368217375477426
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.003647009	0.1368217375477426
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003647009	0.1368217375477426
SECKEL SYNDROME 7; SCKL7	0.003647009	0.1368217375477426
RETT SYNDROME, CONGENITAL VARIANT	0.003647009	0.1368217375477426
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.003647009	0.1368217375477426
BAND HETEROTOPIA; BH	0.003647009	0.1368217375477426
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.003647009	0.1368217375477426
CLASSIC PHENYLKETONURIA	0.003647009	0.1368217375477426
NARP SYNDROME	0.003647009	0.1368217375477426
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.003630524	0.13620328381113964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.003630524	0.13620328381113964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.003630524	0.13620328381113964
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003599519	0.13504009557314306
CENTRAL BILATERAL MACROGYRIA	0.003599519	0.13504009557314306
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.003599519	0.13504009557314306
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.003599519	0.13504009557314306
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.13504009557314306
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003599519	0.13504009557314306
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.003599519	0.13504009557314306
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.003599519	0.13504009557314306
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.003599519	0.13504009557314306
BRANCHIOOCULOFACIAL SYNDROME	0.003599519	0.13504009557314306
KEUTEL SYNDROME	0.003599519	0.13504009557314306
MENTAL RETARDATION, X-LINKED 9	0.003599519	0.13504009557314306
DARIER-WHITE DISEASE; DAR	0.003599519	0.13504009557314306
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.13504009557314306
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.003599519	0.13504009557314306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0035830339999999997	0.1344216418365401
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0035830339999999997	0.1344216418365401
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0035830339999999997	0.1344216418365401
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0035803429999999997	0.13432068587626117
1Q21.1 MICRODUPLICATION SYNDROME	0.0035803429999999997	0.13432068587626117
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0035803429999999997	0.13432068587626117
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0035803429999999997	0.13432068587626117
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0035803429999999997	0.13432068587626117
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0035803429999999997	0.13432068587626117
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0035803429999999997	0.13432068587626117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.003556941	0.13344273292849157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.003556941	0.13344273292849157
MEND SYNDROME; MEND	0.003556941	0.13344273292849157
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.003556941	0.13344273292849157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.003556941	0.13344273292849157
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0034755280000000003	0.13038843058951344
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0034755280000000003	0.13038843058951344
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0034755280000000003	0.13038843058951344
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0034755280000000003	0.13038843058951344
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0034755280000000003	0.13038843058951344
GLYCOGEN STORAGE DISEASE IV	0.0034755280000000003	0.13038843058951344
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0034755280000000003	0.13038843058951344
MEVALONIC ACIDURIA; MEVA	0.0034755280000000003	0.13038843058951344
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0034755280000000003	0.13038843058951344
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0034755280000000003	0.13038843058951344
CAMPOMELIC DYSPLASIA	0.0034755280000000003	0.13038843058951344
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0034755280000000003	0.13038843058951344
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0034755280000000003	0.13038843058951344
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0034755280000000003	0.13038843058951344
PORPHYRIA, ACUTE HEPATIC	0.0034755280000000003	0.13038843058951344
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.003357469	0.1259593114090702
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.003357469	0.1259593114090702
TETRASOMY 5P	0.003357469	0.1259593114090702
TURNPENNY-FRY SYNDROME; TPFS	0.003340984	0.1253408576724673
MCKUSICK-KAUFMAN SYNDROME	0.003340984	0.1253408576724673
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.003340984	0.1253408576724673
3Q29 MICRODELETION SYNDROME	0.003340984	0.1253408576724673
MENTAL RETARDATION, BUENOS AIRES TYPE	0.003340984	0.1253408576724673
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003314891	0.12436194876441872
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003314891	0.12436194876441872
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.003314891	0.12436194876441872
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003314891	0.12436194876441872
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003314891	0.12436194876441872
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.003314891	0.12436194876441872
STT3A-CDG	0.003314891	0.12436194876441872
STT3B-CDG	0.003314891	0.12436194876441872
SSR4-CDG	0.003314891	0.12436194876441872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.003314891	0.12436194876441872
TARP SYNDROME	0.003314891	0.12436194876441872
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.003314891	0.12436194876441872
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003314891	0.12436194876441872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003314891	0.12436194876441872
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003314891	0.12436194876441872
PONTINE TEGMENTAL CAP DYSPLASIA	0.003314891	0.12436194876441872
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.003314891	0.12436194876441872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003314891	0.12436194876441872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003314891	0.12436194876441872
ETHYLMALONIC ENCEPHALOPATHY	0.003314891	0.12436194876441872
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.003314891	0.12436194876441872
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003314891	0.12436194876441872
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.003297459	0.12370796723354446
FETAL GAUCHER DISEASE	0.003297459	0.12370796723354446
MOWAT-WILSON SYNDROME	0.003297459	0.12370796723354446
DISTAL MONOSOMY 3P	0.003297459	0.12370796723354446
PYRUVATE DEHYDROGENASE DEFICIENCY	0.003297459	0.12370796723354446
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003280974	0.12308951349694153
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.003280974	0.12308951349694153
8Q21.11 MICRODELETION SYNDROME	0.003280974	0.12308951349694153
CRANIOFRONTONASAL DYSPLASIA	0.003280974	0.12308951349694153
GERMAN SYNDROME	0.003280974	0.12308951349694153
CAREY-FINEMAN-ZITER SYNDROME	0.003280974	0.12308951349694153
TRISOMY 17P	0.003280974	0.12308951349694153
GRISCELLI SYNDROME, TYPE 1	0.0032548810000000003	0.12211060458889299
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0032548810000000003	0.12211060458889299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0032548810000000003	0.12211060458889299
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0032548810000000003	0.12211060458889299
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0032548810000000003	0.12211060458889299
ADAMS-OLIVER SYNDROME 1; AOS1	0.0032548810000000003	0.12211060458889299
ELEJALDE DISEASE	0.0032548810000000003	0.12211060458889299
KETOADIPICACIDURIA	0.0032548810000000003	0.12211060458889299
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0032548810000000003	0.12211060458889299
NEURAMINIDASE DEFICIENCY	0.0032548810000000003	0.12211060458889299
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0032548810000000003	0.12211060458889299
NIEMANN-PICK DISEASE, TYPE C2	0.0032548810000000003	0.12211060458889299
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0032548810000000003	0.12211060458889299
KLEEFSTRA SYNDROME 2; KLEFS2	0.0032548810000000003	0.12211060458889299
SALLA DISEASE	0.0032548810000000003	0.12211060458889299
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0032548810000000003	0.12211060458889299
HOLOPROSENCEPHALY 2; HPE2	0.0032548810000000003	0.12211060458889299
ASPARTYLGLUCOSAMINURIA; AGU	0.0032548810000000003	0.12211060458889299
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0032548810000000003	0.12211060458889299
PYRUVATE CARBOXYLASE DEFICIENCY	0.0032548810000000003	0.12211060458889299
OHDO SYNDROME	0.0032548810000000003	0.12211060458889299
CYCLIC VOMITING SYNDROME	0.0032548810000000003	0.12211060458889299
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0032548810000000003	0.12211060458889299
METACHROMATIC LEUKODYSTROPHY	0.0032548810000000003	0.12211060458889299
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0032548810000000003	0.12211060458889299
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0032548810000000003	0.12211060458889299
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0032548810000000003	0.12211060458889299
GLYCINE ENCEPHALOPATHY; GCE	0.0032548810000000003	0.12211060458889299
CODAS SYNDROME	0.0032548810000000003	0.12211060458889299
STIMMLER SYNDROME	0.00310559	0.11650978100435011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00310559	0.11650978100435011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00310559	0.11650978100435011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00310559	0.11650978100435011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.00310559	0.11650978100435011
BRESEK SYNDROME	0.00310559	0.11650978100435011
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00310559	0.11650978100435011
OKAMOTO SYNDROME	0.00310559	0.11650978100435011
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00310559	0.11650978100435011
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00310559	0.11650978100435011
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00310559	0.11650978100435011
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00310559	0.11650978100435011
PHENYLKETONURIA	0.00310559	0.11650978100435011
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00310559	0.11650978100435011
JUBERG-MARSIDI SYNDROME	0.00310559	0.11650978100435011
TRISOMY XQ28	0.00310559	0.11650978100435011
NEPHROSIALIDOSIS	0.00310559	0.11650978100435011
HOLMES-GANG SYNDROME	0.00310559	0.11650978100435011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00310559	0.11650978100435011
%613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	0.00310559	0.11650978100435011
WARBURG MICRO SYNDROME 2; WARBM2	0.00310559	0.11650978100435011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00310559	0.11650978100435011
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00310559	0.11650978100435011
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00310559	0.11650978100435011
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00310559	0.11650978100435011
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00310559	0.11650978100435011
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00310559	0.11650978100435011
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00310559	0.11650978100435011
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.0030581	0.11472813902975057
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0030581	0.11472813902975057
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0030581	0.11472813902975057
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0030581	0.11472813902975057
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0030581	0.11472813902975057
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0030581	0.11472813902975057
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.0030581	0.11472813902975057
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0030581	0.11472813902975057
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0030581	0.11472813902975057
MENTAL RETARDATION, X-LINKED 73	0.0030581	0.11472813902975057
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975057
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0030581	0.11472813902975057
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0030581	0.11472813902975057
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0030581	0.11472813902975057
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0030581	0.11472813902975057
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.0030581	0.11472813902975057
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.0030581	0.11472813902975057
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0030581	0.11472813902975057
OTOFACIOCERVICAL SYNDROME	0.0030581	0.11472813902975057
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0030581	0.11472813902975057
CHAR SYNDROME	0.0030581	0.11472813902975057
BLOOM SYNDROME	0.0030581	0.11472813902975057
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.0030581	0.11472813902975057
BONNEMANN-MEINECKE-REICH SYNDROME	0.0030581	0.11472813902975057
PEROXISOME BIOGENESIS DISORDER 14B	0.0030581	0.11472813902975057
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.0030581	0.11472813902975057
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0030581	0.11472813902975057
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0030581	0.11472813902975057
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0030581	0.11472813902975057
BLOOM SYNDROME	0.0030581	0.11472813902975057
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0030581	0.11472813902975057
WOODHOUSE-SAKATI SYNDROME	0.0030581	0.11472813902975057
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0030581	0.11472813902975057
SPINOCEREBELLAR ATAXIA TYPE 27	0.0030581	0.11472813902975057
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0030581	0.11472813902975057
WEILL-MARCHESANI SYNDROME	0.0030581	0.11472813902975057
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0030581	0.11472813902975057
AUROCEPHALOSYNDACTYLY	0.0030581	0.11472813902975057
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0030581	0.11472813902975057
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0030581	0.11472813902975057
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975057
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0030581	0.11472813902975057
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0030581	0.11472813902975057
MUCOLIPIDOSIS III GAMMA	0.0030581	0.11472813902975057
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0030581	0.11472813902975057
MICROPHTHALMIA-ANKYLOBLEPHARON-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975057
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0030581	0.11472813902975057
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0030581	0.11472813902975057
BOUCHER-NEUHAUSER SYNDROME	0.0030581	0.11472813902975057
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0030581	0.11472813902975057
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0030581	0.11472813902975057
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.0030581	0.11472813902975057
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0030581	0.11472813902975057
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0030581	0.11472813902975057
VAN BOGAERT-HOZAY SYNDROME	0.0030581	0.11472813902975057
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.0030581	0.11472813902975057
3MC SYNDROME 1	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.0030581	0.11472813902975057
ISOLATED HEMIHYPERPLASIA	0.0030581	0.11472813902975057
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0030581	0.11472813902975057
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.0030581	0.11472813902975057
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0030581	0.11472813902975057
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.0030581	0.11472813902975057
MENTAL RETARDATION, X-LINKED 58	0.0030581	0.11472813902975057
H SYNDROME	0.0030581	0.11472813902975057
%300115 MENTAL RETARDATION, X-LINKED 50; MRX50	0.0030581	0.11472813902975057
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0030581	0.11472813902975057
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.0030581	0.11472813902975057
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0030581	0.11472813902975057
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0030581	0.11472813902975057
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0030581	0.11472813902975057
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.0030581	0.11472813902975057
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0030581	0.11472813902975057
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.0030581	0.11472813902975057
DISTAL MONOSOMY 6P	0.0030581	0.11472813902975057
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0030581	0.11472813902975057
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0030581	0.11472813902975057
HEMIHYPERPLASIA, ISOLATED	0.0030581	0.11472813902975057
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0030581	0.11472813902975057
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0030581	0.11472813902975057
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0030581	0.11472813902975057
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0030581	0.11472813902975057
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.0030581	0.11472813902975057
NAKAJO-NISHIMURA SYNDROME	0.0030581	0.11472813902975057
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0030581	0.11472813902975057
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0030581	0.11472813902975057
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.0030581	0.11472813902975057
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0030581	0.11472813902975057
ERMINE PHENOTYPE	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0030581	0.11472813902975057
OTOONYCHOPERONEAL SYNDROME	0.0030581	0.11472813902975057
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0030581	0.11472813902975057
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.0030581	0.11472813902975057
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0030581	0.11472813902975057
MIRROR MOVEMENTS 1; MRMV1	0.0030581	0.11472813902975057
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0030581	0.11472813902975057
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0030581	0.11472813902975057
ALOPECIA-INTELLECTUAL DISABILITY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.0030581	0.11472813902975057
OTOPALATODIGITAL SYNDROME TYPE 1	0.0030581	0.11472813902975057
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0030581	0.11472813902975057
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0030581	0.11472813902975057
RFT1-CDG	0.0030554090000000002	0.11462718306947163
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.0030554090000000002	0.11462718306947163
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0030554090000000002	0.11462718306947163
ADRENOMYODYSTROPHY	0.0030554090000000002	0.11462718306947163
KRABBE DISEASE	0.0030554090000000002	0.11462718306947163
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0030554090000000002	0.11462718306947163
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.003038924	0.1140087293328687
MARDEN-WALKER SYNDROME	0.003038924	0.1140087293328687
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.003038924	0.1140087293328687
MATTHEW-WOOD SYNDROME	0.003038924	0.1140087293328687
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003038924	0.1140087293328687
JOHANSON-BLIZZARD SYNDROME	0.003038924	0.1140087293328687
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.003032007	0.11374923012170202
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003032007	0.11374923012170202
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.003032007	0.11374923012170202
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0030320069999999998	0.11374923012170202
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0030320069999999998	0.11374923012170202
TETRASOMY 9P	0.0030320069999999998	0.11374923012170202
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0030320069999999998	0.11374923012170202
DUPLICATION/INVERSION 15Q11	0.0030320069999999998	0.11374923012170202
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.003015522	0.1131307763850991
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.003015522	0.1131307763850991
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.003015522	0.1131307763850991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0030155219999999996	0.11313077638509907
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0030155219999999996	0.11313077638509907
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0030155219999999996	0.11313077638509907
WARSAW BREAKAGE SYNDROME; WABS	0.0030155219999999996	0.11313077638509907
IMMUNODEFICIENCY 23; IMD23	0.0030155219999999996	0.11313077638509907
AU-KLINE SYNDROME; AUKS	0.0030155219999999996	0.11313077638509907
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0030155219999999996	0.11313077638509907
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0028160499999999996	0.10564735486567774
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0028160499999999996	0.10564735486567774
TREACHER-COLLINS SYNDROME	0.0028160499999999996	0.10564735486567774
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0028160499999999996	0.10564735486567774
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0028160499999999996	0.10564735486567774
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0028160499999999996	0.10564735486567774
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0028160499999999996	0.10564735486567774
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0028160499999999996	0.10564735486567774
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002789957	0.1046684459576292
COFFIN-SIRIS SYNDROME 8; CSS8	0.002789957	0.1046684459576292
DDOST-CDG	0.002789957	0.1046684459576292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002789957	0.1046684459576292
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.002789957	0.1046684459576292
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002789957	0.1046684459576292
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002789957	0.1046684459576292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.002789957	0.1046684459576292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002789957	0.1046684459576292
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.002789957	0.1046684459576292
INFANTILE LIVER FAILURE SYNDROME 1	0.002789957	0.1046684459576292
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002789957	0.1046684459576292
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002789957	0.1046684459576292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.002789957	0.1046684459576292
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.002789957	0.1046684459576292
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.002789957	0.1046684459576292
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002789957	0.1046684459576292
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002789957	0.1046684459576292
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002789957	0.1046684459576292
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.002789957	0.1046684459576292
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002789957	0.1046684459576292
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002789957	0.1046684459576292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002789957	0.1046684459576292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002773472	0.10404999222102625
JACOBSEN SYNDROME	0.002773472	0.10404999222102625
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002773472	0.10404999222102625
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.002773472	0.10404999222102625
MARINESCO-SJOGREN SYNDROME; MSS	0.002773472	0.10404999222102625
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.002773472	0.10404999222102625
SHWACHMAN-DIAMOND SYNDROME	0.002773472	0.10404999222102625
XIA-GIBBS SYNDROME	0.002773472	0.10404999222102625
MOEBIUS SYNDROME	0.00275604	0.10339601069015197
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00275604	0.10339601069015197
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00275604	0.10339601069015197
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00275604	0.10339601069015197
NOONAN SYNDROME	0.00275604	0.10339601069015197
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00275604	0.10339601069015197
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002729947	0.10241710178210343
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002729947	0.10241710178210343
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002729947	0.10241710178210343
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002729947	0.10241710178210343
VISCERAL STEATOSIS, CONGENITAL	0.002729947	0.10241710178210343
GM2-GANGLIOSIDOSIS, AB VARIANT	0.002729947	0.10241710178210343
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002729947	0.10241710178210343
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002729947	0.10241710178210343
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002729947	0.10241710178210343
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002729947	0.10241710178210343
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002729947	0.10241710178210343
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002729947	0.10241710178210343
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002729947	0.10241710178210343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002729947	0.10241710178210343
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002729947	0.10241710178210343
XYLOSIDASE DEFICIENCY	0.002729947	0.10241710178210343
JOUBERT SYNDROME 6	0.002713462	0.10179864804550048
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.002713462	0.10179864804550048
MUCOLIPIDOSIS IV; ML4	0.002713462	0.10179864804550048
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002713462	0.10179864804550048
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.002713462	0.10179864804550048
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.002713462	0.10179864804550048
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.002713462	0.10179864804550048
JOUBERT SYNDROME 3; JBTS3	0.002713462	0.10179864804550048
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.002713462	0.10179864804550048
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.002713462	0.10179864804550048
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.002713462	0.10179864804550048
JOUBERT SYNDROME 5	0.002713462	0.10179864804550048
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.002713462	0.10179864804550048
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002713462	0.10179864804550048
LESCH-NYHAN SYNDROME; LNS	0.002713462	0.10179864804550048
SPINOCEREBELLAR ATAXIA 13	0.002713462	0.10179864804550048
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.002713462	0.10179864804550048
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002713462	0.10179864804550048
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.002595403	0.0973695288650573
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.002595403	0.0973695288650573
MATERNAL PHENYLKETONURIA	0.0025954029999999996	0.09736952886505729
CORNELIA DE LANGE SYNDROME 3	0.0025954029999999996	0.09736952886505729
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0025954029999999996	0.09736952886505729
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0025954029999999996	0.09736952886505729
OROFACIODIGITAL SYNDROME I; OFD1	0.0025954029999999996	0.09736952886505729
PFEIFFER SYNDROME TYPE 3	0.0025954029999999996	0.09736952886505729
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0025954029999999996	0.09736952886505729
PFEIFFER SYNDROME TYPE 2	0.0025954029999999996	0.09736952886505729
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0025954029999999996	0.09736952886505729
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025954029999999996	0.09736952886505729
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0025954029999999996	0.09736952886505729
FRYNS SYNDROME	0.0025954029999999996	0.09736952886505729
CHROMOSOME 1P35 DELETION SYNDROME	0.0025954029999999996	0.09736952886505729
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0025954029999999996	0.09736952886505729
DUBOWITZ SYNDROME	0.0025954029999999996	0.09736952886505729
15Q24 MICRODELETION SYNDROME	0.0025954029999999996	0.09736952886505729
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0025954029999999996	0.09736952886505729
OROFACIODIGITAL SYNDROME TYPE 1	0.0025954029999999996	0.09736952886505729
RENPENNING SYNDROME 1; RENS1	0.0025954029999999996	0.09736952886505729
8P11.2 DELETION SYNDROME	0.0025954029999999996	0.09736952886505729
ZIMMERMANN-LABAND SYNDROME	0.0025954029999999996	0.09736952886505729
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025954029999999996	0.09736952886505729
SECKEL SYNDROME 1; SCKL1	0.0025954029999999996	0.09736952886505729
GLASS SYNDROME	0.0025954029999999996	0.09736952886505729
HAWKINSINURIA	0.00251399	0.09431522652607914
INFANTILE SYSTEMIC HYALINOSIS	0.00251399	0.09431522652607914
HYPERCALCEMIA, INFANTILE 2	0.00251399	0.09431522652607914
IMMUNODEFICIENCY 9; IMD9	0.00251399	0.09431522652607914
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00251399	0.09431522652607914
ISOLATED COMPLEX I DEFICIENCY	0.00251399	0.09431522652607914
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00251399	0.09431522652607914
PEARSON SYNDROME	0.00251399	0.09431522652607914
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002490588	0.09343727357830955
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002490588	0.09343727357830955
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002490588	0.09343727357830955
MYOPATHY, CENTRONUCLEAR, 5	0.002490588	0.09343727357830955
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002490588	0.09343727357830955
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.002490588	0.09343727357830955
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002490588	0.09343727357830955
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.002490588	0.09343727357830955
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002490588	0.09343727357830955
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.002490588	0.09343727357830955
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.002490588	0.09343727357830955
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.002490588	0.09343727357830955
MLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002490588	0.09343727357830955
CAP MYOPATHY	0.002490588	0.09343727357830955
LATERAL MENINGOCELE SYNDROME	0.002490588	0.09343727357830955
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.002490588	0.09343727357830955
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.002490588	0.09343727357830955
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.002490588	0.09343727357830955
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002490588	0.09343727357830955
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002490588	0.09343727357830955
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002353353	0.08828874470098447
ARGININOSUCCINIC ACIDURIA	0.002353353	0.08828874470098447
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.002353353	0.08828874470098447
EDINBURGH MALFORMATION SYNDROME	0.002353353	0.08828874470098447
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002353353	0.08828874470098447
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002353353	0.08828874470098447
COG8-CDG	0.002353353	0.08828874470098447
CITRULLINEMIA, CLASSIC	0.002353353	0.08828874470098447
OCULOCEREBRORENAL SYNDROME OF LOWE	0.002353353	0.08828874470098447
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002353353	0.08828874470098447
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002353353	0.08828874470098447
LOWE OCULOCEREBRORENAL SYNDROME	0.002353353	0.08828874470098447
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.002353353	0.08828874470098447
HYPERLEUCINE-ISOLEUCINEMIA	0.002353353	0.08828874470098447
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.002353353	0.08828874470098447
ALG11-CDG	0.002353353	0.08828874470098447
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.002353353	0.08828874470098447
PITUITARY STALK INTERRUPTION SYNDROME	0.002353353	0.08828874470098447
RAMON SYNDROME	0.002353353	0.08828874470098447
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.002353353	0.08828874470098447
MAPLE SYRUP URINE DISEASE	0.0022933429999999998	0.0860374005254587
1P36 MICRODELETION SYNDROME	0.0022933429999999998	0.0860374005254587
MEVALONIC ACIDURIA	0.0022933429999999998	0.0860374005254587
ACROCARDIOFACIAL SYNDROME	0.0022933429999999998	0.0860374005254587
CONGENITAL RUBELLA SYNDROME	0.0022933429999999998	0.0860374005254587
22Q11.2 MICRODUPLICATION SYNDROME	0.0022933429999999998	0.0860374005254587
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.0860374005254587
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0022933429999999998	0.0860374005254587
GRISCELLI SYNDROME	0.0022933429999999998	0.0860374005254587
DYSEQUILIBRIUM SYNDROME	0.0022933429999999998	0.0860374005254587
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0022933429999999998	0.0860374005254587
HARTNUP DISEASE	0.0022933429999999998	0.0860374005254587
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.0860374005254587
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.0860374005254587
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0022933429999999998	0.0860374005254587
SEVERE CANAVAN DISEASE	0.0022933429999999998	0.0860374005254587
POTOCKI-SHAFFER SYNDROME	0.0022933429999999998	0.0860374005254587
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0022933429999999998	0.0860374005254587
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0022933429999999998	0.0860374005254587
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0022933429999999998	0.0860374005254587
DPAGT1-CDG	0.0022933429999999998	0.0860374005254587
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0022933429999999998	0.0860374005254587
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0022933429999999998	0.0860374005254587
2Q31.1 MICRODELETION SYNDROME	0.0022933429999999998	0.0860374005254587
15Q11Q13 MICRODUPLICATION SYNDROME	0.0022933429999999998	0.0860374005254587
WALKER-WARBURG SYNDROME	0.0022933429999999998	0.0860374005254587
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0022933429999999998	0.0860374005254587
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0022933429999999998	0.0860374005254587
49,XXXXY SYNDROME	0.0022933429999999998	0.0860374005254587
COFFIN-SIRIS SYNDROME	0.0022933429999999998	0.0860374005254587
LEBER CONGENITAL AMAUROSIS	0.0022933429999999998	0.0860374005254587
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0022933429999999998	0.0860374005254587
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0022933429999999998	0.0860374005254587
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0022933429999999998	0.0860374005254587
SIALIDOSIS TYPE 1	0.0022933429999999998	0.0860374005254587
SJGREN-LARSSON SYNDROME	0.0022933429999999998	0.0860374005254587
SMITH-LEMLI-OPITZ SYNDROME	0.0022933429999999998	0.0860374005254587
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0022933429999999998	0.0860374005254587
JOUBERT SYNDROME	0.0022933429999999998	0.0860374005254587
LINEAR NEVUS SEBACEUS SYNDROME	0.0022933429999999998	0.0860374005254587
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0022933429999999998	0.0860374005254587
ISOLATED SPINA BIFIDA	0.0022933429999999998	0.0860374005254587
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0022933429999999998	0.0860374005254587
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0022933429999999998	0.0860374005254587
CAMOS SYNDROME	0.0022933429999999998	0.0860374005254587
DISTAL MONOSOMY 19P13.3	0.0022933429999999998	0.0860374005254587
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0022933429999999998	0.0860374005254587
INCONTINENTIA PIGMENTI	0.0022933429999999998	0.0860374005254587
JOUBERT SYNDROME WITH RENAL DEFECT	0.0022933429999999998	0.0860374005254587
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0022933429999999998	0.0860374005254587
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002248538	0.08435648941423672
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.002248538	0.08435648941423672
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002248538	0.08435648941423672
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002248538	0.08435648941423672
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.002248538	0.08435648941423672
MULTIMINICORE MYOPATHY	0.002248538	0.08435648941423672
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.002248538	0.08435648941423672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.002248538	0.08435648941423672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.002248538	0.08435648941423672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.002248538	0.08435648941423672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.002248538	0.08435648941423672
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002248538	0.08435648941423672
NAVAJO NEUROHEPATOPATHY	0.002248538	0.08435648941423672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.002248538	0.08435648941423672
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.002248538	0.08435648941423672
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.002248538	0.08435648941423672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002248538	0.08435648941423672
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.002248538	0.08435648941423672
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.002248538	0.08435648941423672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.002248538	0.08435648941423672
RITSCHER-SCHINZEL SYNDROME 1	0.0021885280000000003	0.08210514523871097
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0021885280000000003	0.08210514523871097
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0021885280000000003	0.08210514523871097
GLYCOGEN STORAGE DISEASE II	0.0021885280000000003	0.08210514523871097
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0021885280000000003	0.08210514523871097
SENGERS SYNDROME	0.0021885280000000003	0.08210514523871097
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0021885280000000003	0.08210514523871097
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0021885280000000003	0.08210514523871097
CEREBELLAR HYPOPLASIA	0.0021885280000000003	0.08210514523871097
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0021885280000000003	0.08210514523871097
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0021885280000000003	0.08210514523871097
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0021885280000000003	0.08210514523871097
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0021885280000000003	0.08210514523871097
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021885280000000003	0.08210514523871097
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0021885280000000003	0.08210514523871097
STUVE-WIEDEMANN SYNDROME	0.0021885280000000003	0.08210514523871097
PSEUDOTRISOMY 13 SYNDROME	0.0021885280000000003	0.08210514523871097
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0021885280000000003	0.08210514523871097
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0021885280000000003	0.08210514523871097
CRANIOFRONTONASAL SYNDROME; CFNS	0.0021885280000000003	0.08210514523871097
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0021885280000000003	0.08210514523871097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0021885280000000003	0.08210514523871097
OPSISMODYSPLASIA; OPSMD	0.0021885280000000003	0.08210514523871097
PIERSON SYNDROME	0.0021885280000000003	0.08210514523871097
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0021885280000000003	0.08210514523871097
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0021885280000000003	0.08210514523871097
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0021885280000000003	0.08210514523871097
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0021885280000000003	0.08210514523871097
CHIARI MALFORMATION TYPE II	0.0021885280000000003	0.08210514523871097
ACID PHOSPHATASE DEFICIENCY	0.0021885280000000003	0.08210514523871097
GLYCOGEN STORAGE DISEASE IXC	0.0021885280000000003	0.08210514523871097
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0021885280000000003	0.08210514523871097
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.08210514523871097
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0021885280000000003	0.08210514523871097
CRANIOSYNOSTOSIS 6; CRS6	0.0021885280000000003	0.08210514523871097
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.08210514523871097
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0021885280000000003	0.08210514523871097
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA 1	0.0021885280000000003	0.08210514523871097
MICROPHTHALMIA, SYNDROMIC 3	0.0021885280000000003	0.08210514523871097
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.002070469	0.07767602605826776
HYPEREKPLEXIA 4; HKPX4	0.002070469	0.07767602605826776
CATEL-MANZKE SYNDROME; CATMANS	0.002070469	0.07767602605826776
PERRAULT SYNDROME 5; PRLTS5	0.002070469	0.07767602605826776
CRISPONI SYNDROME	0.002070469	0.07767602605826776
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002070469	0.07767602605826776
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.002070469	0.07767602605826776
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002070469	0.07767602605826776
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002070469	0.07767602605826776
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002070469	0.07767602605826776
LIPOID PROTEINOSIS	0.002070469	0.07767602605826776
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.002070469	0.07767602605826776
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.002070469	0.07767602605826776
RABSON-MENDENHALL SYNDROME	0.002053984	0.07705757232166482
PSEUDOAMINOPTERIN SYNDROME	0.002053984	0.07705757232166482
ALAZAMI-YUAN SYNDROME	0.002053984	0.07705757232166482
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.002053984	0.07705757232166482
MENTAL RETARDATION, X-LINKED 2	0.002053984	0.07705757232166482
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.002053984	0.07705757232166482
MENTAL RETARDATION, X-LINKED 45	0.002053984	0.07705757232166482
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.002053984	0.07705757232166482
SECKEL SYNDROME 5; SCKL5	0.002053984	0.07705757232166482
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002053984	0.07705757232166482
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.002053984	0.07705757232166482
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002053984	0.07705757232166482
POLYVALVULAR HEART DISEASE SYNDROME	0.002053984	0.07705757232166482
MONOSOMY 22	0.002053984	0.07705757232166482
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.002053984	0.07705757232166482
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.002053984	0.07705757232166482
FRONTOMETAPHYSEAL DYSPLASIA	0.002053984	0.07705757232166482
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.002053984	0.07705757232166482
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.002053984	0.07705757232166482
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.002053984	0.07705757232166482
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.002053984	0.07705757232166482
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.002053984	0.07705757232166482
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.002053984	0.07705757232166482
FEINGOLD SYNDROME 1; FGLDS1	0.002053984	0.07705757232166482
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.002053984	0.07705757232166482
FRASER SYNDROME	0.002053984	0.07705757232166482
OTOFACIOCERVICAL SYNDROME	0.002053984	0.07705757232166482
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002053984	0.07705757232166482
ROBERTS SYNDROME; RBS	0.002053984	0.07705757232166482
MOSAIC TRISOMY 9	0.002053984	0.07705757232166482
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002027891	0.07607866341361627
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.002027891	0.07607866341361627
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002027891	0.07607866341361627
JOUBERT SYNDROME 30; JBTS30	0.002027891	0.07607866341361627
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002027891	0.07607866341361627
ADENYLOSUCCINATE LYASE DEFICIENCY	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002027891	0.07607866341361627
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002027891	0.07607866341361627
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002027891	0.07607866341361627
HOLOPROSENCEPHALY 1; HPE1	0.002027891	0.07607866341361627
MENTAL RETARDATION, X-LINKED 1	0.002027891	0.07607866341361627
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002027891	0.07607866341361627
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002027891	0.07607866341361627
XQ25 DUPLICATION SYNDROME	0.002027891	0.07607866341361627
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002027891	0.07607866341361627
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002027891	0.07607866341361627
TENORIO SYNDROME; TNORS	0.002027891	0.07607866341361627
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002027891	0.07607866341361627
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002027891	0.07607866341361627
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002027891	0.07607866341361627
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002027891	0.07607866341361627
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002027891	0.07607866341361627
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002027891	0.07607866341361627
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002027891	0.07607866341361627
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002027891	0.07607866341361627
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002027891	0.07607866341361627
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002027891	0.07607866341361627
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.002027891	0.07607866341361627
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002027891	0.07607866341361627
COFFIN-SIRIS SYNDROME 2; CSS2	0.002027891	0.07607866341361627
COFFIN-SIRIS SYNDROME 3; CSS3	0.002027891	0.07607866341361627
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.002027891	0.07607866341361627
COFFIN-SIRIS SYNDROME 4; CSS4	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002027891	0.07607866341361627
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002027891	0.07607866341361627
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002027891	0.07607866341361627
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.002027891	0.07607866341361627
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002027891	0.07607866341361627
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002027891	0.07607866341361627
AICARDI-GOUTIERES SYNDROME 7	0.002027891	0.07607866341361627
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.002027891	0.07607866341361627
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.002027891	0.07607866341361627
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.002027891	0.07607866341361627
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002027891	0.07607866341361627
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002027891	0.07607866341361627
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.002027891	0.07607866341361627
GRISCELLI SYNDROME TYPE 1	0.002027891	0.07607866341361627
IMMUNODEFICIENCY 49; IMD49	0.002027891	0.07607866341361627
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002027891	0.07607866341361627
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.002027891	0.07607866341361627
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002027891	0.07607866341361627
TIMOTHY SYNDROME; TS	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002027891	0.07607866341361627
SHASHI-PENA SYNDROME; SHAPNS	0.002027891	0.07607866341361627
LISSENCEPHALY 5; LIS5	0.002027891	0.07607866341361627
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002027891	0.07607866341361627
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002027891	0.07607866341361627
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.002027891	0.07607866341361627
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002027891	0.07607866341361627
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002027891	0.07607866341361627
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002027891	0.07607866341361627
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002027891	0.07607866341361627
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002027891	0.07607866341361627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002027891	0.07607866341361627
ADENYLOSUCCINASE DEFICIENCY	0.002027891	0.07607866341361627
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002027891	0.07607866341361627
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001828419	0.06859524189419494
NEPHROGENIC DIABETES INSIPIDUS	0.001828419	0.06859524189419494
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.001828419	0.06859524189419494
CONGENITAL DISORDER OF GLYCOSYLATION	0.001828419	0.06859524189419494
ATAXIA-TELANGIECTASIA	0.001828419	0.06859524189419494
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419494
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.06859524189419494
HYPER-BETA-ALANINEMIA	0.001828419	0.06859524189419494
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001828419	0.06859524189419494
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001828419	0.06859524189419494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001828419	0.06859524189419494
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001828419	0.06859524189419494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001828419	0.06859524189419494
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419494
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.06859524189419494
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001828419	0.06859524189419494
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001828419	0.06859524189419494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001828419	0.06859524189419494
PROPIONIC ACIDEMIA	0.001828419	0.06859524189419494
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.001828419	0.06859524189419494
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419494
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001828419	0.06859524189419494
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.06859524189419494
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001828419	0.06859524189419494
GAUCHER DISEASE, TYPE II	0.001828419	0.06859524189419494
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419494
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001828419	0.06859524189419494
SANDHOFF DISEASE	0.001828419	0.06859524189419494
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001828419	0.06859524189419494
MOGS-CDG	0.001828419	0.06859524189419494
COPPER DEFICIENCY, FAMILIAL BENIGN	0.001828419	0.06859524189419494
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001828419	0.06859524189419494
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001828419	0.06859524189419494
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001828419	0.06859524189419494
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001828419	0.06859524189419494
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.001828419	0.06859524189419494
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0018119339999999999	0.06797678815759199
NOONAN SYNDROME 8; NS8	0.0018119339999999999	0.06797678815759199
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0018119339999999999	0.06797678815759199
FACIOCARDIORENAL SYNDROME	0.0018119339999999999	0.06797678815759199
OTOPALATODIGITAL SYNDROME TYPE 2	0.0018119339999999999	0.06797678815759199
CHYLOMICRON RETENTION DISEASE	0.0018119339999999999	0.06797678815759199
JOHNSON NEUROECTODERMAL SYNDROME	0.0018119339999999999	0.06797678815759199
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.0018119339999999999	0.06797678815759199
KAPUR-TORIELLO SYNDROME	0.0018119339999999999	0.06797678815759199
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0018119339999999999	0.06797678815759199
ELLIS VAN CREVELD SYNDROME	0.0018119339999999999	0.06797678815759199
FARBER DISEASE	0.0018119339999999999	0.06797678815759199
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0018119339999999999	0.06797678815759199
HOYERAAL-HREIDARSSON SYNDROME	0.0018119339999999999	0.06797678815759199
PSEUDOPROGERIA SYNDROME	0.0018119339999999999	0.06797678815759199
GALACTOSEMIA	0.0018119339999999999	0.06797678815759199
TOWNES-BROCKS SYNDROME	0.0018119339999999999	0.06797678815759199
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0018119339999999999	0.06797678815759199
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0018119339999999999	0.06797678815759199
MPDU1-CDG	0.001768409	0.06634389771866918
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06634389771866918
TRIPLE A SYNDROME	0.001768409	0.06634389771866918
ALG3-CDG	0.001768409	0.06634389771866918
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06634389771866918
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001768409	0.06634389771866918
COFS SYNDROME	0.001768409	0.06634389771866918
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06634389771866918
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06634389771866918
ONDINE SYNDROME	0.001768409	0.06634389771866918
DPM1-CDG	0.001768409	0.06634389771866918
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001768409	0.06634389771866918
20P12.3 MICRODELETION SYNDROME	0.001768409	0.06634389771866918
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866918
ALG9-CDG	0.001768409	0.06634389771866918
CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866918
CANAVAN DISEASE	0.001768409	0.06634389771866918
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06634389771866918
LEIGH SYNDROME	0.001768409	0.06634389771866918
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06634389771866918
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001768409	0.06634389771866918
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06634389771866918
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06634389771866918
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06634389771866918
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06634389771866918
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06634389771866918
PHACE SYNDROME	0.001768409	0.06634389771866918
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001768409	0.06634389771866918
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06634389771866918
CHARGE SYNDROME	0.0017519240000000002	0.06572544398206624
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206624
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.0017519240000000002	0.06572544398206624
JUNG SYNDROME	0.0017519240000000002	0.06572544398206624
SMITH-MAGENIS SYNDROME	0.0017519240000000002	0.06572544398206624
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0017519240000000002	0.06572544398206624
9Q SUBTELOMERIC DELETION SYNDROME	0.0017519240000000002	0.06572544398206624
PERMANENT CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206624
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206624
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0017519240000000002	0.06572544398206624
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206624
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0017519240000000002	0.06572544398206624
PIEBALDISM	0.0017519240000000002	0.06572544398206624
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0017519240000000002	0.06572544398206624
HURLER SYNDROME	0.0017519240000000002	0.06572544398206624
ARTERIAL TORTUOSITY SYNDROME	0.0017519240000000002	0.06572544398206624
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0017519240000000002	0.06572544398206624
ALPHA-MANNOSIDOSIS	0.0017519240000000002	0.06572544398206624
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.0017519240000000002	0.06572544398206624
MARINESCO-SJGREN SYNDROME	0.0017519240000000002	0.06572544398206624
OROFACIODIGITAL SYNDROME TYPE 14	0.0017519240000000002	0.06572544398206624
PENTASOMY X	0.0017519240000000002	0.06572544398206624
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206624
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0017519240000000002	0.06572544398206624
MUCOLIPIDOSIS TYPE IV	0.0017519240000000002	0.06572544398206624
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0017519240000000002	0.06572544398206624
MONOSOMY 13Q14	0.0017519240000000002	0.06572544398206624
COOPER-JABS SYNDROME	0.0017519240000000002	0.06572544398206624
LAURIN-SANDROW SYNDROME	0.0017519240000000002	0.06572544398206624
GOLDENHAR SYNDROME	0.0017519240000000002	0.06572544398206624
FAMILIAL THYROID DYSHORMONOGENESIS	0.0017519240000000002	0.06572544398206624
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206624
VELOCARDIOFACIAL SYNDROME	0.0017519240000000002	0.06572544398206624
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00152905	0.057364069514875285
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00152905	0.057364069514875285
SAY-BARBER-MILLER SYNDROME	0.00152905	0.057364069514875285
NON-DISTAL TRISOMY 10Q	0.00152905	0.057364069514875285
NON-DISTAL TRISOMY 13Q	0.00152905	0.057364069514875285
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00152905	0.057364069514875285
PFEIFFER SYNDROME TYPE 1	0.00152905	0.057364069514875285
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00152905	0.057364069514875285
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00152905	0.057364069514875285
TYPICAL NEMALINE MYOPATHY	0.00152905	0.057364069514875285
ADULT-ONSET NEMALINE MYOPATHY	0.00152905	0.057364069514875285
DISTAL TRISOMY 18Q	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00152905	0.057364069514875285
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00152905	0.057364069514875285
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00152905	0.057364069514875285
SHELDON-HALL SYNDROME	0.00152905	0.057364069514875285
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00152905	0.057364069514875285
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00152905	0.057364069514875285
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00152905	0.057364069514875285
ULBRIGHT-HODES SYNDROME	0.00152905	0.057364069514875285
OROFACIODIGITAL SYNDROME IV; OFD4	0.00152905	0.057364069514875285
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00152905	0.057364069514875285
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00152905	0.057364069514875285
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00152905	0.057364069514875285
LOEYS-DIETZ SYNDROME 3; LDS3	0.00152905	0.057364069514875285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00152905	0.057364069514875285
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00152905	0.057364069514875285
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00152905	0.057364069514875285
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00152905	0.057364069514875285
EMERY-NELSON SYNDROME	0.00152905	0.057364069514875285
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00152905	0.057364069514875285
BRANCHIOOTORENAL SYNDROME 1	0.00152905	0.057364069514875285
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00152905	0.057364069514875285
LANGER MESOMELIC DYSPLASIA	0.00152905	0.057364069514875285
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00152905	0.057364069514875285
HAMAMY SYNDROME; HMMS	0.00152905	0.057364069514875285
RAINE SYNDROME	0.00152905	0.057364069514875285
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00152905	0.057364069514875285
MYOPATHY, DISTAL, 1; MPD1	0.00152905	0.057364069514875285
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00152905	0.057364069514875285
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00152905	0.057364069514875285
PFEIFFER SYNDROME	0.00152905	0.057364069514875285
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00152905	0.057364069514875285
GORDON SYNDROME	0.00152905	0.057364069514875285
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00152905	0.057364069514875285
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00152905	0.057364069514875285
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00152905	0.057364069514875285
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00152905	0.057364069514875285
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00152905	0.057364069514875285
LAING EARLY-ONSET DISTAL MYOPATHY	0.00152905	0.057364069514875285
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00152905	0.057364069514875285
ATELOSTEOGENESIS TYPE III	0.00152905	0.057364069514875285
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00152905	0.057364069514875285
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00152905	0.057364069514875285
FRONTOMETAPHYSEAL DYSPLASIA	0.00152905	0.057364069514875285
NEMALINE MYOPATHY 1; NEM1	0.00152905	0.057364069514875285
MARSHALL SYNDROME	0.00152905	0.057364069514875285
NEU-LAXOVA SYNDROME 2; NLS2	0.00152905	0.057364069514875285
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00152905	0.057364069514875285
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00152905	0.057364069514875285
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00152905	0.057364069514875285
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00152905	0.057364069514875285
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00152905	0.057364069514875285
TRISOMY 8Q	0.00152905	0.057364069514875285
OROFACIODIGITAL SYNDROME IX; OFD9	0.00152905	0.057364069514875285
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00152905	0.057364069514875285
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00152905	0.057364069514875285
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00152905	0.057364069514875285
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00152905	0.057364069514875285
HYPOGLOSSIA WITH SITUS INVERSUS	0.00152905	0.057364069514875285
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00152905	0.057364069514875285
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00152905	0.057364069514875285
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00152905	0.057364069514875285
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00152905	0.057364069514875285
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00152905	0.057364069514875285
PSEUDOXANTHOMA ELASTICUM	0.00152905	0.057364069514875285
9P13 MICRODELETION SYNDROME	0.00152905	0.057364069514875285
OCULOCUTANEOUS ALBINISM TYPE 5	0.00152905	0.057364069514875285
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00152905	0.057364069514875285
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00152905	0.057364069514875285
EVEN-PLUS SYNDROME	0.00152905	0.057364069514875285
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00152905	0.057364069514875285
SWEENEY-COX SYNDROME; SWCOS	0.00152905	0.057364069514875285
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00152905	0.057364069514875285
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00152905	0.057364069514875285
LERI-WEILL DYSCHONDROSTEOSIS	0.00152905	0.057364069514875285
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00152905	0.057364069514875285
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00152905	0.057364069514875285
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00152905	0.057364069514875285
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00152905	0.057364069514875285
CZEIZEL-LOSONCI SYNDROME	0.00152905	0.057364069514875285
ACRORENAL-MANDIBULAR SYNDROME	0.00152905	0.057364069514875285
ASCHER SYNDROME	0.00152905	0.057364069514875285
RHIZOMELIC SYNDROME, URBACH TYPE	0.00152905	0.057364069514875285
RIN2 SYNDROME	0.00152905	0.057364069514875285
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00152905	0.057364069514875285
BRANCHIO-OCULO-FACIAL SYNDROME	0.00152905	0.057364069514875285
ACRO-RENAL-MANDIBULAR SYNDROME	0.00152905	0.057364069514875285
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00152905	0.057364069514875285
MANDIBULOACRAL DYSPLASIA	0.00152905	0.057364069514875285
608028 THAI SYMPHALANGISM SYNDROME	0.00152905	0.057364069514875285
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00152905	0.057364069514875285
NOONAN SYNDROME 3; NS3	0.00152905	0.057364069514875285
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00152905	0.057364069514875285
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00152905	0.057364069514875285
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00152905	0.057364069514875285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001502957	0.05638516060682674
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001502957	0.05638516060682674
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.05638516060682674
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001502957	0.05638516060682674
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.05638516060682674
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001502957	0.05638516060682674
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001502957	0.05638516060682674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001502957	0.05638516060682674
TAY-SACHS DISEASE; TSD	0.001502957	0.05638516060682674
SULFOCYSTEINURIA	0.001502957	0.05638516060682674
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001502957	0.05638516060682674
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001502957	0.05638516060682674
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001502957	0.05638516060682674
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001502957	0.05638516060682674
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001502957	0.05638516060682674
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001502957	0.05638516060682674
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001502957	0.05638516060682674
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001502957	0.05638516060682674
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.05638516060682674
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001502957	0.05638516060682674
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001502957	0.05638516060682674
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.05638516060682674
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001502957	0.05638516060682674
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.05638516060682674
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.05638516060682674
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001502957	0.05638516060682674
PSEUDO-TORCH SYNDROME 2	0.001502957	0.05638516060682674
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001502957	0.05638516060682674
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.05638516060682674
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001502957	0.05638516060682674
SHUKLA-VERNON SYNDROME; SHUVER	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001502957	0.05638516060682674
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001502957	0.05638516060682674
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.05638516060682674
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001502957	0.05638516060682674
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001502957	0.05638516060682674
RING CHROMOSOME 22 SYNDROME	0.001502957	0.05638516060682674
SIALIDOSIS TYPE 2	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001502957	0.05638516060682674
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001502957	0.05638516060682674
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001502957	0.05638516060682674
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.05638516060682674
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001502957	0.05638516060682674
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001502957	0.05638516060682674
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001502957	0.05638516060682674
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.05638516060682674
GLUTAMINE DEFICIENCY, CONGENITAL	0.001502957	0.05638516060682674
ADAMS-OLIVER SYNDROME 2; AOS2	0.001502957	0.05638516060682674
RAPID-ONSET DYSTONIA-PARKINSONISM	0.001502957	0.05638516060682674
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.05638516060682674
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001502957	0.05638516060682674
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001502957	0.05638516060682674
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001502957	0.05638516060682674
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001502957	0.05638516060682674
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.05638516060682674
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.05638516060682674
EPISODIC ATAXIA, TYPE 6	0.001502957	0.05638516060682674
JOUBERT SYNDROME 21	0.001486472	0.0557667068702238
JOUBERT SYNDROME 28	0.001486472	0.0557667068702238
GOLDBERG-SHPRINTZEN SYNDROME	0.001486472	0.0557667068702238
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001486472	0.0557667068702238
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.001486472	0.0557667068702238
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001486472	0.0557667068702238
GIANT AXONAL NEUROPATHY	0.001486472	0.0557667068702238
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001486472	0.0557667068702238
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001486472	0.0557667068702238
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.001486472	0.0557667068702238
JOUBERT SYNDROME 27	0.001486472	0.0557667068702238
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.001486472	0.0557667068702238
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001486472	0.0557667068702238
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001486472	0.0557667068702238
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.001486472	0.0557667068702238
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001486472	0.0557667068702238
JOUBERT SYNDROME 7	0.001486472	0.0557667068702238
JOUBERT SYNDROME 15	0.001486472	0.0557667068702238
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001486472	0.0557667068702238
SIFRIM-HITZ-WEISS SYNDROME	0.001486472	0.0557667068702238
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001486472	0.0557667068702238
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001486472	0.0557667068702238
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001486472	0.0557667068702238
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001486472	0.0557667068702238
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001486472	0.0557667068702238
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.001486472	0.0557667068702238
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001486472	0.0557667068702238
PERIPHERAL HYPOTHYROIDISM	0.001486472	0.0557667068702238
LAMB-SHAFFER SYNDROME	0.001486472	0.0557667068702238
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001486472	0.0557667068702238
COFFIN-SIRIS SYNDROME 10; CSS10	0.001486472	0.0557667068702238
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001486472	0.0557667068702238
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001486472	0.0557667068702238
OPTIC ATROPHY 11; OPA11	0.001486472	0.0557667068702238
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.001486472	0.0557667068702238
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001486472	0.0557667068702238
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001486472	0.0557667068702238
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.001486472	0.0557667068702238
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001486472	0.0557667068702238
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.001486472	0.0557667068702238
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080245
MELNICK-NEEDLES SYNDROME	0.001287	0.04828328535080245
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001287	0.04828328535080245
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080245
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 5; MGORS5	0.001287	0.04828328535080245
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080245
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080245
CYSTIC FIBROSIS	0.001287	0.04828328535080245
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080245
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080245
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080245
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080245
ACROOSTEOLYSIS DOMINANT TYPE	0.001287	0.04828328535080245
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080245
PRUNE BELLY SYNDROME	0.001287	0.04828328535080245
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080245
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001287	0.04828328535080245
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080245
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080245
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080245
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 58; IMD58	0.001287	0.04828328535080245
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
SPINOCEREBELLAR ATAXIA TYPE 7	0.001287	0.04828328535080245
DIARRHEA 9; DIAR9	0.001287	0.04828328535080245
CATEL-MANZKE SYNDROME	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
MELORHEOSTOSIS	0.001287	0.04828328535080245
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080245
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080245
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080245
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080245
VALINEMIA	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080245
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001287	0.04828328535080245
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080245
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080245
PRIMARY PULMONARY HYPOPLASIA	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080245
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.001287	0.04828328535080245
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080245
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.001287	0.04828328535080245
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.001287	0.04828328535080245
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.001287	0.04828328535080245
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080245
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080245
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080245
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080245
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080245
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080245
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 3; MGORS3	0.001287	0.04828328535080245
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.001287	0.04828328535080245
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.001287	0.04828328535080245
BARTH SYNDROME; BTHS	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080245
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.001287	0.04828328535080245
ATYPICAL WERNER SYNDROME	0.001287	0.04828328535080245
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080245
MEIER-GORLIN SYNDROME 2; MGORS2	0.001287	0.04828328535080245
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080245
FREEMAN-SHELDON SYNDROME	0.001287	0.04828328535080245
PROGEROID SYNDROME, PETTY TYPE	0.001287	0.04828328535080245
PSEUDODIASTROPHIC DYSPLASIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001287	0.04828328535080245
ACTH-DEPENDENT CUSHING SYNDROME	0.001287	0.04828328535080245
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080245
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080245
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080245
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.001287	0.04828328535080245
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080245
BARBER-SAY SYNDROME	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080245
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080245
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.001287	0.04828328535080245
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.001287	0.04828328535080245
BRADDOCK SYNDROME	0.001287	0.04828328535080245
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080245
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080245
POPOV-CHANG SYNDROME; POPCHAS	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080245
HARDIKAR SYNDROME	0.001287	0.04828328535080245
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080245
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.001287	0.04828328535080245
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080245
OMENN SYNDROME	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080245
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001287	0.04828328535080245
OROTIC ACIDURIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080245
RAVINE SYNDROME	0.001287	0.04828328535080245
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080245
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001287	0.04828328535080245
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA TYPE 1	0.001287	0.04828328535080245
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001287	0.04828328535080245
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080245
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080245
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080245
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080245
CASPASE 8 DEFICIENCY	0.001287	0.04828328535080245
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.001287	0.04828328535080245
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.001287	0.04828328535080245
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080245
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080245
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080245
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080245
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080245
ISOTRETINOIN SYNDROME	0.00122699	0.046031941175276696
KENNEDY DISEASE	0.00122699	0.046031941175276696
FETAL METHYLMERCURY SYNDROME	0.00122699	0.046031941175276696
NON-DISTAL MONOSOMY 10Q	0.00122699	0.046031941175276696
TOLUENE EMBRYOPATHY	0.00122699	0.046031941175276696
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.046031941175276696
KEARNS-SAYRE SYNDROME	0.00122699	0.046031941175276696
IMAGE SYNDROME	0.00122699	0.046031941175276696
8Q12 MICRODUPLICATION SYNDROME	0.00122699	0.046031941175276696
CENTRAL CORE DISEASE	0.00122699	0.046031941175276696
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.046031941175276696
WAARDENBURG-SHAH SYNDROME	0.00122699	0.046031941175276696
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.046031941175276696
STVE-WIEDEMANN SYNDROME	0.00122699	0.046031941175276696
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.046031941175276696
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.046031941175276696
OPSISMODYSPLASIA	0.00122699	0.046031941175276696
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.046031941175276696
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00122699	0.046031941175276696
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.046031941175276696
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.046031941175276696
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.046031941175276696
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.046031941175276696
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.046031941175276696
ALG12-CDG	0.00122699	0.046031941175276696
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.046031941175276696
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.046031941175276696
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00122699	0.046031941175276696
TETRASOMY X	0.00122699	0.046031941175276696
ALG6-CDG	0.00122699	0.046031941175276696
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.046031941175276696
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.046031941175276696
ANTISYNTHETASE SYNDROME	0.00122699	0.046031941175276696
3Q13 MICRODELETION SYNDROME	0.00122699	0.046031941175276696
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00122699	0.046031941175276696
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.046031941175276696
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.046031941175276696
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.046031941175276696
14Q22Q23 MICRODELETION SYNDROME	0.00122699	0.046031941175276696
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00122699	0.046031941175276696
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.046031941175276696
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00122699	0.046031941175276696
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.046031941175276696
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.046031941175276696
B4GALT1-CDG	0.00122699	0.046031941175276696
COLE-CARPENTER SYNDROME	0.00122699	0.046031941175276696
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00122699	0.046031941175276696
THAKKER-DONNAI SYNDROME	0.00122699	0.046031941175276696
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.046031941175276696
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.046031941175276696
KYPHOMELIC DYSPLASIA	0.00122699	0.046031941175276696
INTESTINAL BOTULISM	0.00122699	0.046031941175276696
INFANT BOTULISM	0.00122699	0.046031941175276696
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00122699	0.046031941175276696
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00122699	0.046031941175276696
THYROID HEMIAGENESIS	0.00122699	0.046031941175276696
DIASTROPHIC DWARFISM	0.00122699	0.046031941175276696
ABETALIPOPROTEINEMIA	0.00122699	0.046031941175276696
COG7-CDG	0.00122699	0.046031941175276696
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00122699	0.046031941175276696
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.046031941175276696
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00122699	0.046031941175276696
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.046031941175276696
SPONASTRIME DYSPLASIA	0.00122699	0.046031941175276696
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.046031941175276696
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.046031941175276696
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.046031941175276696
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00122699	0.046031941175276696
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.046031941175276696
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.046031941175276696
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.046031941175276696
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.046031941175276696
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.046031941175276696
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.046031941175276696
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00122699	0.046031941175276696
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00122699	0.046031941175276696
CODAS SYNDROME	0.00122699	0.046031941175276696
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.046031941175276696
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00122699	0.046031941175276696
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00122699	0.046031941175276696
CRIGLER-NAJJAR SYNDROME TYPE 1	0.001066353	0.040005459350182015
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001066353	0.040005459350182015
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.001066353	0.040005459350182015
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001066353	0.040005459350182015
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.001066353	0.040005459350182015
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001066353	0.040005459350182015
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.001066353	0.040005459350182015
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001066353	0.040005459350182015
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350182015
ACROMELIC FRONTONASAL DYSPLASIA	0.001066353	0.040005459350182015
SJOGREN-LARSSON SYNDROME; SLS	0.001066353	0.040005459350182015
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001066353	0.040005459350182015
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001066353	0.040005459350182015
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001066353	0.040005459350182015
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001066353	0.040005459350182015
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001066353	0.040005459350182015
PHENYLKETONURIA	0.001066353	0.040005459350182015
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001066353	0.040005459350182015
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001066353	0.040005459350182015
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001066353	0.040005459350182015
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.001066353	0.040005459350182015
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001066353	0.040005459350182015
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001066353	0.040005459350182015
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001066353	0.040005459350182015
SCHIZENCEPHALY	0.001066353	0.040005459350182015
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.001066353	0.040005459350182015
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001066353	0.040005459350182015
GALACTOSIALIDOSIS	0.001066353	0.040005459350182015
EPILEPSY-TELANGIECTASIA SYNDROME	0.001066353	0.040005459350182015
WOLFRAM SYNDROME	0.001066353	0.040005459350182015
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001066353	0.040005459350182015
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001066353	0.040005459350182015
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.001066353	0.040005459350182015
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.001066353	0.040005459350182015
ANGELMAN SYNDROME (TYPE 1)	0.001066353	0.040005459350182015
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001066353	0.040005459350182015
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.001066353	0.040005459350182015
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001066353	0.040005459350182015
AUTISM	0.001066353	0.040005459350182015
ACQUIRED PARTIAL LIPODYSTROPHY	0.001066353	0.040005459350182015
DERMOTRICHIC SYNDROME	0.001066353	0.040005459350182015
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001066353	0.040005459350182015
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001066353	0.040005459350182015
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.001066353	0.040005459350182015
DONNAI-BARROW SYNDROME	0.001066353	0.040005459350182015
GLUTATHIONE SYNTHETASE DEFICIENCY	0.001066353	0.040005459350182015
HENNEKAM SYNDROME	0.001066353	0.040005459350182015
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001066353	0.040005459350182015
611961 STEVENSON-CAREY SYNDROME	0.001066353	0.040005459350182015
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001066353	0.040005459350182015
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001066353	0.040005459350182015
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001066353	0.040005459350182015
COFFIN-SIRIS SYNDROME 5	0.001066353	0.040005459350182015
POTOCKI-SHAFFER SYNDROME	0.001066353	0.040005459350182015
ATYPICAL JUVENILE PARKINSONISM	0.001066353	0.040005459350182015
CYSTATHIONINURIA	0.001066353	0.040005459350182015
ANGELMAN SYNDROME (TYPE 2)	0.001066353	0.040005459350182015
LISSENCEPHALY 8; LIS8	0.001066353	0.040005459350182015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.001066353	0.040005459350182015
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 100	0.001066353	0.040005459350182015
ICHTHYOSIS AND MALE HYPOGONADISM	0.001066353	0.040005459350182015
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.001066353	0.040005459350182015
WAISMAN SYNDROME; WSMN	0.001066353	0.040005459350182015
PORENCEPHALY	0.001066353	0.040005459350182015
CEDNIK SYNDROME	0.001066353	0.040005459350182015
LISSENCEPHALY 1; LIS1	0.001066353	0.040005459350182015
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.001066353	0.040005459350182015
SMITH-FINEMAN-MYERS SYNDROME	0.001066353	0.040005459350182015
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001066353	0.040005459350182015
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001066353	0.040005459350182015
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001066353	0.040005459350182015
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.001066353	0.040005459350182015
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.001066353	0.040005459350182015
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.001066353	0.040005459350182015
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001066353	0.040005459350182015
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001066353	0.040005459350182015
224250 DYSMYELINATION WITH JAUNDICE	0.001066353	0.040005459350182015
NETHERTON SYNDROME	0.001066353	0.040005459350182015
311450 PALLISTER W SYNDROME;;W SYNDROME	0.001066353	0.040005459350182015
LEUKOCYTE ADHESION DEFICIENCY	0.001066353	0.040005459350182015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001066353	0.040005459350182015
STURGE-WEBER SYNDROME	0.001066353	0.040005459350182015
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.001066353	0.040005459350182015
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.001066353	0.040005459350182015
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001066353	0.040005459350182015
INCONTINENTIA PIGMENTI; IP	0.001066353	0.040005459350182015
HYPERPROLINEMIA, TYPE II	0.001066353	0.040005459350182015
17Q11.2 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.001066353	0.040005459350182015
PRIMARY CUTIS VERTICIS GYRATA	0.001066353	0.040005459350182015
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.001066353	0.040005459350182015
MENTAL RETARDATION, FRA12A TYPE	0.001066353	0.040005459350182015
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.001066353	0.040005459350182015
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.001066353	0.040005459350182015
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001066353	0.040005459350182015
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.001066353	0.040005459350182015
MOYAMOYA DISEASE	0.001066353	0.040005459350182015
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001066353	0.040005459350182015
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.001066353	0.040005459350182015
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001066353	0.040005459350182015
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.001066353	0.040005459350182015
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001066353	0.040005459350182015
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.001066353	0.040005459350182015
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.001066353	0.040005459350182015
L1 SYNDROME	0.001066353	0.040005459350182015
MULTIPLE SULFATASE DEFICIENCY	0.001066353	0.040005459350182015
CEREBROTENDINOUS XANTHOMATOSIS	0.001066353	0.040005459350182015
XP21 MICRODELETION SYNDROME	0.001066353	0.040005459350182015
MICROPHTHALMIA, LENZ TYPE	0.001066353	0.040005459350182015
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.001066353	0.040005459350182015
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.001066353	0.040005459350182015
OCULODENTODIGITAL DYSPLASIA	0.001066353	0.040005459350182015
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001066353	0.040005459350182015
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.001066353	0.040005459350182015
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.001066353	0.040005459350182015
KBG SYNDROME	0.001066353	0.040005459350182015
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001066353	0.040005459350182015
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350182015
TYROSINEMIA TYPE 2	0.001066353	0.040005459350182015
ASPARTYLGLUCOSAMINURIA	0.001066353	0.040005459350182015
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001066353	0.040005459350182015
WYBURN-MASON SYNDROME	0.001066353	0.040005459350182015
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001066353	0.040005459350182015
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.001066353	0.040005459350182015
BETA-MANNOSIDOSIS	0.001066353	0.040005459350182015
AYME-GRIPP SYNDROME; AYGRP	0.001066353	0.040005459350182015
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.040005459350182015
17Q12 MICRODELETION SYNDROME	0.001066353	0.040005459350182015
17Q12 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350182015
EPILEPSY-TELANGIECTASIA	0.001066353	0.040005459350182015
GURRIERI SYNDROME	0.001066353	0.040005459350182015
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001066353	0.040005459350182015
FOUNTAIN SYNDROME	0.001066353	0.040005459350182015
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001066353	0.040005459350182015
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001066353	0.040005459350182015
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001066353	0.040005459350182015
SUPRABULBAR PARESIS, CONGENITAL	0.001066353	0.040005459350182015
SRD5A3-CDG	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.001066353	0.040005459350182015
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 82	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.001066353	0.040005459350182015
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.001066353	0.040005459350182015
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.001066353	0.040005459350182015
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001066353	0.040005459350182015
RECOMBINANT 8 SYNDROME	0.001066353	0.040005459350182015
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001066353	0.040005459350182015
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 96; MRX96	0.001066353	0.040005459350182015
STURGE-WEBER SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 88	0.001066353	0.040005459350182015
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001066353	0.040005459350182015
HEREDITARY HYPEREKPLEXIA	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001066353	0.040005459350182015
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.001066353	0.040005459350182015
ZLOTOGORA-OGUR SYNDROME	0.001066353	0.040005459350182015
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001066353	0.040005459350182015
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001066353	0.040005459350182015
TETRASOMY 18P	0.001066353	0.040005459350182015
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.001066353	0.040005459350182015
PAPILLORENAL SYNDROME	0.001066353	0.040005459350182015
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001066353	0.040005459350182015
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 72	0.001066353	0.040005459350182015
CONGENITAL HYDROCEPHALUS	0.001066353	0.040005459350182015
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001066353	0.040005459350182015
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001066353	0.040005459350182015
CROUZON SYNDROME	0.001066353	0.040005459350182015
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.001066353	0.040005459350182015
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.001066353	0.040005459350182015
COCKAYNE SYNDROME A; CSA	0.001066353	0.040005459350182015
CROME SYNDROME	0.001066353	0.040005459350182015
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001066353	0.040005459350182015
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001066353	0.040005459350182015
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001066353	0.040005459350182015
ATYPICAL RETT SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.001066353	0.040005459350182015
RUVALCABA SYNDROME	0.001066353	0.040005459350182015
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001066353	0.040005459350182015
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.001066353	0.040005459350182015
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001066353	0.040005459350182015
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001066353	0.040005459350182015
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001066353	0.040005459350182015
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001066353	0.040005459350182015
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350182015
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001066353	0.040005459350182015
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001066353	0.040005459350182015
KIFAFA SEIZURE DISORDER	0.001066353	0.040005459350182015
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001066353	0.040005459350182015
BARAITSER-WINTER SYNDROME 2; BRWS2	0.001066353	0.040005459350182015
GENITOPATELLAR SYNDROME	0.001066353	0.040005459350182015
IMMUNODEFICIENCY 47	0.001066353	0.040005459350182015
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.001066353	0.040005459350182015
SANJAD-SAKATI SYNDROME	0.001066353	0.040005459350182015
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.001066353	0.040005459350182015
MENTAL RETARDATION, X-LINKED 103	0.001066353	0.040005459350182015
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001066353	0.040005459350182015
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001066353	0.040005459350182015
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001066353	0.040005459350182015
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.03607320406343426
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.03607320406343426
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.03607320406343426
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0009615380000000001	0.03607320406343426
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
ETHANOLAMINOSIS	0.0009615380000000001	0.03607320406343426
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.03607320406343426
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	0.03607320406343426
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.03607320406343426
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.03607320406343426
SUSAC SYNDROME	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.03607320406343426
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.03607320406343426
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.03607320406343426
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.03607320406343426
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.03607320406343426
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.03607320406343426
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.03607320406343426
RIGID SPINE SYNDROME	0.0009615380000000001	0.03607320406343426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.03607320406343426
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.03607320406343426
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	0.03607320406343426
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.03607320406343426
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.03607320406343426
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.03607320406343426
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.03607320406343426
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.03607320406343426
CHITAYAT SYNDROME	0.0009615380000000001	0.03607320406343426
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.03607320406343426
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.03607320406343426
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.03607320406343426
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0009615380000000001	0.03607320406343426
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.03607320406343426
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.03607320406343426
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	0.03607320406343426
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA TYPE 29	0.0009615380000000001	0.03607320406343426
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.03607320406343426
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.03607320406343426
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0009615380000000001	0.03607320406343426
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.03607320406343426
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0009615380000000001	0.03607320406343426
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.03607320406343426
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.03607320406343426
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.03607320406343426
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.03607320406343426
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.03607320406343426
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.03607320406343426
SYDENHAM CHOREA	0.0009615380000000001	0.03607320406343426
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.03607320406343426
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.03607320406343426
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0009615380000000001	0.03607320406343426
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.03607320406343426
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0009615380000000001	0.03607320406343426
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.03607320406343426
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.03607320406343426
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 26	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 4	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.03607320406343426
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.03607320406343426
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.03607320406343426
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.03607320406343426
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.03607320406343426
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.03607320406343426
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.03607320406343426
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 25	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.03607320406343426
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.03607320406343426
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 24	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.03607320406343426
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.020311956543392476
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392476
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.020311956543392476
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
HYDRANENCEPHALY	0.000541419	0.020311956543392476
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392476
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
OPTIC PATHWAY GLIOMA	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
KBG SYNDROME	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.020311956543392476
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392476
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392476
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
HARTNUP DISORDER	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392476
PHACE ASSOCIATION	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392476
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020311956543392476
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392476
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
ROSA-DORFMAN DISEASE	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
CHDIAK-HIGASHI SYNDROME	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392476
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
ALG1-CDG	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392476
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392476
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392476
THUMB DEFORMITY AND ALOPECIA	0.000524934	0.01969350280678954
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000524934	0.01969350280678954
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.000524934	0.01969350280678954
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.01969350280678954
DISTAL MONOSOMY 10P	0.000524934	0.01969350280678954
TELECANTHUS	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000524934	0.01969350280678954
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.01969350280678954
CEREBROCOSTOMANDIBULAR SYNDROME	0.000524934	0.01969350280678954
LELIS SYNDROME	0.000524934	0.01969350280678954
CURRY-JONES SYNDROME	0.000524934	0.01969350280678954
DESBUQUOIS SYNDROME	0.000524934	0.01969350280678954
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000524934	0.01969350280678954
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000524934	0.01969350280678954
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.000524934	0.01969350280678954
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.000524934	0.01969350280678954
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000524934	0.01969350280678954
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000524934	0.01969350280678954
DYSSPONDYLOENCHONDROMATOSIS	0.000524934	0.01969350280678954
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
SPONDYLO-OCULAR SYNDROME	0.000524934	0.01969350280678954
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.01969350280678954
CEREBROFACIOTHORACIC DYSPLASIA	0.000524934	0.01969350280678954
CRANIODIAPHYSEAL DYSPLASIA	0.000524934	0.01969350280678954
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000524934	0.01969350280678954
ANE SYNDROME	0.000524934	0.01969350280678954
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.000524934	0.01969350280678954
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.000524934	0.01969350280678954
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.01969350280678954
OTOMANDIBULAR SYNDROME	0.000524934	0.01969350280678954
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.000524934	0.01969350280678954
FEINGOLD SYNDROME 2; FGLDS2	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.01969350280678954
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.000524934	0.01969350280678954
RUVALCABA SYNDROME	0.000524934	0.01969350280678954
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.000524934	0.01969350280678954
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.01969350280678954
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.01969350280678954
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.01969350280678954
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000524934	0.01969350280678954
SOTOS SYNDROME 3	0.000524934	0.01969350280678954
TOWNES-BROCKS SYNDROME 1; TBS1	0.000524934	0.01969350280678954
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.000524934	0.01969350280678954
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.000524934	0.01969350280678954
BASAL CELL NEVUS SYNDROME	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.01969350280678954
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.01969350280678954
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000524934	0.01969350280678954
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.01969350280678954
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.01969350280678954
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000524934	0.01969350280678954
RAHMAN SYNDROME	0.000524934	0.01969350280678954
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000524934	0.01969350280678954
CEREBELLOFACIODENTAL SYNDROME	0.000524934	0.01969350280678954
MECKEL SYNDROME 13; MKS13	0.000524934	0.01969350280678954
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000524934	0.01969350280678954
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.000524934	0.01969350280678954
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000524934	0.01969350280678954
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.01969350280678954
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000524934	0.01969350280678954
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000524934	0.01969350280678954
8P23.1 DUPLICATION SYNDROME	0.000524934	0.01969350280678954
NF1-MICRODELETION SYNDROME	0.000524934	0.01969350280678954
CRI DU CHAT SYNDROME (5P DELETION)	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000524934	0.01969350280678954
WILLIAMS-BEUREN SYNDROME (WBS)	0.000524934	0.01969350280678954
22Q11 DUPLICATION SYNDROME	0.000524934	0.01969350280678954
WAGR 11P13 DELETION SYNDROME	0.000524934	0.01969350280678954
8P23.1 DELETION SYNDROME	0.000524934	0.01969350280678954
CHROMOSOME 15Q14 DELETION SYNDROME	0.000524934	0.01969350280678954
CAT-EYE SYNDROME (TYPE I)	0.000524934	0.01969350280678954
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.01969350280678954
LIG4 SYNDROME	0.000524934	0.01969350280678954
2Q37 MONOSOMY	0.000524934	0.01969350280678954
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000524934	0.01969350280678954
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000524934	0.01969350280678954
MYOTONIA PERMANENS	0.000524934	0.01969350280678954
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000524934	0.01969350280678954
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000524934	0.01969350280678954
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.01969350280678954
ATR-16 SYNDROME	0.000524934	0.01969350280678954
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.01969350280678954
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.01969350280678954
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA TYPE 2	0.000524934	0.01969350280678954
2P15-16.1 MICRODELETION SYNDROME	0.000524934	0.01969350280678954
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000524934	0.01969350280678954
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000524934	0.01969350280678954
FRONTONASAL DYSPLASIA 1; FND1	0.000524934	0.01969350280678954
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000524934	0.01969350280678954
MEGALENCEPHALY	0.000524934	0.01969350280678954
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000524934	0.01969350280678954
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000524934	0.01969350280678954
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000524934	0.01969350280678954
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000524934	0.01969350280678954
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.01969350280678954
WAARDENBURG SYNDROME TYPE 3	0.000524934	0.01969350280678954
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.01969350280678954
HEMIFACIAL MICROSOMIA	0.000524934	0.01969350280678954
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.000524934	0.01969350280678954
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000524934	0.01969350280678954
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000524934	0.01969350280678954
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000524934	0.01969350280678954
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.01969350280678954
BAMFORTH-LAZARUS SYNDROME	0.000524934	0.01969350280678954
BJRNSTAD SYNDROME	0.000524934	0.01969350280678954
BARTSOCAS-PAPAS SYNDROME	0.000524934	0.01969350280678954
APERT SYNDROME	0.000524934	0.01969350280678954
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000524934	0.01969350280678954
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.01969350280678954
OROFACIODIGITAL SYNDROME V; OFD5	0.000524934	0.01969350280678954
FEINGOLD SYNDROME	0.000524934	0.01969350280678954
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000524934	0.01969350280678954
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.01969350280678954
FRAXE INTELLECTUAL DISABILITY	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.01969350280678954
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000524934	0.01969350280678954
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.000524934	0.01969350280678954
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000524934	0.01969350280678954
ACRODYSOSTOSIS	0.000524934	0.01969350280678954
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.01969350280678954
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
HOLOPROSENCEPHALY 3; HPE3	0.000524934	0.01969350280678954
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000524934	0.01969350280678954
HYPOCHONDROPLASIA	0.000524934	0.01969350280678954
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000524934	0.01969350280678954
NEPHRONOPHTHISIS 18; NPHP18	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000524934	0.01969350280678954
FIBULAR HEMIMELIA	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000524934	0.01969350280678954
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.000524934	0.01969350280678954
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000524934	0.01969350280678954
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000524934	0.01969350280678954
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000524934	0.01969350280678954
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000524934	0.01969350280678954
MICROPHTHALMIA, SYNDROMIC 12	0.000524934	0.01969350280678954
LARYNGEAL ABDUCTOR PARALYSIS	0.000524934	0.01969350280678954
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000524934	0.01969350280678954
STICKLER SYNDROME TYPE 1	0.000524934	0.01969350280678954
SECKEL SYNDROME 8; SCKL8	0.000524934	0.01969350280678954
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.01969350280678954
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.000524934	0.01969350280678954
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.01969350280678954
LYSINE MALABSORPTION SYNDROME	0.000524934	0.01969350280678954
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000524934	0.01969350280678954
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.01969350280678954
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.01969350280678954
245800 LAURENCE-MOON SYNDROME	0.000524934	0.01969350280678954
LAMBERT SYNDROME	0.000524934	0.01969350280678954
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.000524934	0.01969350280678954
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000524934	0.01969350280678954
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000524934	0.01969350280678954
MICROPHTHALMIA, SYNDROMIC 4	0.000524934	0.01969350280678954
RICHARDS-RUNDLE SYNDROME; RRNS	0.000524934	0.01969350280678954
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.000524934	0.01969350280678954
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000524934	0.01969350280678954
MASA SYNDROME	0.000524934	0.01969350280678954
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.01969350280678954
KID SYNDROME	0.000524934	0.01969350280678954
3MC SYNDROME 3	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000524934	0.01969350280678954
CHROMOSOME XP11.3 DELETION SYNDROME	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 63	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 84	0.000524934	0.01969350280678954
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000524934	0.01969350280678954
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 92	0.000524934	0.01969350280678954
BRUNNER SYNDROME; BRNRS	0.000524934	0.01969350280678954
MCDONOUGH SYNDROME	0.000524934	0.01969350280678954
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000524934	0.01969350280678954
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.000524934	0.01969350280678954
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000524934	0.01969350280678954
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.01969350280678954
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.01969350280678954
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.01969350280678954
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.01969350280678954
N SYNDROME	0.000524934	0.01969350280678954
COWCHOCK SYNDROME; COWCK	0.000524934	0.01969350280678954
OPTIC ATROPHY 2	0.000524934	0.01969350280678954
PROTEUS-LIKE SYNDROME	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.000524934	0.01969350280678954
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.000524934	0.01969350280678954
HYDROXYPROLINEMIA	0.000524934	0.01969350280678954
SCARF SYNDROME	0.000524934	0.01969350280678954
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000524934	0.01969350280678954
3MC SYNDROME	0.000524934	0.01969350280678954
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.01969350280678954
HOMOCARNOSINOSIS	0.000524934	0.01969350280678954
VAN DEN BOSCH SYNDROME	0.000524934	0.01969350280678954
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.000524934	0.01969350280678954
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000524934	0.01969350280678954
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.01969350280678954
IMINOGLYCINURIA	0.000524934	0.01969350280678954
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.01969350280678954
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.000524934	0.01969350280678954
FOCAL DERMAL HYPOPLASIA; FDH	0.000524934	0.01969350280678954
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.01969350280678954
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.000524934	0.01969350280678954
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.000524934	0.01969350280678954
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.000524934	0.01969350280678954
PTEN HAMARTOMA TUMOR SYNDROME	0.000524934	0.01969350280678954
WOODHOUSE-SAKATI SYNDROME	0.000524934	0.01969350280678954
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.000524934	0.01969350280678954
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.01969350280678954
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000524934	0.01969350280678954
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.01969350280678954
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000524934	0.01969350280678954
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.01969350280678954
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.000524934	0.01969350280678954
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.000524934	0.01969350280678954
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000524934	0.01969350280678954
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000524934	0.01969350280678954
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.01969350280678954
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.01969350280678954
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000524934	0.01969350280678954
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.01969350280678954
ALDH18A1-RELATED DE BARSY SYNDROME	0.000524934	0.01969350280678954
HYPOCHONDROPLASIA	0.000524934	0.01969350280678954
X-LINKED ADRENOLEUKODYSTROPHY	0.000524934	0.01969350280678954
COENZYME Q10 DEFICIENCY	0.000524934	0.01969350280678954
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.000524934	0.01969350280678954
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000524934	0.01969350280678954
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.01969350280678954
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000524934	0.01969350280678954
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000524934	0.01969350280678954
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.01969350280678954
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.000524934	0.01969350280678954
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.01969350280678954
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000524934	0.01969350280678954
3MC SYNDROME 2	0.000524934	0.01969350280678954
GORLIN SYNDROME	0.000524934	0.01969350280678954
OROFACIODIGITAL SYNDROME III	0.000524934	0.01969350280678954
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000524934	0.01969350280678954
OLIVER SYNDROME	0.000524934	0.01969350280678954
OCULORENOCEREBELLAR SYNDROME	0.000524934	0.01969350280678954
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.000524934	0.01969350280678954
RODRIGUES BLINDNESS	0.000524934	0.01969350280678954
SACCHAROPINURIA	0.000524934	0.01969350280678954
OCULOPALATOCEREBRAL SYNDROME	0.000524934	0.01969350280678954
SONODA SYNDROME	0.000524934	0.01969350280678954
PENDRED SYNDROME	0.000524934	0.01969350280678954
ATTENUATED CHDIAK-HIGASHI SYNDROME	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 16, X-LINKED	0.000524934	0.01969350280678954
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.01969350280678954
VAN DEN BOSCH SYNDROME	0.000524934	0.01969350280678954
VACTERL WITH HYDROCEPHALUS	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.01969350280678954
NIJMEGEN BREAKAGE SYNDROME	0.000524934	0.01969350280678954
JAWAD SYNDROME	0.000524934	0.01969350280678954
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.000524934	0.01969350280678954
MICROCEPHALY-CARDIOMYOPATHY	0.000524934	0.01969350280678954
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.01969350280678954
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000524934	0.01969350280678954
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.01969350280678954
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000524934	0.01969350280678954
WEISMANN-NETTER SYNDROME	0.000524934	0.01969350280678954
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.01969350280678954
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.01969350280678954
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.01969350280678954
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000524934	0.01969350280678954
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000524934	0.01969350280678954
DE SANCTIS-CACCHIONE SYNDROME	0.000524934	0.01969350280678954
MMEP SYNDROME	0.000524934	0.01969350280678954
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.000524934	0.01969350280678954
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.000524934	0.01969350280678954
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000524934	0.01969350280678954
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.000524934	0.01969350280678954
CHANARIN-DORFMAN SYNDROME	0.000524934	0.01969350280678954
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.01969350280678954
T-SUBSTANCE ANOMALY	0.000524934	0.01969350280678954
TYROSINE TRANSAMINASE DEFICIENCY	0.000524934	0.01969350280678954
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.000524934	0.01969350280678954
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000524934	0.01969350280678954
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.000524934	0.01969350280678954
ISOLATED BRACHYCEPHALY	0.000524934	0.01969350280678954
ISOLATED PLAGIOCEPHALY	0.000524934	0.01969350280678954
PROPIONIC ACIDEMIA	0.000524934	0.01969350280678954
MUCOLIPIDOSIS III ALPHA/BETA	0.000524934	0.01969350280678954
MORQUIO SYNDROME C	0.000524934	0.01969350280678954
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.01969350280678954
LEBER OPTIC ATROPHY AND DYSTONIA	0.000524934	0.01969350280678954
CONGENITAL VARICELLA SYNDROME	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.01969350280678954
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000524934	0.01969350280678954
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.01969350280678954
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.01969350280678954
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.000524934	0.01969350280678954
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000524934	0.01969350280678954
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.000524934	0.01969350280678954
CAHMR SYNDROME	0.000524934	0.01969350280678954
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000524934	0.01969350280678954
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.01969350280678954
DYSTONIA 16	0.000524934	0.01969350280678954
IRIDA SYNDROME	0.000524934	0.01969350280678954
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000524934	0.01969350280678954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000524934	0.01969350280678954
BIEMOND SYNDROME II	0.000524934	0.01969350280678954
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000524934	0.01969350280678954
HYDROXYKYNURENINURIA	0.000524934	0.01969350280678954
GEMIGNANI SYNDROME	0.000524934	0.01969350280678954
CEPHALIN LIPIDOSIS	0.000524934	0.01969350280678954
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000524934	0.01969350280678954
HYPERTRICHOSIS CUBITI	0.000524934	0.01969350280678954
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.000524934	0.01969350280678954
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000524934	0.01969350280678954
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.01969350280678954
USHER SYNDROME TYPE 1	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.000524934	0.01969350280678954
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.01969350280678954
ARGININOSUCCINIC ACIDURIA	0.000524934	0.01969350280678954
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.01969350280678954
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000524934	0.01969350280678954
ICF SYNDROME	0.000524934	0.01969350280678954
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.01969350280678954
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.000524934	0.01969350280678954
CHARGE SYNDROME	0.000524934	0.01969350280678954
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000524934	0.01969350280678954
PROLIDASE DEFICIENCY	0.000524934	0.01969350280678954
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.01969350280678954
BEHR SYNDROME	0.000524934	0.01969350280678954
FLOATING-HARBOR SYNDROME	0.000524934	0.01969350280678954
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.01969350280678954
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.01969350280678954
DYSOSTEOSCLEROSIS	0.000524934	0.01969350280678954
FRONTONASAL DYSPLASIA 2; FND2	0.000524934	0.01969350280678954
GILLESPIE SYNDROME; GLSP	0.000524934	0.01969350280678954
MEDNIK SYNDROME	0.000524934	0.01969350280678954
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.01969350280678954
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000524934	0.01969350280678954
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000524934	0.01969350280678954
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.01969350280678954
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000524934	0.01969350280678954
TRISOMY 12P	0.000524934	0.01969350280678954
ALPHA-METHYLACETOACETIC ACIDURIA	0.000524934	0.01969350280678954
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000524934	0.01969350280678954
CHROMOSOME 13Q14 DELETION SYNDROME	0.000524934	0.01969350280678954
AGENESIS OF CEREBRAL WHITE MATTER	0.000524934	0.01969350280678954
DERMATOLEUKODYSTROPHY	0.000524934	0.01969350280678954
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000524934	0.01969350280678954
207790 ARACHNOID CYSTS, INTRACRANIAL	0.000524934	0.01969350280678954
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000524934	0.01969350280678954
PHENOBARBITAL EMBRYOPATHY	0.000524934	0.01969350280678954
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.000524934	0.01969350280678954
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.000524934	0.01969350280678954
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.01969350280678954
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.000524934	0.01969350280678954
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000524934	0.01969350280678954
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.000524934	0.01969350280678954
FETAL IODINE SYNDROME	0.000524934	0.01969350280678954
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.000524934	0.01969350280678954
EEC SYNDROME	0.000524934	0.01969350280678954
OROFACIODIGITAL SYNDROME XI; OFD11	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.01969350280678954
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.000524934	0.01969350280678954
LOWRY-WOOD SYNDROME	0.000524934	0.01969350280678954
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.000524934	0.01969350280678954
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.000524934	0.01969350280678954
JUBERG-HAYWARD SYNDROME	0.000524934	0.01969350280678954
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.000524934	0.01969350280678954
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000524934	0.01969350280678954
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.000524934	0.01969350280678954
OSTEOPETROSIS AND RELATED DISORDERS	0.000524934	0.01969350280678954
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.01969350280678954
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000524934	0.01969350280678954
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.000524934	0.01969350280678954
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000524934	0.01969350280678954
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000524934	0.01969350280678954
FETAL IODINE DEFICIENCY DISORDER	0.000524934	0.01969350280678954
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000524934	0.01969350280678954
MONILETHRIX	0.000524934	0.01969350280678954
OCULOFACIOCARDIODENTAL SYNDROME	0.000524934	0.01969350280678954
MUCOPOLYSACCHARIDOSIS TYPE 1	0.000524934	0.01969350280678954
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000524934	0.01969350280678954
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000524934	0.01969350280678954
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000524934	0.01969350280678954
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.01969350280678954
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.000524934	0.01969350280678954
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.000524934	0.01969350280678954
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.01969350280678954
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.000524934	0.01969350280678954
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.000524934	0.01969350280678954
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.000524934	0.01969350280678954
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000524934	0.01969350280678954
LOWRY-MACLEAN SYNDROME	0.000524934	0.01969350280678954
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000524934	0.01969350280678954
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.000524934	0.01969350280678954
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.01969350280678954
PFEIFFER-PALM-TELLER SYNDROME	0.000524934	0.01969350280678954
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.000524934	0.01969350280678954
GERODERMA OSTEODYSPLASTICUM; GO	0.000524934	0.01969350280678954
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000524934	0.01969350280678954
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000524934	0.01969350280678954
CONE-ROD DYSTROPHY 1; CORD1	0.000524934	0.01969350280678954
GLUTATHIONURIA	0.000524934	0.01969350280678954
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
RHOMBENCEPHALOSYNAPSIS	0.000524934	0.01969350280678954
16P13.11 MICRODUPLICATION SYNDROME	0.000524934	0.01969350280678954
TRISOMY 9P	0.000524934	0.01969350280678954
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000524934	0.01969350280678954
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.000524934	0.01969350280678954
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.01969350280678954
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.01969350280678954
ACROGERIA	0.000524934	0.01969350280678954
DEAFNESS AND MYOPIA; DFNMYP	0.000524934	0.01969350280678954
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000524934	0.01969350280678954
FRONTONASAL DYSPLASIA	0.000524934	0.01969350280678954
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.01969350280678954
MASA SYNDROME	0.000524934	0.01969350280678954
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000524934	0.01969350280678954
CYSTEINE PEPTIDURIA	0.000524934	0.01969350280678954
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.01969350280678954
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.01969350280678954
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000524934	0.01969350280678954
PENDRED SYNDROME	0.000524934	0.01969350280678954
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000524934	0.01969350280678954
DERMATOLEUKODYSTROPHY	0.000524934	0.01969350280678954
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000524934	0.01969350280678954
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000524934	0.01969350280678954
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.000524934	0.01969350280678954
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000524934	0.01969350280678954
N SYNDROME	0.000524934	0.01969350280678954
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.01969350280678954
MIETENS SYNDROME	0.000524934	0.01969350280678954
ENCEPHALOMALACIA, MULTILOCULAR	0.000524934	0.01969350280678954
ELLIS-VAN CREVELD SYNDROME	0.000524934	0.01969350280678954
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.000524934	0.01969350280678954
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.01969350280678954
DIBASIC AMINO ACIDURIA I	0.000524934	0.01969350280678954
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000524934	0.01969350280678954
CREE MENTAL RETARDATION SYNDROME	0.000524934	0.01969350280678954
HURLER SYNDROME	0.000524934	0.01969350280678954
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.000524934	0.01969350280678954
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.000524934	0.01969350280678954
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000524934	0.01969350280678954
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.01969350280678954
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.01969350280678954
